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 For several decades a great number of researchers worldwide are trying to mimic the 
mineral phase of bone in order to enhance bone regeneration and formation. It has been 
shown that the mineral phase of bone is composed by calcium phosphate crystals and several 
ions such as, fluoride, carbonate, magnesium, sodium and silicon. In 1970´s Carlisle and 
Schwarz demonstrated the positive effect of silicon on bone mineralization. Therefore, to 
combine the positive effect of silicon and the bioactive properties of hydroxyapatite (HA), a 
calcium phosphate with a similar chemical and structural composition to the inorganic phase 
of bone, a new biomaterial was developed, silicon-substituted hydroxyapatite (Si-HA). It has 
been shown that this material enhances bone apposition/ingrowth in vivo when compared to 
HA. However, the complexity of the in vivo model does not allow the full understanding of 
the mechanism behind this enhanced bioactivity. Therefore, the in vitro testing has been 
chosen as a model and the most important steps have been studied.  
This thesis was designed to address the following aspects; the effect of the 
incorporation of silicon into the HA lattice, (i) on a physical-chemical point of view; (ii) 
interaction of Si-HA material with different solutions: tris-hydroxymethyl amino-methane 
buffer, simulated body fluid (SBF), SBF with human serum proteins; (iii) adhesion of 
different proteins: albumin and imunoglobulin that are important components of the 
adsorption layer at the surface of an implanted material, and also collagen type I that can be 
defined as “a structural protein of the extracellular matrix” and finally, (iv) to study the effect 
of silicon incorporation on the adhesion, proliferation and differentiation of two types of 
human cells, osteoblasts and osteoclasts. 
On a chemical and structural point of view the incorporation of silicon into the HA 
structure resulted in a decrease on the surface charge of the material towards more negative 
values and also a slight increase on the hydrophilicity of the material was observed. XPS and 
FTIR results clearly support the substitution mechanism proposed by Gibson et al for Si-HA. 
Vibrational wavelength of 888 cm-1 and 504 cm-1 indicate the presence of SiO44- and the 
binding energy of silicon at 101 eV corresponds to (Si-O) bonding. The XPS and EDX results 
showed that silicon is preferential released from the Si-HA material. The FTIR spectra also 
demonstrated a decrease on the intensity of the OH- band, being a direct result of the 
substitution of the phosphate groups by the silicate groups and the loss of hydroxyl groups 
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due to a charge balance. After incubation in SBF an apatite layer was formed on the surface of 
Si-HA earlier than on unmodified HA. The more electronegative Si-HA surface provides a 
preferential site for the nucleation of an amorphous calcium phosphate apatite layer than the 
HA surface. This phenomenon may occur via the adsorption of calcium (Ca2+) ions onto the 
electronegative surface, resulting on an increase in surface charge and the attraction of 
phosphate groups (PO43-), also combined with a faster supersaturation of SBF due the higher 
dissolution rate of Si-HA. The presence of human serum proteins delayed the formation of 
this layer. The proteinaceous layer acted as a barrier to the dissolution and diffusion of ions 
from the surface to the surrounding medium.  
The 0.8 wt % Si-HA material showed to have a higher binding affinity to human 
serum proteins, when compared to HA and 1.5 wt % Si-HA. In the case of a single protein 
solution a relation between collagen adhesion and silicon content was observed. The 1.5 wt % 
Si-HA substrate showed to have higher binding affinity per area to this protein. 
The human osteoblast seeded on the Si-HA material proliferated and expressed 
different osteoblastic markers. The cells responded differently to the two compositions of Si-
HA. The cells seeded on 0.8 wt % Si-HA surface had a higher rate of proliferation and 
increased production of proteins. While in the case of 1.5 wt % Si-HA a higher ALP 
production at early time points was observed, indicating that the cells were more 
differentiated. After 21 days calcium phosphate deposits were observed on the surface of HA 
and Si-HA.  
The Si-HA material allowed the differentiation of osteoclast precursors (peripheral 
mononuclear cells and monocytes CD 14 positive) to mature osteoclasts. These cells 
expressed the typical osteoclast markers: actin rings, several nuclei, expressed TRAP and 
presented vitronectin receptors. On the samples seeded with osteoclasts significant differences 
on the concentration of calcium and phosphorous in the medium were observed, indicating 
that the osteoclasts were active and resorbing, especially on 1.5 wt % Si-HA. 
The results obtained during these studies showed that the enhanced bioactivity of the 
Si-HA is a combination of acellular and cellular mechanisms. The more negative surface and 
higher dissolution rate decreases the time required for the formation of an apatite layer, which 
is considered to be an important factor for osteointegration. And also the enhanced 
proliferation and differentiation of bone cells (human osteoblast and osteoclast) induced by 
the presence of Si-HA can lead to faster bone regeneration.  
 
 





 Inúmeros investigadores, desde há várias décadas, têm tentado desenvolver materiais 
semelhantes à fase inorgânica do osso, de forma a aumentar a regeneração óssea. A fase 
mineral do osso é composta por fosfatos de cálcio e diversos iões tais como: flúor, magnésio, 
carbonato, sódio e silício. Na década de 70 Carlisle e Schwarz demonstraram o efeito positivo 
do silício na mineralização óssea. Combinando o efeito positivo do silício e as propriedades 
bioactivas da hidroxiapatite (HA) um novo material foi desenvolvido, a hidroxiapatite 
modificada com silício (Si-HA). Os estudos in vivo demonstraram que este biomaterial 
aumenta a regeneração óssea. A complexidade do modelo in vivo não permite a determinação 
do mecanismo subjacente à sua bioactividade, daí a necessidade de estudar as diversas 
componentes deste sistema num sistema in vitro.  
Esta tese foi estruturada com o objectivo de se estudar os aspectos relevantes na 
osteointegração in vivo da Si-HA, através de diversos ensaios in vitro, nomeadamente: (i) o 
efeito da incorporação de silício na malha da HA de um ponto de vista físico-químico; (ii) a 
interacção da Si-HA com diferentes soluções: tris-hidroximetil amino-metano, solução 
fisiológica simulada (SFS), SFS com proteínas do soro humano; (iii) adsorção de diferentes 
proteínas: albumina e imunoglobulina que são importantes componentes da camada de 
proteínas que adere ao material assim que este é implantado e colagénio tipo I que é definido 
com uma proteína estrutural da matriz extracelular. Por último, (iv) estudar o efeito da 
incorporação do silício na adesão, proliferação e diferenciação de dois tipos de células 
humanas, os osteoblastos e os osteoclastos.  
Do ponto de vista físico-químico, a incorporação de silício na estrutura de HA resulta 
na diminuição da carga superficial do material (valores mais negativos) e num pequeno 
aumento da sua hidrofilicidade. Os resultados de espectroscopia de fotoelectrões de raios -X e 
espectroscopia de infravermelho suportam claramente o mecanismo de substituição proposto 
por Gibson et al. Os comprimentos de onda a 888 cm-1 e 504 cm-1 indicam a presença de 
SiO44- e a energia de ligação a 101 eV correspondente à ligação (Si-O). As análises de 
espectroscopia de fotoelectrões de raio-X e energia dispersiva de raio-X demonstraram que o 
silício é preferencialmente dissolvido do material para o meio. As análises de infravermelho 
também demonstraram uma diminuição na intensidade da banda correspondente ao grupo 
hidroxilo, sendo este resultado uma consequência directa do mecanismo de substituição dos 
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grupos fosfatos pelos grupos silicatos e da perda de alguns grupos hidroxilo devido ao 
balanço de carga.  
Nos ensaios de imersão em SFS, o tempo necessário para a formação de uma camada 
de apatite na superfície da Si-HA é menor em comparação com HA. A superfície mais 
negativa da Si-HA fornece um local preferencial para a nucleação de uma camada amorfa de 
fosfatos de cálcio, através da adsorção de iões cálcio (Ca2+), resultando num aumento da carga 
superficial e consequente atracção de grupos fosfato (PO43-). Adicionalmente, a sua cinética 
de dissolução resulta numa mais rápida supersaturação da solução de SFS, conduzindo à 
precipitação de fosfatos de cálcio. A presença de proteínas do soro humano atrasa a formação 
da camada de apatite, uma vez que protege a sua superfície, actuando como uma barreira à 
dissolução e difusão dos iões da superfície do material para o meio.  
A incorporação de 0,8 % (p/p) de silício na malha da HA aumenta a adsorção de 
proteínas do soro humano por unidade de área, quando comparada com HA e 1,5 % (p/p) Si-
HA. O colagénio tipo I tem maior afinidade para 1,5 % (p/p) Si-HA.  
Os osteoblastos humanos aderiram, proliferaram e diferenciaram-se na superfície do 
Si-HA, contudo, as células responderam de forma diferente às duas composições. As células 
cultivadas na superfície de 0,8 % (p/p) Si-HA proliferaram mais rapidamente e produziram 
níveis mais elevados de proteínas enquanto que, no caso de 1,5 % (p/p) Si-HA as células 
apresentam maior actividade de fosfatase alcalina, indicando um estádio de maior 
diferenciação. Após 21 dias, observou-se a formação de fosfatos de cálcio na superfície de 
HA e nas duas composições de Si-HA.  
A Si-HA permitiu a diferenciação de percursores de osteoclastos (células 
mononucleares do sangue e monócitos CD 14 positivos). As células apresentaram as 
características típicas de osteoclastos: anéis de actina, vários núcleos, receptores para 
vitronectina e expressaram TRAP. Nos materiais cultivados com osteoclastos, a concentração 
de cálcio e fósforo libertado da superfície de Si-HA para meio foi significativamente maior 
em comparação com HA, sendo este efeito mais evidente na Si-HA com 1,5 % (p/p) de Si, 
indicando que os osteoclastos estavam mais activos. 
Os resultados obtidos indicam que a elevada bioactividade da Si-HA material se deve 
à combinação de mecanismos celulares e acelulares. A superfície mais electronegativa 
diminui o tempo necessário para formação da camada de apatite, sendo este factor 
considerado importante na osteointegração do material in vivo. A incorporação de silício na 
HA teve um efeito positivo na produção de proteínas e diferenciação de osteoblastos, assim 
como na diferenciação e actividade de osteoclastos.  




Depuis plusieurs dizaines d’années, les rechercheurs essaient de développer des 
matériaux qui puissent se ressembler à la phase inorganique de l’os, pour augmenter la 
régénération osseuse. Il a déjà été démontré que la phase minérale de l’os est composée de 
phosphates de calcium, et aussi de plusieurs ions comme le fluorure, le magnésium, le 
carbonate, le sodium et le silicium. Dans les années 70 Carlisle et Schwarz ont démontré 
l’éfect positif du silicium dans le procès de minéralisation osseuse. De cette façon, en 
combinant l’éfect positif du silicium et les propriétés bioactives de l’hidroxiapatite (HA), un 
nouveau matériel a été developé, l´hidroxiapatite modifiée au silicium (Si-HA). Des études en 
des conditions in vivo ont prouvé que ce matériel augmente la régénération de l’os. La 
complexité du modèle in vivo ne permet pas de déterminer le mécanisme derrière sa 
bioactivité. Donc le système in vivo a´-t- été divisé dans plusieurs étapes in vitro.  
Cette thèse a-t-été structurée avec l’objectif d’étudier les aspects les plus relevants 
agissant sur l’osteointégration in vivo, en utilisant des essais in vitro, en particulier : (i) l’éffet 
de l'íntégration de silicium dans le réseau de l’hidroxiapatite d’un point de vue physico-
chimique ; (ii) l’interaction de Si–HA avec plusieurs solutions : tris-hidroximetil amino-
metane, solution physiologique simulée (SPS), SPS avec des protéines du sérum humain; (iii) 
adhérence de plusieurs protéines: albumine, immunoglobuline, qui sont des composants 
importants de la couche proteíque adhérant aux matériaux lorsqu’ils sont implantés, le 
collagèn du type I, lequel est définit comme une proteíne structurelle de la matrice 
extracellulaire. Finalement, (iv) l’étude de l’effet de l’intégration de silicium dans l’adhésion, 
la prolifération et la différentiation de deux types de cellules humaines, les ostéoblastes et les 
ostéoclastes. 
Du point de vue physico-chimique l’intégration du silicium dans le réseaux de l’HA 
résulte dans la diminution de la charge de surface du matériel (des valeurs plus négatifs), et 
dans l’augmentation de l’hidrofilicité de ce matériel. Les résultats de spectroscopie de 
photoélectrons de rayons X et de spectroscopie d’infrarouge renforcent clairement l’idée du 
mécanisme de substitution proposé par Gibson et al. Pour les longueurs d’onde de 888 cm-1 et 
de 504 cm-1 on obtien la présence de SiO44- et l’énergie de liaison à 101 eV correspond à la 
liaison (Si-O). Les résultats de l’XPS et de dispersion d’énergie de rayons X ont prouvé que le 
silicium est préférablement dissolu. Les analyses d'infrarouge ont aussi démontré qu’il y a une 
diminution de l’intensité de la bande correspondant au groupe hidroxil, ce que résulte 
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directement du mécanisme de substitution des groupes de phosphate par des groupes silicate 
et de la perte de quelques groupes hidroxil a cause du bilan de charges. Après l’incubation en 
SPS une couche d’apatite a-t-été formée plus rapidement sur la surface de la Si-HA que sur 
celle de la HA. D’après le mécanisme proposé, la surface plus négative fournit un endroit 
préférentiel pour la nucléation d‘une couche amorphe de phosphate, par adsorption d’ions 
Ca2+ à la surface plus électronégative, provocant l’augmentation de la charge de surface et par 
conséquence l’attraction de groupes de phosphate. La présence des protéines du sérum 
humain retarde la formation de la couche d’apatite, puisque qu’elle va fonctionner comme une 
barrière a la dissolution et a la diffusion des ions de la surface pour le milieu.  
L’intégration de 0,8 % (p/p) de silicium dans la HA accroît l’adhérence des protéines 
du sérum humain par unité de surface, si comparée avec la HA et avec 1,5 % (p/p) Si-HA. Le 
collagène du type I a une plus grande affinité avec 1,5 % (p/p) Si-HA. 
Les ostéoblastes humains ont adhéré, proliféré et différentié sur la surface de Si-HA. 
Toutefois, les cellules ont répondu de façon diverse aux différentes compositions de Si-HA. 
Les cellules cultivés à la surface de 0,8 % (p/p) Si-HA ont proliféré plus rapidement et ont 
produit une concentration plus élevée des protéines, tandis que dans le cas de 1,5 % (p/p) Si-
HA les cellules ont produit une concentration plus élevée de phosphatase alcaline, ce que 
indique que les cellules étaient plus différentiées. Après 21 jours les cellules ont commencé à 
produire des phosphates de calcium à la surface de HA de même façon de ce qui est arrivé 
pour les deux compositions de Si-HA.  
Le Si-HA a permit la différentiation des précurseurs d’ostéoclastes (des cellules 
perfériales mononucléaires du sang et des monocytes CD 14 positifs). Les cellules avaient des 
caractères typiques d’ostéoclastes : des anneaux d’ actine, multinucléaires et positives par 
rapport a la vitronectine et au TRAP. En présence des ostéoclastes les concentrations de 
calcium et de phosphore libérées pour le milieu par la Si-HA ont été considérablement 
supérieures par rapport a l’HA, en étant plus noté cet effet pour 1,5 % (p/p) Si-HA, ce qui 
indique que les ostéoclastes sont actifs. 
Les résultats obtenus indiquent que l’élevée bioactivité de la Si-HA est due a 
l’association de mécanismes cellulaires et acellulaires. La surface plus électronégative 
provoque une diminution du temps nécessaire pour la formation de la couche d’apatite, ce que 
est considère un facteur très important dans l’osteointegration du matériel en des conditions in 
vivo. L’intégration du silicium dans l’HA a eu un effet positif dans la production de proteínes 
et dans la différentiation des ostéoblastes, aussi bien que dans la différentiation et activité des 
ostéoclastes.  
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General Introduction  
Nowadays, the life expectancy is two times higher than in the begin of the 20th century 
(e.g. in the EUA in 1900 the life expectancy was approximately 48 years and nowadays is 
around 75-80 years). Therefore, the human body is subjected to higher cumulative stress that 
results in degradation of the tissues and so new therapies are required to overcome these 
problems [1, 2]. 
The bone grafts field has been developed to increase the quality of life of a patient 
who suffers from a bone disease, (e.g. osteoporosis, osteomalacia, osteogenesis imperfecta) or 
bone defect (e.g. bone fracture).  
 A biomaterial can be defined as ”a nonviable material used in a medical device, 
intended to interact with biological systems” [3]. Different materials can be used as 
biomaterials, namely, polymers, ceramics, glasses and metal alloys. The most important 
characteristic of a biomaterial is its biocompatibility that can be defined as “the ability to 
perform with an appropriate host response in a specific application” [3]. 
A bone graft should have particular characteristics depending on its application, for 
example if high strength is required, a single crystal material should be used, if a quick bond 
to bone is required, then a bioactive material should be used [1]. Hench defined a bioactive 
material as “a non-toxic, biologically active and that forms an interfacial bond with the host” 
[1]. 
The use of bone graft is required to restore skeletal integrity and enhance bone healing 
in several orthopaedic and maxillofacial procedures. There are several types of bone grafts: 
autograft, allografts, and xenografts, these grafts have advantages and disadvantages. 
Autografts are the ideal graft due to the lack of immunological response and the ability to 
provide osteoinductive growth factors, osteogenic cells and structural scaffolds [4]. The use of 
autograft, whilst often effective has several disadvantages, such as additional incision site, 
increased blood loss, limited supply and causes extra morbidity to the patient [5, 6]. As an 
alternative, allografts can be used. Allografting procedures are less successful then autografts. 
The processing of allograft tissue does not eliminate the risk of transferring viral 
contaminants such as HIV, hepatitis B and hepatitis C and the promotion of immunological 
reactions. When bone from one species is implanted into a member of different species is 
designated by xenografts. Due to adverse antigenic responses, xenografts are not considered 
suitable for bone grafting. 
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Therefore, the limitation in autografts and allografts has led to great advances in the 
development of synthetic alternatives. Hydroxyapatite (HA), Ca10(PO4)6(OH)2 is the most 
commonly used bone graft material, due to its chemical composition, which is similar to the 
mineral phase of bone.  
HA has the ability to bond and integrate with the host tissue when implanted. 
Although, the rate by which bone forms directly on its surface is quite slow when compared 
to others calcium phosphate biomaterials [7, 8]. The natural apatite can be described as a 
multi-substituted calcium phosphate apatite [9, 10]. Hence, one way to improve HA 
bioactivity is by the incorporation of different ions into the HA lattice in order to obtain a 
closer chemical composition to the mineral phase of bone. The most common substitution is 
by carbonate ions [11, 12], there are also reports regarding the incorporation of other ions 
present in the mineral phase of bone such as magnesium [13], fluoride [14] and sodium [15]. 
Santos et al showed that the bioactivity of HA can also be enhanced by the incorporation of 
glass based on the P2O5-CaO-Na2O system, a material recently patented as Bonelike® [16-
18]. This system allows the incorporation of different ions such as magnesium, sodium and 
fluoride, resulting in a material with a chemical composition similar to the mineral phase of 
bone [19, 20]. 
Several studies have highlighted the beneficial role of silicon. In 1970s Carlisle et al 
and Schwarz et al demonstrated that mineralization requires a minimum of soluble silicon 
[21-23]. So, combining the properties of HA and the positive effect of silicon, a new 
biomaterial was developed, silicon-substituted hydroxyapatite, resulting in an worldwide 
patent, “Silicon-Substituted Apatite and Process for the Preparation “ [24] 
It has been shown that the incorporation of silicon into the HA lattice increases the 
bone ingrowth/apposition [25]. However, the complexity of the in vivo system does not allow 
the full understanding of the mechanism behind the enhanced bioactivity of Si-HA. So, the in 
vitro testing has been chosen as a model and the most important steps have been studied. This 
thesis was designed to address the following aspects: 
• Effect of the incorporation of silicon into the HA lattice, on a physical-
chemical point of view.  
• Interaction of Si-HA material with different solutions: tris-hydroxymethyl 
amino-methane buffer, simulated body fluid (SBF) and SBF with human serum 
proteins. 
• Adhesion of different proteins: albumin and imunoglobulin that are important 
components of the adsorption layer at the surface of an implanted material. 
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Also, collagen type I that can be defined as “a structural protein of the 
extracellular matrix”. 
• Adhesion, proliferation and differentiation of two types of human cells, 
osteoblasts and osteoclasts onto the Si-HA surface. 
 
The aim of this thesis is to contribute to the understanding of the biological 
mechanism behind the enhanced bioactivity of silicon-substituted hydroxyapatite (Si-HA).  
The silicon incorporation has a beneficial effect on the bioactivity of hydroxyapatite; 
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Bone Physiology  
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Bone is a highly specialized form of connective tissue that has different functions: 
protection for vital organs and bone marrow; mechanical as a support and site for muscle 
attachment for locomotion; and metabolic, due to its ability to store several ions, especially 
calcium and phosphate, being therefore the major organ responsible for the maintenance of 





Anatomically, long bones can be divided into the following zones: epiphysis, 
diaphysis (or midshaft) and metaphysis (development zone) (Figure 1). The epiphyses (wider 
extremities of the long bones) and methaphysis are formed by two independent ossification 
centres, and are separated by a layer of cartilage designed by epiphyseal cartilage (or growth 
plate). This layer is composed by proliferative cells and expanding cartilage; it is responsible 
for the longitudinal growth in long bones. The methaphysis are the regions just below the 
growth plate, and it is in this area that immature bone growths. The last one, the diaphyses are 
the middle regions between the methaphysis and they provide mechanical stability. It is in this 
area that the hematopoietic marrow is located. Bone has two surfaces: the periosteal surface 
(external surface) and the endosteal surface (internal surface). These surfaces are covered by 










Figure 1- Structure and blood supply of long bones [26, 27]. 
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From the morphological point of view, there are two types of bone: cancellous and 







Figure 2 - Gross specimen of a longitudinally sliced long bone. Inside are the marrow cavity 
and the bony trabeculae [26]. 
 
The cancellous bone is formed by a network of thin calcified trabeculae. The 
trabeculae are made up of irregular osteon fragments, receiving their nutrients from blood 
vessels located in the marrow around them. Generally this type of bone is not penetrated by 
large blood vessels. The voids are filled with hematopoietic marrow in continuity with the 
medullar cavity of the diaphysis.  
The cortical bone is denser (80-90%) than the cancellous bone (15-25%); hence its 
function is mainly mechanical and protective. It is composed by densely packed collagen 
fibres that form concentric lamellae. The structural units of the cortical bone are designated by 
Haversian systems; they are mainly located at the diaphyses. The network of trabeculae in 
cancellous bone is approximately 20% of the total human bone mass; the remainder is cortical 
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 The Haversian system has a central canal with a blood vessel and is surrounded by 
concentrically arranged lamellae of bone tissue that run parallel to the canal. Among the 
lamellae, several lacunae connect with each other and to the central canal by canaliculi. 
In the lacunae there are several osteocytes arranged circumferentially around the 
Haversian canal. Each Haversian system (or osteon) is separated from its neighbour and forms 











Figure 4 - Three-dimensional diagram of a dried sample of compact bone [26]. 
 
Oxygen and nutrients reach the lacunae of bone cells through the canaliculi of the 
Haversian systems, and the waste products are removed from the osteocyte by the same 
pathway. The canaliculi deposit their contents into the Haversian systems, which connected to 
Volkmann’s canals, in turn theses canals connect to blood vessels in the periosteum [29]. 
 
Periosteum and Blood supply  
 
 The periosteum is a layer of dense, fibrous connective tissue that covers the external 
surface of most bones. It is highly adherent to the epiphysis and less adherent in the 
diaphyseal region [30]. The principal function of this layer is blood supply to bones. The 
periosteum is composed by a network of capillaries and capillary-like vessels. The blood 
vessels in this layer communicate with the cortical bone through the Volkmann’s canal.  
The blood supply to long bones is made via three main set of arteries: the nutrient 
artery, the metaphyseal-epiphyseal arteries and the periosteal arteries. The nutrient artery 
enters the diaphysis diagonally through a distinct foramen and branches into ascending or 
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descending medullar arteries. Upon reaching the marrow, the arteries divide into arterioles 
that penetrate the endosteal surface, to supply blood to the diaphyseal cortex. The 
metaphyseal-epiphyseal arteries originated from the peri-articular arteries, are connected to 
the bone by a foramina that are localized at specific positions in the thin cortex of the 
metaphysis. Their function is to supply blood to the spongy medulla and the metaphyseal 




Bone has two distinct phases: an organic matrix, composed by 80 - 90 % of collagen 
and the remaining is composed by proteoglycans and several non-collagenous proteins, 
namely osteocalcin, osteopontin, bone sialoprotein, osteonectin/SPARC (secreted protein 
acidic and rich in cysteine), decorin and biglycan. The mineral phase strengthens the organic 
phase with calcium salts.  
 
Bone matrix (Organic Phase) 
 
The bone matrix is composed by collagenous (80-90 %) and non-collagenous proteins. 
The mineralized tissue has type I and type V collagen, but the most abundant is collagen type 
I (> 95% of total collagen). The collagen fibres are held together by an amorphous continuous 
phase called ground substance [32]. Besides collagen the bone matrix is composed by 
proteoglycans and numerous proteins.  
 
Non-collagenous proteins  
 
Osteocalcin, osteopontin, bone sialoprotein, osteonectin/SPARC (secreted protein 
acidic and rich in cysteine) are some of the proteins that belong to this group. These proteins 
have different characteristics, for example osteopontin and bone sialoprotein have the RGD 
sequence that can be recognized by αvβ3 integrin receptor mediating cell attachment and 
activate cell signalling pathway and they are also involved in the hydroxyapatite binding, but 
while bone sialoprotein can nucleate the formation of hydroxyapatite crystals in vitro [33], 
osteopontin inhibits the mineral growth [34]. The exact role of osteocalcin in bone formation 
is not clear but it may be involved in mineral maturation. Biglycan (CS-PGI) is the 
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proteoglycan with higher representation in bone matrix, its precise involvement in bone 
formation is unknown, although it can bind to TGF-β and extracellular matrix 
macromolecules.  
 
Collagen type I  
 
 Collagen type I is the most abundant extracellular protein in bone, it belongs to the 
family of glycoproteins. In 1967 Ramachandran et al established the triple-helix model for the 
collagen fibrils [35]. The triple helix motif has three polypeptide chains. These chains are 
composed by several repetitions of the amino acid sequence (Gly-X-Y)n, where Gly stands for 
glycine, in most cases X is proline and Y is hydroxyproline, this amino acid stabilizes the 
triple helix and confers unique characteristics to the protein. Collagen type I is also a fibrillar 
protein, therefore its triple helix self-assembles into organized fibrils. These fibrils have a 
very high tensile strength and have a major role in providing a structural framework for body 
structures such as skeleton, skin, blood vessels, intestines, or fibrous capsules of the organism 
[36]. 
The triple helix of most of collagen type I molecules are composed by two α1 chains 
and one α2 chain coiled around each other. Both chains have a N-terminal peptide, followed 
by a C-terminal peptide [37-40]. On mature molecules this terminals are cleaved by proteases.  
In bone, molecules of collagen type I and type V are organised into collagen fibrils, 
these molecules are assemble in parallel arrays. Between these molecules there are gaps (37.5 
nm) that seem to be filled with “hydroxyapatite” minerals [41]. The fibrils are stabilized by 
inter and intra-molecular crosslinks, the number and distribution of this crosslinks will 
determine whether the tissue will mineralise [42]. 
 
Bone Mineral  
 
 
 The exact chemical composition and crystal structure of bone mineral has been the 
subject of intensive study for the last decades. DeJong, in 1926 demonstrated the similarities 
between the mineral phase of bone and synthetic hydroxyapatite using X-ray diffraction. 
Hydroxyapatite can be described by the chemical formula Ca10(PO4)6(OH)2 and a calcium 
phosphate ratio of 5:3 (1.67) [43]. Although, several differences have been demonstrated 
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between hydroxyapatite and the biological apatite that is present in bone tissue, namely, 
composition, crystallinity , stoichiometry, physical and mechanical properties. Bone mineral 
is characterized by calcium and hydroxyl deficiency, with a range of Ca:P ratios of 1.37-1.87 
and also by several ionic substitutions within the apatite lattice and an internal crystal 
disorder. In 1969, Posner demonstrated that bone mineral is 10 % deficient in calcium [44] 
and in 1983 Driessens  proposed the following composition for bone mineral: 15 % of 
magnesium whitlockite (Ca9Mg(HPO4)(PO4)6), 25% sodium and carbonate substituted apatite 
(Ca8.5Na1.5[(PO4)4.5(CO3)1.5](CO3) and 60% of carbonated octacalcium phosphate  
(Ca8(PO4)4(OH)2CO3 [45]. Therefore, it is more correct to refer to bone mineral as a 
substituted apatite and not as hydroxyapatite. 
A biological apatite has always carbonate substitutions (CO32-) [9-11]. As mentioned 
before, not only CO32- is present in biological apatite, but also sodium (Na+), magnesium 
(Mg2+), potassium (K+), fluoride (F-), chloride (Cl-) and also some trace elements such as 
strontium (Sr2+), lead (Pb2+), barium (Ba2+). The role of many of these ionic species in bone is 
not fully understood, mainly due to the difficulties in monitoring and quantifying the ionic 
content in bone mineral. The concentration of these ions is also dependent on diet and 
pathologies [46], but it is accepted that all these ions are very important in bone biochemistry. 
Neuman and Neuman, in 1958 described the presence of a layer of fluid, designated by 
hydration layer [47]. It is believed that this layer binds to the bone crystals surface and the 
ions are diffused through this layer to and from the crystal surfaces, being this layer 
responsible for the ionic substitution into apatite lattice. Posner, in 1969 proposed that the 
ions that cannot be substituted into the lattice are probably adsorbed onto the surface [44].  
 The divalent ions (cations) such as Mg2+, Sr2+ and Ba2+ can be incorporated into the 
lattice on the calcium sites. The mono-valent cations such as Na+ and K+ can also replace the 
calcium, but in this case a balance charge is required, therefore this balance will result in the 
protonation of an adjacent hydroxyl group. The anions (F- and Cl-) will substitute the 
hydroxyl groups. These substitutions induce complex structures changes at the unit-cell level 
and play a role on the dissolution rate of the apatite, which may favour osseointegration [48] 
and also induce crystalline imperfections due to the ionic substitutions combine to make bone 
mineral metabolically active [49].  
 The use of X-ray diffraction allowed the detection of an amorphous phase in mature 
bone [44, 50, 51]. Glimcher et al [52, 53] proposed that the initial mineralization occurs by 
the formation of a poorly crystalline non-stoichiometric apatite that increases in crystallinity 
and approaches stoichiometry with time although it never reaches.  
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Bone cells and their origin 
 
The three main type cells related to bone formation, maintenance and resorption are: 












Figure 5 – Transmission electron micrograph of bone. M – marrow cavity; Opc – 
osteoprogenitor cells; Ob – Osteoblasts;  Os – osteoid; Oc – osteocyte; CB – calcified bone 
matrix; C – canaliculi; and L – boundary between two adjacent lamellae [26]. 
 
The source of these cells has been a topic of a great deal of publications and it has 
been reviewed by different researchers [54-57]. According to Rasmussen and Bordier 
osteoblasts and osteoclasts derive from a common osteoprogenitor cell that has the ability to 
differentiate into an osteoblast or an osteoclast, depending on the environmental conditions 
[58]. Later on, Owen demonstrated that in the embryo the osteoblast is derived from a stromal 
mesenchyme cell system in marrow and the osteoclast from a haemapoietic cells system in 
marrow [59].  
 A mature osteoblast has its origin in a mesenchymal stem cell (bone marrow stromal 
stem cell or connective tissue mesenchymal stem cell), that is stimulated by local growth 
factors like fibroblast growth factors, bone morphogenetic proteins and WNt proteins and has 
transcription factors Runx2 and Osterix. The mesenchymal stem cell will undergo 
proliferation, differentiation to preosteoblasts until mature osteoblasts [60]. During the 
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of the stage in which the cells are. CBFA-1 is mainly expressed during lineage commitment; 
histone, collagen, TGFβ1 and osteopontin are especially expressed during proliferation; 
alkaline phosphatase, bone sialoprotein and also collagen are characteristic during matrix 
maturation. 
 The osteocyte is a mature osteoblast that became trapped into the calcified matrix. 
This cell type is connected to the adjacent lacunae through canaliculi.  
 The osteoclast cell derives from the fusion of mononuclear cells that are derived from 
the hematopoetic tissue [61, 62] (Figure 6). These cells are related to the monocyte-
macrophage lineage, but they belong to the leukocyte family. The osteoclasts are motile cells 
and they only form in the close vicinity of mineralized bone [63]. Their differentiation 
requires transcription factors such as PU-1 and MiTf at the initial stages. When stimulated by 
M-CSF they differentiate into the monocyte lineage, proliferate and express the RANK 
receptor. Additionally, these cells need RANKL that is produced by stromal cells, TRAF6, 
NFkB and c-Fos. The differentiation of these cells into osteoclast occurs at promonocyte 
stage, but monocytes and macrophages can differentiated into osteoclasts when under the 









Figure 6 - A sketch of osteoclastogenesis. The maturation occurs from peripheral blood 
mononuclear cells from the macrophage lineage [64]. 
 
 Osteoblasts  
 
 Osteoblasts are the bone cells responsible for producing bone matrix. These cells have 
distinct morphology, a round nucleus at the base of the cell facing the opposite bone surface, a 
basophilic cytoplasm and a prominent Golgi complex located between the nucleus and the 
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analyzed at an ultrastructural level this osteoblastic cell as an extremely well developed rough 
endoplasmatic reticulum with dilated cisternae and a dense granular content, and it is also 
characterized by a large circular Golgi complex comprising multiple Golgi stacks [60]. The 
plasmatic membrane is rich in alkaline phosphatase and has receptors for parathyroid 
hormone and prostaglandins, but not for calcitonin (typical of osteoclasts). The expression of 
the bone/liver/kidney isoform of alkaline phosphatase in a population of bone cells increases 
if there is a corresponding shift to a more differentiated state [65]. Additionally, at the 
membrane some other cytokines are expressed, the colony-stimulating factor I and RANKL, 
that can be cleaved to activate osteoclastogenesis. These cells can inhibit osteoclasts 
formation by secreting osteoprotegerin, a decoy RANK receptor capable of inhibiting 
osteoclast formation. They are also capable of producing several adhesion molecules 
(integrins), estrogens and vitamin D3. Its cytoplasmatic processes extend deep into the osteoid 















During remodelling, some osteoblasts become buried in the osteoid (non-calcified 
tissue) and differentiate into osteocytes (Figure 8). These cells are surrounded by mineralised 
bone matrix, with the exception of a 1-2 µm wide space which forms the osteocyte lacunae 
[26]. Morphological evidence suggests that these cells are spidery in appearance. The lacunae 
have collagen fibrils and are involved in cytoplasmic processes, via canaliculi that will divide 





Developed Golgi apparatus 
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between the matrix and the cytoplasmic processes contains interstitial fluid where metabolites 
are transported between cells. The morphology of the osteocyte is dependent on their age and 
functional activity. At the ultrastructural level a young osteocyte has similar characteristics to 
a mature osteoblast, although there is a decrease in its volume and importance of the 
organelles responsible for proteins synthesis (rough endoplasmatic reticulum and Golgi 
apparatus). With time the osteocyte is located deeper in the calcified bone and accumulates 
glycogen in the cytoplasm. During osteoclastic bone resorption these cells are phagocytized 
and digested at the same time as other matrix components.  It is believed that these cells may 
have a role as a mechanosensors and in the local activation of bone turnover. Regeneration of 
osteocytes is only achieved by resorption and remodelling processes, as osteocytes are non-













Figure 8 – Electron micrograph of an osteocyte, showing a large rough endoplasmatic 




 They are bone resorbing cells derived from mononuclear haematopoietic precursor 
cells [61, 62]. They are fundamental to normal physiological processes of bone turnover and 
endochondral ossification.  These cells are multinucleated and completely differentiated.  
 Morphologically, an osteoclast is a giant multinucleated cell containing 4-20 nuclei. 
These cells are usually in contact with calcified bone surface and with a Howship`s lacunae, 
G
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resulting from its own resorptive activity. The nuclei appearance varies within the same cell. 
They can be rounded and euchromatic or irregular in contour and heterochromatic, which 
possibly reflects the asynchronous fusion of its mononuclear precursors [60].  
 Osteoclasts attach to the bone surface forming a tight sealing zone enclosing the 
resorption lacunae. This feature was previously described by Scott and Pease [67]. This 
“ruffled border” or “brush border” is an area of the plasma membrane composed of a 
collection of folds and finger-like projections. After the attachment the cell produces an 
extracellular environment between itself and the bone surface (Figure 9). The ruffled border 
promotes a sealing zone, where the resorption takes place. This structure is rich in actin 
filaments, almost devoid of organelles and is organized in the shape of a ring [68]. The ruffled 
border is formed by protrusions of the plasma membrane known has posodomes [57]. The 
dissolution of the inorganic phase of bone precedes the matrix degradation [69]. This process 
involves the acidification of the microenvironment mediated by a vacuolar H+ - adenosine 
triphosphate and the secretion of lytic enzymes tartrate-resistant acid phosphatase (TRAP) 
and pro-cathepsin K in the cell’s ruffled membrane [64]. The pH of approximately 4.5 results 
from the release of hydrochloric acid (HCL) into the microenvironment [70]. This acidic 
environment will dissolve the bone mineral and subsequently, the demineralised organic 
component of bone will be degraded by a lysosomal protease cathepsin K (CATK) [71, 72]. 
The products from bone resorption are endocytosed by the osteoclast and then transported and 








Figure 9 – A sketch of an osteoclast resorbing bone, a – adhesion and cytodiferentiation; b – 
secretion and resorption [64]. 
Bone growth  
 
 Bone growth or ossification can occur by two distinct methods, intramembraneous 
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difference between the bone tissue formed by these methods, this classification is only related 




Flat bones of the skull and face, mandible and clavicle are formed through the 
intramembraneous ossification. The first evidence of the intramembraneous bone occurs at 
early stages of embryonic development. At this stage elongated mesenchymal cells within the 
mesenchyme migrate and aggregate in specific areas, where bone is to be formed. At the same 
time some mesenchymal cells proliferate and differentiate into osteoprogenitor cells.  Some of 
these cells come into apposition with the initially formed spicules and differentiate into 
mature osteoblast laying down more matrix. During the appositional growth the size of the 
spicules increase and joint in a trabecular network. Due to the mitotic property, 
osteoprogenitor cells provide a constant source of osteoblast. These new cells lay down bone 
matrix in successive layers leading to the formation of the woven bone. The immature bone or 
woven bone is characterized by interconnecting spaces occupied by connective tissue and 




The majority of bones in the human skeleton grow through endochrondral ossification 
(bones of the extremities and those parts of the axial skeleton that bear weight). The growth of 
this type of bone is preceded by precursors known as cartilage models.  
 The first step on the formation of endochondral bone is similar to the 
intramembraneous ossification. The mesenchymal cells proliferate and migrate to the site of 
future bone. In this case the mesenchymal cells differentiate into chondroblasts (cartilage 
cells) that produces cartilage matrix. This cartilage (Hyaline Cartilage) acquires the shape of 
the bone that will be formed (the cartilage model). Ossification occurs within this model, as it 
is penetrated by blood vessels. The increase in width is due to matrix production by the new 
chondrocytes that differentiate from the chondrogenic layer of the perichondrium surrounding 
the cartilage mass. The osteoblasts under the perichondrium in the foetal bone deposit bone 
around the outside of the cartilage shaft. Once this process occurs, the perichondrium is 
known as the periosteum, which in turn deposits more layers of bone. It is possible to describe 
Introduction - Chapter 1 
 17
an osteogenic layer within the periosteum because the cells in this layer are differentiating 
into osteoblasts. The developing long bones also need to grow in length. The metaphysis in 
long bones is described as the primary source of ossification and the epiphysis as the 
secondary source of ossification. Between the metaphysis and epiphysis there is a 
cartilaginous centre (growth plate or epiphyseal plate). The bone growth ends when the cells 
stop proliferating at the growth plate and the epiphysis fuses with the metaphysis of the shaft.  
 
Bone remodelling  
 
 Bone is a dynamic connective tissue, after the formation of the skeleton, bone keeps 
changing its internal structure by remodelling. In this process old bone is removed and new 
bone is formed to replace it. Bone remodelling enables bones to adapt to the mechanical stress 
and it has a very important role in the mineral metabolism. 
 Bone remodelling occurs in specific locations and involves a several groups of cells. 
The mechanism by which bone is remodelled is dependent on the type of bone, cortical or 
cancellous.  
The cortical bone is remodelled by the removal and refilling of osteons or Haversian 
systems (cutting cone). The activated osteoclast resorbs the old bone from the surface and it 
stays in a Howship lacunae. As soon as the resorption reaches a certain depth a new phase in 
the remodelling process starts, the reversal phase, in this step the osteoclast progresses and 
resorb the whole osteon. On the next step the osteoblast begins to lay down new bone. During 
the formation of the osteoid the osteoblasts are entrapped and differentiated into osteocytes, 
leading to a remodelled Haversian system. 
 Due to the different characteristic of the cancellous bone (large surface area of 
trabeculae and lack of osteons), the remodelling process will be different. Five different 
stages can be identified: 1) quiescence – resting state of the bone surface; 2) activation – 
recruitment of osteoclast to the bone surface; 3) resorption – removal of bone by osteoclast; 4) 
reversal - the process by which osteoclast stop resorbing bone and osteoblast start producing 




 The healing events following the implantation of a bone graft are quite similar to the 
healing steps after a bone fracture. A bone fracture is characterized by the loss of bone 
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continuity [73]. The introduction of an implant will also result in the loss of continuity of 
bone tissue. An important factor is the presence of blood caused by the disruption of the blood 
vessels.  
The most important difference between bone remodelling and healing is the presence 
of extravasated blood. In the remodelling process, the osteogenic population is derived from 
perivascular cells that migrate through the primitive perivascular connective tissue. In the 
healing process of a fracture and bone grafts implantation the osteogenic population comes 
from marrow. Osteogenic population migrates through the temporary scaffold provided by the 
extravasated and clotted blood [74].  
 When assessing the biological behaviour of a bone graft it is important to have special 
attention to three different phenomena: 1) the first biological molecules to interact with 
material are proteins and other macromolecules, therefore cells will subsequently interact with 
the protein layer; 2) the release of cytokines and growth factors from the degranulation of 
platelets in the blood clot has a stimulating effect on bone regeneration and finally 3) the 
properties of the implanted material may have an immense effect on early blood cell 
reactions.  
 The blood clot or haematoma caused by the haemorrhage from the damage blood 
vessels is composed mainly by red blood cells (erythrocytes) and platelets. Besides the clot 
formation two other mechanisms influence the haemostasis: a transient vasoconstriction at the 
ends of the damage local blood vessels limits the amount of blood entering the injured site 
and clot retraction that condenses the haemostatic plug, reducing the wound site. The lack of 
circulation results in poor oxygenation, which consequently causes local ischemia and 
necrosis. The leukocytes are involved in clot and necrotic tissue demolition through 
extracellular and intracellular phagocytic digestion mechanism. 
The next step is the formation of granulation tissue. This tissue is characterized by 
large amount of blood vessels (60% wt) and several types of cells such as: macrophages, 
pluripotent pericytes, fibroblastic cells, and endothelial cells lining capillaries. All this cells 
are surrounded by a matrix composed mainly by fibronectin, proteoglycans, hyaluronic acid 
and collagen type III, that will develop to type I with time [75]. The large number of blood 
vessels gives the granular appearance. The angiogenesis is initiated mainly from the 
postcapillary venules. At this site the endothelial cells degrade the subendothelial basement 
membrane, migrate and proliferate to form hollow capillary buds [74]. The initial haematoma 
is removed and replaced by a fibrous vascular tissue that undergoes neovascularization [76]. 
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 During osteoconduction a migratory osteogenic population of cells spread on the 
surface of bone or implant. The cells stop migrating as soon as they start producing bone 
matrix. These cells that migrated are not mature osteoblasts, but they have osteogenic 
potential. Therefore, the osteoconduction phenomena precede the de novo bone formation by 
these cells [74]. 
 Bone formation requires the migration of osteogenic cells, but also the differentiation 
to mature secretory cells. The osteoblast that reach the solid surface will produce matrix, 
although some cells differentiate before reaching the wound or implant site, at this point they 
stop migrating and start producing matrix, leading to the formation of bony spicule that 




 Bone grafts are used in several orthopaedic surgical procedures to restore skeletal 
integrity that was compromised by disease, trauma or ageing and also to promote bone 
healing.  
A bone graft has mechanical and biological functions; it should offer support or fill 
voids and enhanced the bone regeneration at the implantation site. A perfect bone graft should 
have several characteristics: a) capacity to form bone, to carry living bone cells (osteoblasts, 
osteoclasts or their precursors); b) its surface should stimulate osteoprogenitor cells to 
differentiate into bone forming cells in a osseous or non-osseous site; c) provide a bioactive 
surface, where the osseous tissue can regenerate [4]. Meaning, the material should be 
osteogenic, osteoinductive and osteoconductive, respectively.  
Bone grafts can be classified according to its origin, autografts if the tissue is obtained 
from the patient itself; allograft if the tissue is obtained from a different donor, but the same 
specie, xenograft if the tissue is obtained from a different donor and different specie [77] or 




The surgical procedures involving autografts require two surgeries, the first one to 
harvest the bone from one site within the patient and the second one to implant the tissue into 
the damage site. The major advantage of the use of autografts is its osteogenic, osteoinductive 
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and osteoconductive properties [4]. This bone graft contains cartilage matrix, minerals, 
proteins and osteogenic marrow cells [78]. It has been described that in 1821 von Walther 
obtained healing of bone plates in a human skull through trephining and a few years later, 
1889, another successful surgery involving bone grafting was reported by Seydel, he removed 
tissue from the tibiae from the patient and implanted in the skull of the same patient [79].  
The problems associated with this type of bone grafts are mainly related with its 
limited supply and the need to subject the patient to a second surgery, which results in more 
pain and morbidity at the donor site. According to several researchers these symptoms persist 
even after wound healing [5, 6]. The main source for autografts is the iliac crest. It has been 
reported that harvesting bone tissue from the iliac crest can lead to several problems, namely 




 The use of allograft eliminates the need of a second surgery, because tissue from a 
human donor is harvested and implanted in a different patient. The main source of allografts 
is cadavers. The use of allografts it has been described since the XIX century. It has been 
reported that the first successful human allografts was performed in 1881 by Macewen [79]. 
He removed tissue from the tibiae of a boy and implanted in the humerus of another boy. 
Around 1916 more than 350 allograft procedures were already performed successfully [79].  
 Allografting procedures are less successful then autograft. The use of allografts 
eliminates the need of a second surgery, being this fact one of the great advantages of 
allografting. Although, the processing of allograft tissue does not eliminate the risk of 
transferring viral contaminants such as HIV, hepatitis B and hepatitis C or also the 
transmission of potential unknown diseases and the promotion of immunological reactions. 
The use of sterilization by gamma radiation (or ethylene oxide) and removal of blood and 
cellular constituents diminish the risks of infection. The method used on the preparation of the 
tissue affects its properties, if the tissue is freeze-dried or sterilized by gamma radiation, its 
structure will be affected, loosing its osteoinductive ability and osteogenic properties, because 
most of the cells are damaged during the preparation process. Therefore, most allografts do 
not have cells, resulting in a loss of the osteogenic properties [4, 81].  
 The use of fresh allograft may be very low due to the risks mentioned previously and 
severe immunological reactions they may cause. So, a new process for the preparation of 
Introduction - Chapter 1 
 21
fresh allograft was developed, in this case the bone marrow is removed, following the 
removal of fat from the bone and finally the minerals are removed by hydrochloric acid. After 
this process the collagen matrix is not damaged. The biological characteristic of the 
demineralised allograft is dependent of the demineralisation process. In 1965, Urist implanted 
decalcified allografts intramuscularly in rabbits, mice, rats and guinea-pigs and he found that 
new bone was formed [82]. He also found that the decrease in the osteogenic properties of the 
demineralised allograft was related to the amount of hydrochloric acid used in the process. 
Urist found that its osteogenic property was due to the presence of glycoproteins, known as 
transforming growth factor family [79].  
 Even with the development of new techniques allografting still has the risk of 
transmitting infections, toxins or contaminants and the preparation methods induce a 
significant lost of biological and mechanical properties. The limitations of autografts and 





A wide range of materials have been proposed for bone replacement, such as metals, 
polymers, ceramics and composites. The principal materials used are titanium, aluminium, 
stainless steel, cobalt-chromium alloys and titanium alloys [1]. Due to the lack of biological 
properties their integration with the host tissue is very poor and its use can lead to the 
resorption of the surrounding bone due to the mismatch on the mechanical properties. This 
bone grafts do not have osteoconductive, osteoinductive or osteogenic properties. Therefore, 
their osseointegration is very poor. The mechanical properties of the metallic implants are 
different form the mechanical properties of bone, which can cause shielding, leading to the 
eventual resorption of the surrounding bone [83].  
 For the last forty decades there was an increase interest in ceramics for bone 
regeneration. Bioceramics may be used to fill spaces, as coatings or as a second phase in a 
composite [1]. The in vivo response to bioceramics will depend on several factors, such as: 
tissue type, health and age, implant composition and phase, blood circulation in tissue and 
interface, surface morphology and porosity motion at the interface, chemical reactions, 
closeness of fit and mechanical load [1].  
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Bioceramics can be also classified according to biological reaction they elicit in vivo 
(Table 1). Some materials can elicit a toxic response that will damage and/or kill cells or 
release chemical substances that can go into the blood stream and cause systemic damage to 
the patient [84], therefore they are not used in clinic. 
 
Table 1 – Reaction induced by biomaterials after implantation [1]. 
  
The physical-chemical properties of the material influence the intensity and time 
duration of the inflammatory and wound-healing processes [85] caused by the implantation of 
the bone graft. The haemorrhage caused by the surgical procedure leads to the formation of a 
blood clot or haematoma containing mainly erythrocytes and platelets [74]. 
 When a nearly inert biomaterial is implanted a sequence of events will follow until the 
formation of a fibrous capsule. During the inflammation phase, plasma proteins and 
leukocytes (mainly neutrophils) migrate to the implantation site [86-88]. After the migration 
of the leukocytes to the implant site, phagocytosis and the release of enzymes start followed 
by the activation of neutrophils and macrophages. The inflammatory cells such as 
polymorphonuclear granulocytes, monocytes and macrophages remove the debris and the 
foreign body. When the cellular mechanism does not have the ability to phagocytate the 
implant, enzymes of the macrophages will induce the fibroblasts to produce the collagen 
leading to the formation of the fibrous capsule around the implant. For as long as phagocytic 
activity continues the capsule becomes thicker. If the surface of particles are too large the 
macrophages will fuse together to form a giant cell [1] and this capsule will isolate the 
implant from the rest of the tissue [89]. The biological response to these materials is 
Implant  Consequence  Materials 
Biologically nearly inert This material induces a very small 
response from the host tissue, leading 
to the formation of a non-adherent 
fibrous capsule around the implant. 
Zirconia, Alumina 
Bioactive This material elicits a specific 
biological response at the interface of 
the material resulting in the formation 
of a bond between the tissue and the 
material. 
Bioactive glasses, Bioactive 
glass-ceramics, HA, 
Bonelike® 
Resorbable Implant dissolves and /or is degraded 
by cells and replaced by tissue.  
Tricalcium Phosphate, 
Bioactive glasses 
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dependent on the chemistry of the material, but most important is related to movement. If the 
implant is not properly fitted the movement will cause a thickness of the capsule until 
equilibrium is reached. On the other hand if the implant is properly fitted the phagocytic 
response is transient, the capsule will be very thin and inactive soon after the implantation. In 
the presence of alumina or zirconia a very thin layer will form, but if the material is more 
chemical reactive the layer will be thicker [90]. The formation of a capsule membrane around 
nearly inert materials is a protection mechanism from the host-tissue in order to isolate the 
implant. Most materials induce this response, like most metals and most polymers [1]. 
 The bioactive materials form an interfacial bond, due to a controlled rate of chemical 
reactivity leading to the formation of dynamic equilibrium at the interface. The formation of a 
bioactive interface between the host-tissue and the implant occurs when the tissue apposes 
directly the implant surface, leading to a biological fixation, which prevents motion of the 
implant [1]. A common characteristic of the bioactive implants is the formation of a hydroxyl-
carbonate apatite layer; this layer has a similar composition and structure to the mineral phase 
of bone [1].  
 Synthetic hydroxyapatite (HA) is used as a bone graft substitute, due to its similarity 
in composition to the mineral phase of bone and to its bioactivity. Several reports showed that 
HA has the ability to form an interface with bone, without the presence of a fibrous capsule 
[91-93]. The interfacial strength between bone and HA is significantly higher when compared 
to the “bond” between bioinert surfaces and host tissue [94].  
A resorbable material can be degraded by the body fluids or digested by macrophages. 
Most important the degradation products cannot be toxic to the cells and should be easily 
disposed by the cellular mechanisms [1]. The main goal of this type of materials is to degrade 
slowly and be replaced by the natural tissue, leading to the regeneration of the tissue [1]. The 
high degree of solubility can pose problems regarding the mechanical performance while the 
regeneration is taking place. Another problem related to this type of material is the difficulty 
in matching the dissolution rate of the material with the repair rate of the tissue. The 
tricalcium phosphate ceramic can be degraded to calcium and phosphate salts in the body and 
be used as bone filler.  
 Several bioceramics are nowadays used in clinical, such as: bioactive glasses, HA, 
tricalcium phosphate [1]. The characteristics of the material should be optimized, depending 
on the function that the material should play in the body (Figure 10), for example a single 
crystal such as sapphire can be used as a dental implant due to its high strength, A/W glass-
ceramic can be used to replace vertebrae due to its high strength and its ability to bonds to 
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bone. Bioactive glass has low strength, although they bond very rapidly to bone, therefore 






















Figure 10 – Clinical uses of bioceramics [1, 27]. 
 
Hydroxyapatite and Substituted Apatite  
 
 In 1920 Albee reported the first successful bone repair with a calcium phosphate 
material [95]. Later on, two groups described a method to prepare a ceramic apatite from a 
mineral fluorapatite [96, 97]. A few years later several groups developed synthetic 
hydroxyapatite [98-101] to be used as a biomaterial for bone repair. Calcium phosphates are 
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 The word apatite is used to describe a crystalline mineral with the composition 
( ) 26410 XZOM  [108, 109]. The M, Z and X site can be occupied by different ions. Calcium 
(Ca2+), strontium (Sr2+), barium (Ba2+), lead (Pb2+), can occupy the M site, in the case of the Z 
site it can be fulfilled by phosphorous (P5+), silicon (Si4+) and the X site by fluoride (F-), 
chloride (Cl-), hydroxyl group (OH-), or it can be vacant.  
 Depending on the ions present and the calcium phosphate molar (Ca/P) ratio of the 
materials, their physicochemical and mechanical characteristics will be distinct [110].  
 Hydroxyapatite is an inorganic calcium phosphate that can be described by the 
following chemical formula: ( ) ( )26410 OHPOCa . This material is characterized by a calcium 
phosphate ratio (Ca/P) of 1.67.  It has a defined crystallographic structure that was initially 
proposed by Beevers and McIntyre [111] and refined by Posner et al [112] using X-ray 
diffraction. Kay et al [113] using neutron diffraction studies showed that HA consists of the 
hexagonal arrangement of calcium (Ca2+) and phosphate (PO43-) ions around columns of 
monovalent hydroxyl (OH-) ions. Calcium hydroxide has a hexagonal system, with a space 
group P63/m, being characterized by a six-fold c-axis perpendicular to three equivalent a-axes 
at angles 120º to each other. The unit cell contains a complete representation of the apatite 
crystal with Ca2+, PO4-3 and OH- groups closely packed. The cell dimensions are a=b=0.943 











Figure 11 - The structure of hydroxyapatite (adapted from Aoki, 1991 – top image [108]; 
Bystrov et al , 2003 – bottom image [114]). 
 
Four calcium atoms occupy the Ca(I) position: two at levels z = 0 and two at z = 0.5, 
the other six calcium ions occupy the Ca(II) positions. A group of three calcium atoms forms 
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a triangle at z = 0.25 and the remaining three describe a triangle at z = 0.75, surrounding the 
OH- groups at the corners of the unit cell. The six phosphate tetrahedra are positioned in a 
helical arrangement from level z = 0.25 to z = 0.75. The basic skeletal framework of 
phosphate (PO43-) groups provides stability to the apatite structure [10]. 
The Ca/P ratio will influence the characteristic of the material. In Table 2 are listed 
different calcium phosphates with various Ca/P ratios. It is believed that the Ca/P ratio will 
influence the rate of hydrolysis and solubility of the bioceramic. It has been reported that HA 
is the least soluble calcium phosphate in vivo [115]. The bioresorption of the calcium 
phosphate ceramic it is also dependent on the structure of the material [92]. A microporous 
ceramic has a larger surface area than a dense ceramic, therefore it will dissolve faster.  
 




As discussed in previous sections, HA has a similar chemical composition to bone 
mineral [43] and it presents osteoconductive properties. 
The clinical use of calcium phosphate is limited due to its poor mechanical properties. 
Several groups developed new approaches in order to enhance the mechanical properties of 
HA. Bonfield et al developed a polyethylene-HA composite [116], Ioku et al added a second, 
Name Abbreviation Empirical formula Molar Ca/P ratio 
Tetracalcium phosphate TeCP Ca4O(PO4)2 2.00 
Hydroxyapatite HA Ca10(PO4)6(OH)2 1.67 
Fluorapatite FA Ca10(PO4)6F2 1.67 
Chlorapatite CA Ca10(PO4)6Cl2 1.67 
Tricalcium phosphate TCP Ca3(PO4)2 (α,β,γ) 1.50 
Octacalcium phosphate OCP Ca8H2(PO4)6.5H2O 1.33 
Dicalcium phosphate dehydrate (Brushite) DCPD CaHPO4.2H2O 1.00 
Dicalcium phosphate  (Monetite) DCP CaHPO4 1.00 
Calcium pyrophosphate (α,β,γ) CPP Ca2P2O7 1.00 
Calcium pyrophosphate dihydrate CPPD Ca2P2O7. 2H2O 1.00 
Heptacalcium phosphate HCP Ca7(P5O16)2 0.70 
Tetracalcium dihydrogen phosphate TDHP Ca4H2P6O20 0.67 
Calcium metaphosphate (α,β,γ) CMP Ca(PO3)2 0.50 
Monocalcium phosphate monohydrate MCPM Ca(H2PO4)2.2H2O 0.50 
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high-strength ceramic phase, such as yttria-doped zirconia [117], and Santos et al, introduce a 
glass reinforced phase, a CaO-P2O5 glass [118].  
In previous sections it was mentioned that it is not correct to refer to the mineral phase 
of bone as hydroxyapatite, but that it should be a referred to as a “substituted apatite”. 
Therefore, an approach to increase the bioactivity of HA is to incorporate different ions into 
the lattice and as mentioned previously the HA lattice is susceptible to ionic substitutions, 
such as carbonate ions (CO32-) [11], magnesium (Mg2+) [13], fluoride (F-) [14], sodium (Na+) 
[15], and silicon (Si4+) [24, 119]. These substitutions cause changes in the lattice parameters, 
crystal morphology, solubility, crystallinity and thermal stability of HA. The characteristics of 
the substituted apatite will be dependent on the ion incorporated and the site of substitution. 
The ions can substitute for calcium, phosphorous or the hydroxyl group. These substitutions 
can happen independently, just one ion or simultaneously more than one ion [120]. If these 
substitutions occur simultaneous they may have a synergistic or antagonistic effect on the 
properties of the apatite. A coupled substitution of Mg2+ and CO32- has synergistic effect on 
the solubility of HA and crystallinity , while the substitutions of Mg2+and F- or CO32- and F- 




 The cationic substitutions, such as magnesium (Mg2+), barium (Ba2+), lead (Pb2+), 
potassium (K+), sodium (Na+), strontium (Sr2+) take places at the calcium (Ca2+) site. All of 
these ions introduce specific changes into the apatite substitutions.  
 The incorporation of Mg2+ into the apatite structure changes the lattice parameters and 
its properties. The a axis and the crystallinity decrease and the dissolution rate increases 
[123]. The substitution of Sr2+ for Ca2+ results in an increase in the unit cell parameters, both 
axis a and c increase. The incorporation of this ion also increases the dissolution of the apatite 
when compared to Sr-free apatite [124]. The divalent cations such as Ba2+ and Pb2+ can 
substitute for Ca2+ and due to its size, larger than Ca2+, the lattice parameters increase. The 
incorporation of other ions like aluminium (Al3+), manganese (Mn2+) and zinc (Zn2+) decrease 
the crystallinity of the apatites [120]. The incorporation of some of these ions can cause 
imbalances in the charges causing disorder within the crystal structure of HA. For example, in 
the case of the substitution of Na+ into the apatite structure, due to the similarities between the 
ionic radii of Na+ and Ca2+ no change into the lattice are expected [120], although the 
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difference in valency caused by this substitution requires a reduction in anionic charge to 
maintain charge balance. This is achieved through the formation of vacancies on the anion 
sites [15]. Studies have reported that the substitution of Ca2+ by Sr2+ ion increases the 
solubility of the apatite [122, 125], while the presence of Mg2+, Fe2+, Mn2+ and Al3+ ions 




The anionic substitutions may occur at the phosphate site or hydroxyl (OH-) site. 
Fluoride (F-) and chloride (Cl-) will replace some OH- groups into the HA structure. The 
presence of F- has several positive biologic effects, it promotes bone formation in vivo [126], 
enhances mineralization and calcification in vitro [122, 127]. On the structural level the 
incorporation of F- increases the structural stability of the apatite [128], decreases the a axis, 
but does not influences the c axis and induces a higher crystallinity. On the other hand, the 
incorporation of Cl- results in an expansion of the a axis and a decrease in the c axis. The 
apatites containing Cl- are stable when exposed to heat resulting in a higher formation of 
secondary phases, such as β-TCP.  
 The substitution of carbonate (CO32-) can occur in two different atomic sites into the 
HA lattice, being classified as type A and type B substitutions. The first type is the 
substitution of CO32- ions for OH- group [129] and the second type involves the substitution 
of CO32- ions for PO43-ions [12]. The substitution type B will result in a decrease of the a axis 
and an increase of the c axis. The incorporation of CO32- will increase the solubility of the 
apatite [120]. The amount of CO32- incorporation into the structure is influenced by the 
presence of other ions in solutions, for example the presence of Na+ allows a maximum 
incorporation, while the presence of Sr2+ diminish its- incorporation [120]. 
  
Silicate Substitutions  
 
Gibson et al demonstrated that silicate (SiO44-) ions can substitute for the PO43- site in 
HA [119, 130]. Through Rietveld structural refinement of the X-ray diffraction it was 
demonstrated that the incorporation of 0.4, 0.8 and 1.5 wt. % silicate ions decreased the a axis 
and increased the c axis of the unit cell of hydroxyapatite [119, 131]. The ionic bond lengths 
of a P-O bond (0.157 nm) with tetrahedral coordination are comparable to a similarly 
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coordinated Si-O bond (0.166 nm) [132]. Preliminary results showed that the incorporation of 
silicate ions into the HA structure increases the solubility and enhances osteoblast-like cells 
activity [133]. And more recently Patel et al demonstrated that the incorporation of silicate 




 Several theories have been developed regarding the effect of silicon in several 
metabolic processes. 
 Silicon is one of the most common elements on earth. It can be found in igneous rocks 
and sedimentary rocks, in different forms such as: quartz (SiO2), potassium feldspar 
(KAlSi3O8) and plagioclase (NaAlSi3O8+CaAl2Si2O8). In the hydrosphere most of the silicon 
is in the form of silicic acid (Si(OH)4), with small amounts of monosilicate ion (SiO(OH)3-) in 
sea water. The concentration of silicon in sea water is approximately 0.1 mM and 0.22 mM in 
river water [134]. 
 A large number of studies regarding the effect of silicon on metabolic pathways were 
made using a diatom, unicellular algae, due to its metabolic similarities with the mammalian 
systems. Dietrich Werner [135] showed that a Cyclotella cryptica (diatom), had sequential 
metabolic effects when subjected to Si(OH)4 starvation. Several changes in the metabolism 
occurred such as: inhibition of synthesis of a protein net, inhibition of DNA synthesis, 
inhibition of chlorophyll synthesis and an increase in the production of fatty acids synthesis 
by more than 100 %. Leading to a reduction of apparent photosynthesis and chrysolaminaran 
utilisation later on. 
 Volcani [136] showed, when these diatoms were subjected to silicon starvation, the 
exponential growth stopped, the rate of carbon dioxide fixation, oxygen evolution and 32P 
assimilation decreased, until reaching a steady state. The synthesis of nucleic acids, proteins, 
carbohydrates, chlorophylls and fucoxanthin was also stopped, but the production of lipids 
was not affected. Throughout the culture the synthesis of nucleoside triphosphate (NTP), 
cellular carbon, DNA and diadinoxanthin increased slowly. When the silicon source was 
reinstated, the most notorious changes were in the lipid production that decreased abruptly, 
increased activity of the photosynthetic carbon reduction cycle intermediates and tricarboxylic 
acid cycle intermediates, as well an increase in protein production. So, the silicate uptake in 
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diatoms requires active transport. It is involved on DNA synthesis, through the synthesis of 
two nuclear DNA polymerases and it is also involved in the formation of thymidylate kinase.  
 The work of Marshal Darley [137] supported the results reported by Volcani [136]. It 
was demonstrated that in the absence of silicon C. fusiformis does not have nuclear division, 
indicating that silicon is required for DNA replication and or/mitosis. Baxter et al and 
Finkelstein et al [138, 139] suggested that in animal cells some the DNA-binding proteins 
may be implicated in the regulation of gene expression.  
Through the measurement of different proteins synthesized in the presence of silicon, 
several hypotheses arised; being the most important related to the effect of silicon on the 
regulation of gene expression in the diatom. Two mechanisms were proposed to explain the 
differences observed: 1- the synthesis of a nuclear polymerase involved in DNA replication 
may be stimulated by silicate or derivative or even by a product of the silicate metabolism, 
resulting in DNA replication. Stein et al [140] suggested that this control could be at a 
transcriptional level; 2- silicon or a derivative can act as a post-translational level as a 
constituent of proteins, as a covalently bonded silicon in glycosaminoglycans and 
polyuronides. If these proteins did not have enough silicon, they could be translated on 
ribosomes, but not acquire a tertiary or quaternary conformation.   
 In a more specific area, bone biology, two different groups presented very similar 
results, Schwarz and Carlisle [22, 23, 141]. Schwarz demonstrated that a deficient diet in 
silicon in rats retarded the growth, disturbed the development of bone structure, namely, 
changes in the skull size and bone architecture. According to the author it is possible that 
silicon plays a special role in situations where an organism tries to bind structures due to the 
stability of the Si-O-Si bond. One of the most important findings of Schwarz was an enzyme 
capable to remove silicic acid from a bond synthetic form, Silicase. This enzyme is a 
membrane-bound located at the mitochondria and microsomes in pancreas, stomach and 
kidney (lower concentration), it is quite stable and it can be heat at 100ºC for 10 min, without 
loosing activity. Schwarz also proposed a correlation between the effect of silicon and 
arthritis, bone diseases (osteomalacia and osteogenesis imperfecta), scleroderma, wound 
healing and atherosclerosis [141].  
Carlisle demonstrated similar effects in chicks, leading to the conclusion that silicon 
may play an important role in mineralization [21]. The author also demonstrated  that silicon 
plays an important role in bone growth and development, connective tissue metabolism, bone 
calcification processes, connective tissue formation as a structural component in aging of 
certain connective tissues [21]. It was demonstrated that chicks with a deficient diet in silicon 
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presented atrophied organs, retard skeletal development, less flexible legs, smaller skulls and 
flatter bones. Using electron microprobe Carlisle demonstrated that silicon is concentrated in 
the cytoplasm of osteoblasts in young bones and that there is a direct relation between the 
concentration of silicon and the degree of calcification. Further studies, showed that 
osteogenic cells have larger amounts of calcium, phosphorous, magnesium and silicon, being 
the later on the most abundant anion on these cells. The increase of calcium is followed by a 
decrease in silicon, especially when the concentration of calcium reaches the values observed 
in bone apatite. The maximum amount of silicon observed was with a Ca/P ratio of 0.7 and 
decreases dramatically when Ca/P ratio reaches 1.67. It has been suggested that one of the 
most important factors in calcification is the binding of calcium and these studies suggested 
that silicon plays an important role in the processes. The abnormalities observed in the bone 
skull are related with a deficiency in collagen of the connective tissue matrix. In the articular 
cartilage of the chicks fed with a deficient diet in silicon presented lower amount of cartilage, 
glycosaminoglycans and collagen. Therefore, Carlisle showed that the site of action of silicon 
in connective tissue metabolism is on the glycosaminoglycan-protein complexes of the 
ground substance. In higher animals it was founded that silicon is bounded to 
glycosaminoglycans and associated with polysaccharide and smaller protein moieties. 
The mechanism proposed for the role of silicon in the architecture of connective tissue 
is related to its ability to act as a cross-link between polysaccharide chains and linking 
polysaccharide chains to proteins. Silicon can also be related with the aging of some tissues. 
A significant decrease in this ion in the human normal aorta and human skin was reported 
with time. In addition, a decrease on the concentration of silicon was observed on the arterial 
wall leading to atherosclerosis [21].  
Loeper, Loeper and Charnot [142, 143] showed that the decrease of silicon is followed 
by an accumulation of lipid deposits. According to these authors silicon partially inhibits 
lipidic accumulation, maintains the normal calibre of the elastic fibres, conserves the integrity 
of mucopolysaccharides and increases the impermeability of the endothelium to lipids.  
 Voronkov [144] demonstrated that nucleic acids contain silicon. In DNA one atom of 
silicon corresponds to an average of 20-30 atoms of phosphorus, and in the RNA this ratio 
changes to 25-45 atoms. Therefore, according to Voronkov this result proves the key role of 
silicon on the mechanism of protein biosynthesis and the transmission of hereditary 
information and in the structure of nucleic acids. Keeting et al [145] showed that Zeolite A 
stimulate the proliferation and differentiation of osteoblast-like cells in culture. This material 
Introduction - Chapter 1 
 32
releases silicic acid and aluminium salts, so is not possible to isolate the effect of the silicic 
acid. 
More recently, Hildebrant et al [146] demonstrated that certain genes are activated by 
hydrated silicon and Reffit et al [147] showed that at a physiologic concentration (10 – 20 
µM) silicon stimulates collagen type I synthesis, differentiation, alkaline phosphatase activity 
and osteocalcin synthesis in human osteoblast like cells. 
 
 All the studies clearly demonstrated the enormous advantage of the incorporation of 
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Preliminary studies carried out by Gibson et al showed that the incorporation of 
silicon into the HA lattice resulted in enhanced bioactivity. It was also demonstrated that the 
incorporation of this ion induced structural changes, such as distortion in the lattice of HA, a 
axis decreased and the c axis increased with the silicate content.   
 
 In this chapter we tried to further characterize the structural changes induced by the 
incorporation of silicon. We also characterize the changes occurred in the materials during in 
vitro dissolution. This work was done in collaboration with Dr. Alexandra Porter from the 
Department of Materials Science and Metallurgy, University of Cambridge who performed 
the transmission electron microscopy (TEM) analysis.  
 Hydroxyapatite (HA) and silicon-substituted hydroxyapatite (Si-HA) were 
characterised by several techniques, such as: X-ray photoelectron spectroscopy (XPS), 
electrophoretic mobility (zeta potential), Fourier transform infra-red spectroscopy (FTIR), 
transmission electron microscopy (TEM), environmental scanning electron microscopy 
(ESEM), energy dispersive X-ray (EDX).   
 
The incorporation of silicon into the HA structure resulted in a decrease of the surface 
charge of the material towards more negative values and also an increase on the 
hydrophilicity of the material.  
XPS and FTIR results clearly support the substitution mechanism proposed by Gibson 
et al. Vibrational wavelength at 888 cm-1 and 504 cm-1 indicate the presence of SiO44- and the 
binding energy of silicon at 101 eV corresponds to (Si-O) bonding. The XPS and EDX results 
showed that silicon is preferential released from the Si-HA material to the medium. The FTIR 
spectra also demonstrated a decrease on the intensity of the OH- band, being a direct result of 
the substitution of the phosphate groups by the silicate groups and the loss of hydroxyl groups 
due to a charge balance.  
After incubation in SBF an apatite layer was formed on the surface of Si-HA earlier 
than on unmodified HA. The more electronegative Si-HA surface provides a preferential site 
for the nucleation of an amorphous calcium phosphate apatite layer than the HA surface. This 
could occur via the adsorption of Ca2+ ions onto the electronegative surface, resulting in an 
increase in surface charge and the attraction of phosphate groups.  
An important finding of this study was the similarities between the dissolution 
mechanism in vitro and in vivo. In both cases, 1.5 wt% Si-HA was the most soluble, followed 
by 0.8 wt % Si-HA and HA.  
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The aim of this study was to determine the effect of the incorporation of silicon on the 
surface charge of hydroxyapatite (HA) and to assess surface structural changes of HA and Si-
HA induced by dissolution in a static and dynamic system. X-ray photoelectron spectroscopy 
(XPS) analysis showed that SiO4-4 groups were substituted for PO4-3 groups in the silicon-
hydroxyapatite (Si-HA) lattice according to a previously proposed substitution mechanism 
without formation of other crystalline phases, such as tricalcium phosphate or calcium oxide. 
The substituted silicon induced a decrease in the net surface charge and the isoelectric point of 
HA as determined by zeta potential (ZP) measurements. At physiological pH=7.4 the surface 
charge of Si-HA was significantly lowered compared to unmodified HA, i.e. –50 ± 5 eV to –
71 ± 5 eV, caused by the presence of silicate groups in HA lattice, which may account for a 
faster in vitro apatite formation using SBF testing. XPS results indicated that silicon seems to 
be preferentially leached out from Si-HA surface compared to other ionic species after 
dissolution studies in tris-buffer using a dynamic system. 
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In the 1970´s several groups demonstrated that bone mineralization requires a 
minimum concentration of soluble silicon [1-4] and Voronkov suggested that gene activation 
by silicon may be due to the presence of Si-O bonds within the DNA and RNA and he 
concluded that silicon is an inherent component of nucleic acids where it substitutes P5+[5]. 
Hench reported that the deterioration in the proliferation and function of osteoblasts due to 
osteopenia and osteoporosis are related with the loss of biologically available silicon [6] and 
according to Keeting et al bone cells in culture proliferate more rapidly in the presence of 
soluble silicon [7]. These studies clearly demonstrate the enormous advantage of the 
incorporation of silicon in the biomaterials lattice aimed at regenerating bone tissue.  
Specifically related to the biomaterials field, glasses and glass-ceramics with SiO2–
based components have been developed and are now being used in several clinical 
applications [8]. When these materials are introduced in physiological solutions the reactions 
involving the silicate groups are very rapid, which enhances the bioactivity of materials [9] 
leading to the formation of an apatite layer on the surface. In vivo a similar layer is also 
observed at the bone/implant interface [8]. 
In order to take advantage of the positive biological effect of silicon a new apatite 
bioceramic has been developed, Si-substituted hydroxyapatite (Si-HA), using a chemical 
precipitation route [10, 11]. Previous studies have shown that the silicon substitution resulted 
in enhanced cell activity in vitro [12] and increased bone apposition/ingrowth in vivo [13] 
relative to stoichiometric hydroxyapatite. 
 It is well known that surface charge plays an important role in the cell adhesion 
process [14-16]. Cells adhere on both positively and negatively charged surfaces but the 
morphology of adhering cells may vary depending on the sign of the electrical charge [16, 
17]. Numerous studies have demonstrated that the surface structure and composition of 
bioceramics influence their cytocompatibility and affect the sequence of steps that lead to 
bone bonding [18-23]. 
The aim of this study was to determine the effect of the incorporation of silicon on the 
surface charge of HA and to assess surface structural changes of HA and Si-HA induced by 
dissolution testing performed in a SOTAX-Flow through dissolution system. Surface charge 
was calculated by electrophoretic mobility and surface analysis by Fourier transformed infra-
red spectroscopy (FTIR) and X-ray photoelectron spectroscopy (XPS).  
 





Material and Methods 
 
The preparation of the Si-HA was done using a precipitation chemical route and is 
fully described elsewhere [11, 12]. Sintered powders of the HA and Si-HA materials were 
prepared by compacting the as-precipitated powders and sintering them at 1300oC and then 
grinding/milling the sintered specimens to form a fine powder. Powders with a specific 
granule size (between 20-53 µm) were selected for use in this study by sieving in a variety of 
sieve sizes. 
To determine phase purity of the precipitated material used in this study X-ray 
diffraction (XRD) was performed using a Siemens D5000 X-ray diffractometer. Data were 
collected between 25º and 40  2 θ using a step size of 0.02o and a count time of 2.5 seconds. 
Phase identification was carried out by comparing the peak positions of the diffraction 
patterns with ICDD (JCPDS) standards. The X-ray fluorescence confirmed the incorporation 
of 0.8 wt % Si and 1.2 wt % Si in the HA lattice using a Philips PW1606 spectrometer. 
Surface charge was measured in 10-4 M KNO3 solution in a Zeta meter 3.0+ System at 
different values of pH ranging from 3 to 10, according to Smoluchowki`s equation: 
                                                                                                 
 (Eq.1) 
    
where η, D and EM are the viscosity, in poise, and the dielectric constant of the suspending 
liquid and electrophoretic mobility, respectively.   
 
The dissolution of HA and Si-HA in a static system was assessed, whereby sintered 
samples were soaked in a simulated body fluid (SBF K-9).  In addition to studying the 
dissolution in a static environment, this test would distinguish between the ability of an 
apatite layer to form on a HA and a Si-HA surface. Polished dense (98% of the theoretical 
density of HA) discs were placed into 20 ml of SBF K-9 solution and incubated at 37oC and 
pH = 7.4 for periods of time between 0 and 28 days. After each time point, the Ca2+ and PO43- 
ion concentration of the SBF solution was measured using inductively coupled plasma-
emission spectrometry, ICP-ES (Department of Geology, Imperial College, London).  
As an alternative to the static dissolution experiment a dynamic dissolution test was 
performed in a Flow Through Dissolution System (Sotax CE6, a fraction collector Sotax C-
160) in a Tris-hydroxymethyl amino-methane buffer solution at 37ºC and pH = 7.4 using a 









The HA and Si-HA powders were analysed by XPS and FTIR before and after the 
dynamic dissolution test. In the XPS analyses Mg-Kα was used as the radiation source and 
spectra referred to adventitious carbon at 285.0 eV. A Gaussian-Lorentzian function was 
applied for fitting the spectra using the XPSPEAK Version 4.0 software. FTIR spectra were 
obtained using a System 2000 FT-IR/NIR FT-Raman with a resolution of 4 cm-1 and by 




The X-ray diffraction patterns of the HA and 1.2 wt% Si-HA sintered powders are 
presented in Figure 1. The substitution of silicon into the HA lattice did not affect the phase 














Figure 1- X-Ray diffraction patterns for HA and Si-HA. 
 
Figure 2 shows the FTIR spectra of HA and Si-HA. In the spectrum of HA is possible 
to observe the peaks that correspond to PO43- group, 1089, 1046, 958, 600 and 569 cm-1 and 
to the OH- group, 3570 and 630 cm-1, whose wavelengths are in accordance with literature 
values [25]. For the 1.2 wt % Si-HA, two additional peaks were detected at 888 and 504 cm-1 
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Figure 2 – FTIR spectra of HA, 0.8 wt % Si-HA and 1.2 wt % Si-HA.   
  – PO4-3;      - SiO4-4;    - OH- 
 
The results in Figure 3 showed that the isoelectric point of HA was at a pH≈5.5 and 
with the substitution of 0.8 wt % of silicon in to the HA, a shift was observed towards a lower 
pH≈3.8. Another interesting observation was that at a physiological pH=7.4±0.1 the zeta 
potential of HA was –50 ± 5 eV, whereas the zeta potential for 0.8 wt % Si was -71 ± 5 eV. 
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Soaking HA and 1.2wt% Si-HA samples in a simulated body fluid for periods of up to 
28 days showed two different results. Firstly, at the first time point (7 days) both the HA and 
the Si-HA behaved similarly, showing an increase in the calcium and phosphate ion content 
of the SBF solution, which corresponded to dissolution of these ions from the test specimens 
(Figure 4 and 5). It should be noted that the increase in the Ca2+ ion content (approximately 
0.3mmol/l) was significantly greater than the increase in the PO43- ion content (0.05mmol/l). 
Secondly, the Si-HA sample resulted in a rapid decrease in the ion concentration of the SBF 
after 7 days, whereas the same behaviour in the HA sample appeared to be delayed by several 
days. This decrease in the calcium and phosphate ion concentration corresponded to the 
precipitation of an apatite phase from the SBF solution on to the surface of the test specimens, 
as confirmed by SEM (data not shown). Although the HA sample initially resulted in the 
continued dissolution of calcium ions after 7 days, it is interesting to note that when the 
behaviour of both materials changed from dissolution to precipitation/apatite layer formation, 
the decrease in the calcium and phosphate ion contents was approximately 1mmol/l and 
0.6mmol/l, respectively. The Ca/P molar ratio of this decrease corresponds to approximately 
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Figure 5 – [PO43-] concentration in SBF. 
 
Comparing the FTIR spectra of HA before and after dissolution no significant change 
was detected. For Si-HA, however, a decrease in the peak intensities that correspond to the 
most important groups (SiO44-, OH- and PO43-) was observed.  
The FTIR results were complement with XPS analysis of the surface of samples 
before and after dynamic dissolution testing, and although only small changes in the atomic 
percentage of Ca2+, P5+, and O2- could be quantified after dissolution (see Table 1), the Si5+ 
showed a decrease after dissolution, indicating preferential release. From the Figure 6, which 
shows the silicon peak detected in the Si-HA, the binding energy at 101 eV corresponds to 









 Ca P O Si 
HA – b 23.31 16.60 60.09 - 
HA – a 23.03 17.58 59.39 - 
1.2 wt % Si-HA - b 23.46 15.98 59.28 1.28 
1.2 wt % Si-HA - a 22.71 15.85 60.42 1.02 
Table 1 – Relative atomic percentages of Ca, P, O and Si elements before (b) and after 
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Figure 6 – XPS spectra of 1.2 wt % Si-HA. 
 
Discussion and Conclusion 
 
Analysis of the HA and Si-HA compositions produced for this study using XRD and 
FTIR confirmed that the proposed mechanism of silicon (or silicate) substituting for 
phosphorus (or phosphate), in accordance with the results reported previously [12]. The 
analysis by XPS, however, has been able to confirm conclusively that the silicon does exist as 
a tetrahedral silicate, SiO4 group, rather than as a polymeric or as a SiO2 form. This important 
finding supports the analogy between silicon, or silicate substitution with the well-
characterised carbonate substitution of phosphate groups in hydroxyapatite. 
The displacement observed in the zeta potential curves is attributed to the substitution 
of some PO4-3 groups by SiO4-4 groups that occurred in the Si-HA material, which can be 
explained by the mechanism of substitution showed in equation (2).  
 
10Ca2+ + (6-x)PO43- + xSiO44- + (2-x)OH-    Ca10(PO4)6-x(SiO4)x(OH)2-x     (Eq.2) 
 
In fact, it is known that PO4-3 groups are preferentially located at HA surface [28] and 
therefore the substitution of these ions for SiO4-4 groups should result in a decrease in surface 
charge, as indicated by zeta potential measurements. The decrease of intensity of the peak in 
the FTIR spectra that corresponds to the OH- group on the Si-HA was expected since 
according to the mechanism of equation (2) the substitution of the phosphate group for the 
silicate group leads to some OH- loss in order to maintain the charge balance. 
FTIR and XPS results clearly support the substitution mechanism of equation 2 for Si-
HA. Vibrational wavelength of 888 cm-1 and 504 cm-1 indicate the presence of SiO4 and the 
binding energy of silicon at 101 eV corresponds to (Si-O) bonding [27]. 





To complement the above-mentioned interpretation, zeta potential results indicate the 
dislocation of zeta potential of Si-HA towards negative values compared to unmodified HA. 
Literature reveals that PO43- seem to be preferentially located at surface of HA, which may 
somehow contribute to the lower Ca/P ≈ 1.4 observed under XPS analysis when compared to 
the stoichiometric value of Ca/P ≈ 1.67 since under this technique only around the first 
nanometers are analysed. 
Soaking the HA and the 1.2wt% Si-HA samples in a simulated body fluid produced 
comparable trends, but differed in the time-scale of the events. In particular, the Si-HA 
changed from a dissolution behaviour (increased ion concentration in the SBF solution) to a 
surface precipitation behaviour (a decrease in ion concentration in the SBF solution) in less 
time than the HA sample. This result may be due to a greater solubility of the Si-HA material, 
leading to a faster super-saturation of the SBF solution and therefore a faster precipitation of 
an apatite layer from the super-saturated SBF. The data in Figure 4 and 5 does, however, 
suggest that the Ca2+ and PO43- ion concentrations of the SBF solutions from the HA and Si-
HA samples were comparable at 7 days, which is the measured time point before apatite layer 
formation occurred with the Si-HA. The surface properties of the HA and Si-HA ceramics 
may therefore have controlled the time-scale for the change from dissolution to apatite 
precipitation. The results in this study show that the surface charge/zeta potential of the two 
materials were significantly different at pH=7.4. The more electronegative Si-HA surface may 
provide a preferential site for the nucleation of an amorphous calcium phosphate apatite layer 
than the HA surface. This could occur via the adsorption of Ca2+ ions onto the electronegative 
surface, resulting in an increase in surface charge and the attraction of phosphate groups. The 
effect of the real-time formation of an apatite layer on the surface charge of Si-HA and HA 
will be studied in the future.  
Due to low dissolution rate of the materials under study, a higher amount of silicon 
was incorporated in the material to be analysed (1.2 wt % Si) in the dissolution testing. No 
compositional modification was detected for HA before and after dissolution, as shown in 
Table 1. However, preferential ionic release of silicon was observed for Si-HA. Previous 
results showed that the silicon substitution caused a substantial increase in distortion index of 
HA and a decrease in the number OH- groups [29]. It is possible that these lattice disturbances 
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Recent histological studies have demonstrated that the substitution of silicate ions into 
hydroxyapatite (HA) significantly increases the rate of bone apposition to HA implant.  The 
enhanced bioactivity of silicon-substituted HA (Si-HA) over pure HA has been attributed to 
the effect of silicate ions in accelerating dissolution.  In the present study, high-resolution 
transmission electron microscopy (HR-TEM) was employed to compare dissolution of HA 
and Si-HA in an acellular simulated body fluid (SBF) to dissolution in an in vivo model. 
 HR-TEM observations confirmed a difference in morphology of apatite precipitates 
in vivo and in SBF: apatite deposits were plate like in vivo and nodular in SBF.  
Compositional mapping suggested that preferential dissolution of silicon from the implant 
promotes the nucleation of carbonate apatite around the implant. The in vivo findings 
illustrated an absence of dissolution at the bone-HA or Si-HA interface, whereas dissolution 
was extensive from within the implant.  The amount of dissolution in acellular SBF was 
similar to dissolution from within the implant, although the site at which dissolution nucleates 
was different: dissolution predominates at crystallite surfaces in SBF, whereas, grain 
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boundary dissolution predominates in vivo. These findings suggest that proteins in the in vivo 
milieu modify the processes of dissolution from the implant.     
 




Hydroxyapatite (HA) possesses a hexagonal Bravais lattice and a P63/m space group 
with cell dimensions of a = 9.1404 and c = 6.8747 Å, and is known to be bioactive [1, 2].  The 
substitution of silicate ions (SiO44-) for phosphate ion tetrahedra (PO43-) in the HA unit cell 
has been shown to have the potential to increase the rate and amount of bone apposition to 
HA bioceramic implants [2]. However, uncertainty remains about the mechanism by which 
silicate ion incorporation increases the in vivo bioactivity. In previous studies, defect 
structures in silicon-substituted HA (Si-HA) were observed and characterized using high-
resolution transmission electron microscopy (HR-TEM) [1]. Phase pure, sintered granules of 
HA and Si-HA were implanted for 6 and 12 weeks in an ovine model. Samples containing the 
bone-implant interface were prepared for TEM via ultramicrotomy using an anhydrous 
sample preparation procedure. HR-TEM was used to compare the in vivo reactivity of sintered 
granules of HA and Si-HA at both 6 and 12 weeks [3]. 
 Recent HR-TEM results revealed the presence of dislocations and grain boundaries in 
pure HA and Si-HA with a significant increase in density of triple junctions per unit area in 
Si-HA over pure HA [1]. Dissolution was found to be particularly prevalent at grain 
boundaries and triple junctions in vivo and followed the order 1.5 wt% Si-HA > 0.8 wt% Si-
HA > pure HA [3]. These findings suggested that increased numbers of defects in Si-HA play 
a significant role in increasing the rates of dissolution of calcium, phosphate and silicate ions 
from Si-HA. 
As an alternative approach to using in vivo studies for evaluating the bioactivity at the 
bone-biomaterial interface, in vitro immersions in simulated body fluid (SBF) or cell-
containing media may be employed. The commonly proposed mechanism underlying the 
phenomenon of the bioactivity of HA involves the dissolution of calcium and phosphate ions 
from HA [4]. This process may occur through the surrounding environment (extracellular 
fluid) and may also be actively mediated by osteoclast cells [5]. Dissolution generates 
increased concentrations of calcium and inorganic phosphate in the spaces between the 
existing bone and the implant [4]. Precipitation of HA into this space will ensure 
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incorporation of the implant into the existing bone [6]. It is commonly believed that 
dissolution and reprecipitation of apatite crystallites promote incorporation of biological 
molecules [7]. 
The evaluation of bioactivity using in vitro immersion techniques have been criticized 
because they do not fully replicate the complicated series of dynamic reactions that occur at 
the bone-biomaterial interface in vivo. In particular, the biological response of CaP 
biomaterials implanted in vivo might be different from that evaluated with standard in vitro 
tests because of the interaction of calcium phosphate compounds with the complex array of 
constituents in the body, in particular macromolecules. Nevertheless, these systems aid 
evaluation of specific cellular and proteinaceous responses at the bone-implant interface [8-
11]. In vitro studies also minimize the need for animal experiments and offer potential to 
study the dissolution-reprecipitation mechanism at very early time points. 
A recent study demonstrated that many interfacial reactions are paralleled in vivo and 
in vitro [12]. A study by Fujibayashi et al comparing in vivo bone ingrowth and in vitro 
apatite formation on Na2O-CaO-SiO2 glasses illustrated that the depth of bone ingrowth 
among glass particles increased in proportion to their apatite forming ability in vitro [12]. The 
in vitro results of an investigation of the apatite forming ability of Si-HA with several 
compositions, corroborate our histological in vivo studies: the time required to form a surface 
apatite layer on Si-HA in SBF decreased with increasing silicate ion substitution [11]. 
Furthermore, silicate ion substitution stimulates osteoblast-like cell activity in vitro when 
compared to stoichiometric HA. Despite these similarities on the microstructural scale, 
questions remain as to whether mechanisms of apatite dissolution and precipitation at the 
ultrastructural level are similar in both in vivo and in vitro model systems. 
The objective of the current study was to use HR-TEM to compare in vitro dissolution 
of ultrathin (<90 nm) sections of HA and Si-HA in acellular SBF at 6 hours, 1 and 3 days, 
with the results of a previous study investigating dissolution and bone remodelling around 
pure HA, and Si-HA (0.8 and 1.5 wt%) in vivo [13]. We proposed that the combination of in 
vivo and in vitro studies may lead to an improved understanding of surface reactions of 
bioactive ceramics in the body and their effects on bone formation and cell function. Only a 
few studies have investigated the ultrastructure of apatite deposits in SBF solutions [14]. The 
lack of information that describes ultrastructural characteristics arises from the difficulty of 
preparing samples for TEM observation. This study develop a simple, alternative 
methodology for preparing samples for in vitro TEM observation. 
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Material and Methods 
 
Chemical Synthesis 
Phase pure HA with a Ca/P molar ratio of 1.67 was prepared by a precipitation 
reaction between calcium hydroxide [Ca(OH)2] and orthophosphoric acid, [H3PO4] solution 
according to the methods described elsewhere [15]. Two types of Si-HA (0.8 wt% and 1.5 
wt%) were also prepared by acid-base neutralization reactions according to the methods of 
Gibson et al [16]. In addition to calcium hydroxide and orthophosphoric acid, silicon acetate 
[Si(CH3COOH)4] was incorporated into the reaction mixture as a source of silicate ions. The 
quantities of reactants were calculated by assuming that silicate ions would substitute for 
phosphate ions in the HA lattice. Therefore, the number of moles of H3PO4 in phase pure HA 
was the same as the number of moles of H3PO4 + Si(CH3COOH)4 for the Si-HA samples, with 
the number of moles of Ca(OH)2 being kept constant. Precipitation reactions were carried out 
at room temperature and the pH was maintained at 10.5 by the addition of ammonium 
hydroxide solution. After complete mixing of the reactants, the suspensions were aged 
overnight. The resulting precipitates were filtered, washed and dried at 80 oC overnight. 
 
Sample Preparation 
 HA and Si-HA were prepared both as powders to compare dissolution in SBF and as 
granules to compare dissolution in vivo. 
Aged, filtered and dried precipitates of pure HA and 1.5 wt% Si-HA were ground into 
a fine powder. The powders were subsequently calcined at 1200 oC for 120 minutes using a 
ramp rate of 2.5 oC/minute. An X-ray fluorescence (XRF) analysis was performed from 
previous work [3] showed the Ca/P molar ratio of the pure HA to be 1.67, which is equivalent 
to stoichiometric HA. The Ca/(P+Si) molar ratios of 0.8 wt% Si-HA and 1.5 wt% Si-HA were 
1.68. The X-ray diffraction (XRD) measurements for HA powders indicated that the sintered 
HA, 0.8 wt% and 1.5 wt% Si-HA were phase pure, with no additional phases present. The 
effect of the silicate ion substitution on the crystal structure of HA was determined by 
Rietveld structure refinement of the XRD data. Silicate ion substitution resulted in a decrease 
in the a axis and an increase in the c axis of the unit cell of HA and a slight decrease in the 
unit cell volume. These results suggest that the larger silicate ion (SiO44-) substitutes for the 
phosphate (PO43-) group in the HA lattice [1].  
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Embedding of the HA and Si-HA powders 
Powders of HA and Si-HA were treated with three changes of 100% ethanol and three 
of propylene oxide over 1 hour, and then infiltrated with Spurr’s resin (Agar Scientific, Essex, 
UK) over several days: Spurr’s resin was prepared with 10 g epoxy monomer vinyl 
cyclohexene dioxide (ERL), 4.5 g diglycidyl ether of polypropylene glycol (DER-736), 26 g 
nonenyl succinic anhydride (NSA), and 0.7 g benzlydimethylamine (BDMA). The samples 
were agitated at room temperature in 1:1 solutions of propylene oxide and Spurr’s resin for 2 
days, 1:3 solutions of propylene oxide/Spurr’s resin for 1 day, then 100% Spurr’s for 2 weeks 
under vacuum. The Spurr’s resin was changed every 24 hours. Samples were then cured in 
fresh Spurr’s resin for 23 hours at 60 oC. Pre-casting a ~ 200 µm layer of Spurr’s resin into 
the truncated beam capsules before adding the HA powders facilitated sectioning of the 
blocks. 
 
          Dispersion of powders in SBF and transmission electron microscopy preparation 
 Sections (90 nm) of HA, 0.8 wt% Si-HA and 1.5 wt% Si-HA powders were cut onto a 
water bath using a diamond knife a Leica Ultracut. Sections were collected on lacey carbon 
support gold TEM grids and most of these were dispersed in SBF solutions [9] at a pH of 7.4, 
at 37 oC for 6 hours, 1, 3 and 5 days. It was assumed that convection would be sufficient to 
stir the SBF solutions. The fluid was prepared by dissolving reagent-grade NaCl, KCl, 
K2HPO4·3H2O, MgCl2·H2O, CaCl2, and NaSO4 into distilled water and buffered to pH 7.4 
with tris [hydroxymethyl]aminomethane, [(CH2OH3)3CNH3)], and hydrochloric acid. 
   
            Transmission electron microscopy 
TEM and selected area electron diffraction (SAED) were performed in a Philips 
CM30 operated at 300 kV. Diffraction contrast was employed for bright-field imaging.   
 
           Environmental scanning electron microscopy (ESEM) 
 ESEM was performed on the Phillips ESEM-FEG, XL30 in low vacuum mode, using 











TEM observations of sintered powders 
The TEM of the pure HA, 0.8 and 1.5 wt% Si-HA powders in ethanol revealed 
smooth, discrete edges with no loss of mineral at the subgrain boundaries or triple junctions. 









Figure 1 - ATEM micrograph of a sintered 0.8 wt% Si-HA powder, illustrating a triple-
junction grain boundary. 
 
Dispersion in Simulated Body Fluid 
 
Pure HA 
After 6 hours dispersion in SBF, the ultrastructure of the HA was preserved; there was 
no loss of mineral from the pure HA. After 1 day, in a few regions, apatite deposits had 
nucleated on the surface of the HA and in the surrounding region (Figure 2a). SAED 
confirmed these deposits to be crystalline. The apatite precipitates were composed of several 
almost nodular shaped crystals, which had agglomerated. In many regions the surfaces of the 
HA grains appeared mottled, suggesting dissolution had occurred (Figure 2b). This mottled 
morphology was present throughout the grains and was most prevalent at their surfaces. At 3 
days, both dissolution and reprecipitation of apatite mineral were much more prevalent. In 
many regions, extensive dissolution of the HA occurred (Figure 2c) as indicated by the 
presence of voids and it was not related to beam damage [3]. In several regions there were 
needlelike crystallites that emanated from the surface of many of the HA crystallites (Figure 
2c).  These crystallites grew almost perpendicular to the surface of the HA crystallites (Figure 
2c).  The apatite deposits were associated with regions of the HA that exhibited mottled 
contrast (Figure 2d). In other regions there were nodular precipitates of apatite, which 
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nucleated on the surface of the HA (Figure 2e). Energy dispersive X-ray (EDX) analysis 
showed these precipitates had 55.26 wt % Ca, 41.69 wt.% P, 2.91 wt % Si in region 1; 53.94 
wt % Ca, 45.96 wt % P, 0.78 wt % Si in region 2; and averages 54.60 wt % Ca, 43.83 wt % P, 
and 1.85 wt % Si. Indexing of the SAED patterns confirmed the precipitates to be apatite 

























Figure 2 - TEM micrograph of grains of pure HA 1 day after dispersion in SBF, indicating (a) 
apatite deposits precipitated on the surface of HA and in the surrounding region (arrows) and 
(b) the mottled appearance of grains suggesting the occurrence of dissolution (arrows). Pure 
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regions comprising of voids, which is related to dissolution; (d) needle-like apatite deposits 
precipitated on the surface of the implant; and (e) nodular precipitates of apatite, 
 nucleated on the surface of the HA, with (f) the associated SAED pattern from the apatite 
deposits. 
 
0.8 wt. % Si-HA 
In general, the dissolution and reprecipitation of apatite appeared more extensive on 
the surface of the 0.8 wt% Si-HA grains after 6 hours dispersion in SBF solution. In a few 
regions the apatite deposits nucleated both on the surface of the 0.8 wt% Si-HA and in the 
surrounding regions (Figure 3a). Apatite deposits were also observed on the 0.8 wt% Si-HA 
grains at 1 day (Figure 3b). After 3 days, dissolution and reprecipitation of apatite appeared to 
be more extensive (Figure 3c), and many needlelike apatite deposits had nucleated in the 

















Figure 3 - TEM micrographs of 0.8 wt% Si-HA illustrating apatite deposits (a) 6 hours after 
dispersion in SBF; (b) 1 day after dispersion in SBF with apatite deposits nucleated on the 
surface of the 0.8 wt.% Si-HA (arrows), and (c) 3 days after dispersion in SBF, illustrating 
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1.5 wt % Si-HA 
At 6 hours, in several regions, clusters of apatite nucleated on the surface of the Si-HA 
and in the surrounding regions (Figure 4a). These apatite precipitates appeared to be nodular. 
A SAED analysis confirmed these deposits to be apatite. In other regions the Si-HA appeared 
to have undergone some dissolution (Figure 4b).  After 1 day, dissolution and reprecipitation 
of the Si-HA were much more extensive than on the HA and 0.8 wt% Si-HA (Figure 4c). In 
several regions there were apatite deposits with needlelike morphology present and they 
appeared to emanate from the surfaces of grains. SAED confirmed that the precipitates were 
apatite. Dissolution from the surface of the Si-HA was even more extensive after 3 days in 
SBF (Figure 4d). Many grains appeared to have almost entirely dissolved. Furthermore, many 
of the grains of Si-HA were very unstable under the electron beam (Figure 4e). Indexing of 
the electron diffraction patterns from a dissolving grain confirmed that the dissolved regions 
corresponded to HA. Dissolution from the Si-HA predominated at the crystal surfaces. The 
apatite precipitates maintained the nodular morphology at 3 days. EDX revealed them to have 
59.31wt.% Ca, 26.68 wt.% P and 3.92 wt.% Si in region 1; 47.76 wt% Ca, 49.28 wt% P, and 
2.57 wt% Si in region 2; 49.18 wt% Ca, 47.99 wt.% P and 2.27 wt% Si in region 3; and 
































Figure 4 - TEM micrographs illustrating 1.5 wt.% Si-HA (a,b) after 6-h dispersion in SBF, 
showing (a) clusters of apatite nucleated on the surface of the Si-HA and in the surrounding 
regions, and (b) some dissolution extending throughout the grains; (c) after 1-day dispersion 
in SBF, illustrating apatite deposits with a needle-like morphology emanating from the 
surfaces of grains; (d) after 3-day dispersion in SBF, showing extensive dissolution of grains 
(arrow); and (e) after 3-day dispersion in SBF, indicating a grain that was particularly 
unstable under the electron beam (arrow). 
 
Environmental Scanning Electron Microscopy (ESEM)  
The ESEM of 1.5 wt% Si-HA after 5 days in SBF confirmed that dissolution had 
occurred in several regions (Figure 5a). EDX mapping revealed preferential dissolution of 









Figure 5 - ESEM of 1.5 wt.% Si-HA after 5 days in SBF (a) confirming that dissolution had 
occurred in several regions and (b) a corresponding EDX map revealing preferential 
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In vivo study 
The results of an in vivo study were described in a recent article [13]. Therefore, this 
paper only highlights the most important findings, which are relevant to this study. After 6 
and 12 weeks in vivo, dissolution of the HA (Figure 6a) and 0.8 and 1.5 wt% Si-HA grains 
(Figure 6b) was not observed at the bone/implant interface of any of the ceramics, although 
extensive dissolution was observed within the implant (Figure 6c). After 12 weeks in vivo, 
needle-like crystallites emanated from the surface of many of the Si-HA crystallites within the 
implant, indicating that extensive dissolution had occurred (Figure 6c). A widespread mottled 
effect was observed on the surface of the 1.5 wt% Si-HA samples localized between the 
needle-like crystallites and the dissolving grains (Figure 6d). Dissolution within the implant 

















Figure 6 - TEM micrographs of the bone/implant interface after 12 weeks in vivo, 
demonstrating no dissolution of either (a) the HA or (b) the 0.8 wt.% Si-HA grains at the 
bone/implant interface and (c) needlelike crystallites emanating from the surface of many of 
the Si-HA crystallites within the implant, indicating that extensive dissolution had occurred. 
(d) An extensive mottled effect comprising of voids on the surface of the 1.5 wt.% Si-HA 









In vivo and in vitro studies have suggested that the formation of the apatite layer is an 
essential requirement in events leading to subsequent osteointegration of the implant [4]. The 
bioactivity of calcium phosphate and many other materials has been related to their propensity 
to nucleate carbonate apatite crystals [17]. Formation of a biologically equivalent apatite layer 
can be reproduced in vitro by immersion experiments using SBF. In vitro studies by Gibson et 
al demonstrated that the time required to form an apatite layer on Si-HA in SBF decreased 
with increasing silicate ion substitution [11]. These results corroborate in vivo histological 
findings by Patel et al, illustrating increased amounts of bone apposition to Si-HA implants 
compared to pure HA [2]. These findings demonstrate the value of SBF bioactivity tests to 
model the in vivo system. Nevertheless, uncertainty remains about whether the ultrastructural 
characteristics of in vitro dissolution-reprecipitation processes mimic those processes 
occurring in vivo.   
 The lack of information describing the ultrastructural characteristics of HA immersed 
in SBF results from the difficulty in preparing these samples for TEM observation. In the 
current study, a procedure was developed for preparing ultrathin samples for TEM by 
sectioning embedded powders using an ultramicrotome and immersing the sections in SBF. 
This methodology does not allow for direct comparison between the timing of events at the 
bone-HA and SBF-HA interface.  Nevertheless, for the purpose of this study it was successful 
in providing a qualitative comparison of the changes in the ultrastructure of synthetic HA and 
apatite deposits in vivo and in vitro.   
A notable finding in this study was that the current in vitro results uphold in vivo 
findings of dissolution following the order 1.5 wt% Si-HA> 0.8 wt% Si-HA > pure HA after 6 
and 12 weeks [3].  Dissolution of the 1.5 wt% Si-HA was extensive after 3 days in SBF, 
whereas dissolution was less extensive on the surface of the pure HA at 3 days. These results 
suggest that SBF is a valuable medium for modelling the amount of dissolution in vivo.   
It was interesting finding in this study that the silicon content of apatite deposits 
surrounding the Si-HA was higher than that surrounding the pure HA after 3 days in SBF. 
The effect of silicic acid on calcium phosphate precipitation in vitro was investigated in order 
to test the possible involvement of silica in dental plaque as a promoter of calculus formation 
[18]. An in vitro study by Damen et al [19], illustrated that silica decreases the time for 
spontaneous precipitation of HA from supersaturated solutions with a wide range of Ca/P 
ratios in vitro. Furthermore, the study demonstrated that silica was capable of stimulating 
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apatite precipitation in the presence of bacterial inhibitors to calcium phosphate precipitation 
[19]. The current results suggest that dissolution of silicate ions from the implant promotes 
the heterogeneous nucleation apatite.   
In a previous study, Rietveld structural refinements clearly illustrated silicate ions 
were being substituted for phosphate ions in the HA lattice [1]. These HR-TEM observations 
confirmed that grain boundaries in pure HA and 0.4 wt% Si-HA did not contain second 
phases such as tricalcium phosphate or silicon-rich amorphous phases. In comparison, energy 
filtered TEM imaging of some triple junctions in 1.5 wt% Si-HA revealed the presence of a 
less crystalline phase at some the triple-junctions, extending along the grain boundaries. 
These combined XRD and HR-TEM observations suggested that silicon as silicate ions is 
generally distributed uniformly within the lattice of the HA but silicon may also be 
segregating as a silicon-rich secondary phase at some grain boundaries in Si-HA. A 
subsequent, in vivo dissolution study demonstrated that grain boundary dissolution was 
prominent in Si-HA but was not observed in phase pure HA. Instead, the presence of voids, 
within grains of pure HA containing dislocations at 12 weeks in vivo suggested that 
dislocations may be the major initiation sites for dissolution. These investigations of the 
dissolution of HA and Si-HA provided further evidence for the proposed difference in the 
grain boundary structure between pure HA and Si-HA. These findings suggested that the less 
crystalline phase is dissolving preferentially in vivo. If this phase were silicon rich, these 
results would imply preferential dissolution of silicon from the Si-HA. In an in vitro study 
using X-ray photoelectron spectroscopy (XPS), Botelho et al demonstrated a preferential 
release of silicate ions from Si-HA compared to HA [20]. The authors suggested that the 
incorporation of silicate ions into the HA lattice would distort and destabilize the structure, 
therefore making it energetically favourable for silicate ions to dissolve preferentially from 
the HA [20]. The current in vitro findings suggest that these two dissolution models are 
plausible. EDX mapping of the Si-HA after 5 days immersion in SBF demonstrated a 
preferential loss of silicon in dissolving regions of the ceramic. These results are particularly 
significant, because silicon has been shown to be a promoter of bone calcification [21]. If 
silicon is being rapidly released as a bolus from the implant, silicon may accelerate bone 
mineralization. 
The current study also highlights the differences in apatite morphology observed in 
vivo and in vitro. In the in vitro model, apatite deposits were frequently nodular and 
agglomerated, whereas in vivo apatite deposits were plate- or needlelike. These results reflect 
the difference in the in vivo and in vitro environments and suggest that noncollagenous 
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proteins, such as phosphoproteins and albumin and also the collagen fibrils, act as the 
controllers of apatite nucleation, as well as growth and morphology [22]. 
The results of a recent HR-TEM study, which investigated dissolution from HA, 
0.8wt% Si-HA and 1.5wt% Si-HA implants after 6 and 12 weeks in vivo, illuminated 
differences in the morphology of apatite deposits at the Si-HA/bone interface and within the 
pores of the implant [3]. Larger, needlelike crystallites were observed on the surface of the 
1.5wt% Si-HA granules in the deeper regions of the implant when compared to the smaller 
plate like apatite crystallites at the bone/Si-HA interface. Furthermore, extensive dissolution 
was observed from the Si-HA within the implant, whereas no signs of dissolution were 
observed at the interface between the bone and the Si-HA. A study by Combes et al 
demonstrated that in the in vitro system proteins act not only as promoters but also as 
inhibitors to CaP precipitation, because the proteins slow down the ionic diffusion to the 
crystal surfaces [23]. This recent study hypothesized that these differences in ultrastructure 
were caused by proteins (e.g fibronectin) that adsorb onto the surface of the implant and form 
a surface layer, which may prevent degradation of the implant surface. Based on these 
findings, it was suggested that the biological environment of the HA within the implant was 
more analogous to that of an acellular in vitro medium. The current findings confirmed this 
hypothesis to be valid and demonstrated similarities in the morphology of dissolution features 
on HA and Si-HA within the implant in vivo and dispersed in SBF.   
The current study clearly illustrates similarities in the amount of dissolution and the 
morphology of dissolution features in vivo and SBF models. Despite these similarities, the 
current HR-TEM observations reveal differences in the site at which nucleation initiates in 
vivo and in vitro: in vitro dissolution predominates throughout grains, whereas dissolution 
within the implant initiates predominantly at grain boundaries in the in vivo model. This 
difference may be the attributable to the interaction of proteins with the implant surface prior 
to dissolution and apatite formation in vivo. Future work will establish whether factors 
associated with non-collagenous proteins, such as protein size or concentration, are the 




This study confirmed a difference in the morphology of apatite precipitates in vivo and 
in SBF: apatite deposits were plate like in vivo and nodular in SBF. The site at which 
dissolution nucleates was also different: dissolution predominates at crystal surface in SBF, 
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whereas grain boundaries dissolution predominates in vivo.  Compositional mapping in this 
study suggested that silicon dissolves preferentially from the Si-HA and encourages 
nucleation of carbonate apatite around the implant. A previous study illustrated that no 
dissolution whatsoever occurred at the bone-HA or Si-HA interface in vivo. In comparison, 
dissolution within the implant was similar to dissolution observed in SBF. These results 
suggest that the proteins and cells prevent dissolution from the surface of the implant. In 
summary, the present study suggests that, despite being unable to accurately model the 
ultrastructure of dissolution and reprecipitation features found in vivo, SBF is a valuable 
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 Protein adsorption is one of the first events that occur after implantation in a living 
system. This event takes place well before cells appear, consequently cells will respond to this 
layer. Thus, the protein layer is a key factor that can control the bioreaction to implants. The 
formation of an apatite layer is considered to be an important step to osteointegration. 
Therefore, in this chapter we study the effect of human serum proteins on the dissolution and 
apatite layer formation on hydroxyapatite (HA) and silicon-substituted hydroxyapatite (Si-
HA). We also study the adsorption of specific proteins to the materials, such as: collagen type 
I (COL I), immunoglobulin G (IgG) and albumin (BSA).  
 
 HA, 0.8 wt % Si-HA and 1.5 wt % Si-HA were incubated in solutions containing 
human serum proteins for different periods of time. Therefore, it was possible to follow the 
effect of these proteins in different stages of the apatite formation. Additionally, another set of 
samples was incubated in solutions containing single proteins (COL I, IgG and BSA) and 10 
% (v/v) of human serum proteins, in order to study the affinity of the proteins to the different 
substrates. 
 
On the basis of the result presented in this chapter, it is proposed that the presence of a 
protein layer surface on HA and Si-HA acts as a dissolution barrier, preventing ions from 
diffusing directly from the surface of Si-HA to the solution. As dissolution constitutes the first 
step in physiological apatite formation, this proposed mechanism accounts for the retarded 
apatite layer formation observed in the HS-supplemented groups. Furthermore, the dissolution 
features observed on Si-HA surfaces and in particular on 1.5 wt % Si-HA after incubation in 
SBF free of human serum proteins suggest the importance of silicon dissolution in the 
formation of the apatite layer on Si-HA. 
 
All incubated materials demonstrated a higher binding affinity to collagen. A slight 
increase in the affinity of collagen was observed with the increase of the silicon content. HA 
and Si-HA showed the same affinity to IgG, but in the case of the albumin a slight decrease 
was observed on the Si-HA. 0.8 wt % Si-HA showed to have a higher affinity for human 
serum proteins when compared to the other two materials.  
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Human serum proteins adhere to calcium phosphate within seconds after implantation. 
This layer influences the biological behaviour of the biomaterials. Hydroxyapatite (HA) and 
0.8 wt% of silicon substituted hydroxyapatite (Si-HA) were incubated in three different 
solutions; simulated body fluid, simulated body fluid with 0.1 % and 10 % in volume of 
human serum. The surface of Si-HA underwent significant surface changes more rapidly than 
the HA surface. After a period of 7 days incubation in SBF an apatite layer was observed by 
ESEM and AFM on the Si-HA surface, but not on the HA surface. At the HA surface calcium 
phosphate deposits were only observed after 28 days of incubation. The formation of an 
apatite layer on the surface of both materials seems to have been delayed with the addition of 
human serum proteins. 
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Several studies have demonstrated the enormous advantage of the incorporation of 
silicon in the biomaterials lattice aimed at regenerating bone tissue [1-3]. Therefore to take 
advantage of the positive biological effect of silicon, Si-substituted hydroxyapatite (Si-HA) 
has been developed using a chemical precipitation route [4, 5]. 
The organic matrix has an important role in the ossification process by guiding 
mineral deposition and favouring mineralization [6]. Collagen provides an oriented matrix for 
mineral deposition, but it seems that noncollagenous matrix substances, which can bind to 
calcium phosphates, modify the calcium/phosphorous ratio and so will influence crystal 
formation and growth [7]. The role of these proteins is still poorly understood. Several factors 
can alter the behaviour of these proteins, such as the supersaturation ratio of the solution, the 
local concentration of co-precipitating ions, and the presence of others proteins and whether 
proteins are free in solution or immobilized [6]. 
This work is aimed at assessing the effect of human serum (HS) proteins on the 
dissolution and ability to form an apatite layer of HA and Si-HA. Tapping mode AFM and 
ESEM were the techniques used to examine the physical changes that occurred at the surface 
of the HA and Si-HA as result of immersion in different physiological solutions. 
 
Material and Methods 
 
The preparation Si-HA and HA has been fully described elsewhere [4, 5]. As-prepared 
dense discs were placed into three different solutions: Simulated Body Fluid (SBF), SBF with 
0.1 % and 10 % in volume of Human Serum (HS) (HD Supplies, UK), incubated at 37 º C for 
a period of time between 0 and 28 days. The ratio of solution surface area per volume used 
was 0.1 cm-1. The surface changes were observed using atomic force microscopy (AFM) and 
environmental ESEM. AFM imaging was performed with a help a Digital Instruments 
NanoScope III and ESEM signals were collected in low vacuum mode, with an off axis 
gaseous secondary electron detector. 
 






The materials were analysed by X-ray diffraction to assess their phase purity. The 
surface of the materials was observed by ESEM and AFM before incubating in the different 
solutions. No dissolution features or deposits were detected.   
At day 1 no changes were detected on the HA surface after incubation in SBF and SBF 
with 0.1 % (v/v) HS, while some deposits were observed on the HA surface incubated with 10 
% (v/v) HS. These deposits were seen on all samples incubated in SBF with 10 % (v/v) HS, 
and at all immersion time points (Figure 1 (a,b)). Until now, it was not possible to determine 
the chemical composition of these deposits due to their fragility and disintegration when 
exposed to the electron beam. When incubating Si-HA in SBF for 1 day, it was possible to 
observe some calcium phosphate deposits in the Si-HA grains, and also dissolution at the 
grain boundaries (Figure 2 (a,b)). This may be due to the preferential dissolution of silicon 
from the grain boundaries, as no significant change was detected in the calcium and 
phosphorous concentrations of the SBF. These results are in agreement with previously 
published work [8]. Another interesting result was observed on the Si-HA surface incubated 
in SBF with 10 % (v/v) HS (Figure 3). Due to the interaction between the surface and the 
solution, the deposits on the surface were aligned at the grain boundaries. These features were 











Figure 1 – Deposits on the HA surface after incubating in SBF with 10 % (v/v) HS for 1 day 


















Figure 2 – Deposits at the Si-HA surface after 1 day in SBF (a – 5 x 5 µm) and clear 










Figure 3 – Deposits at the Si-HA grain boundaries after 1 day in SBF with 10 % (v/v) HS 
(scale bar 10 µm). 
 
When HA was incubated for a period of 7 days in SBF, most of the grains were intact 
with no dissolution features or significant deposits, although when incubated in SBF with 0.1 
% (v/v) and 10 % (v/v) HS the surface was partially covered by an amorphous film (Figure 4 
(a,b)). Significant changes were detected on the Si-HA surface for the same period of 
incubation. An apatite layer was observed on the samples incubated in SBF, although the 
surface was not completely covered. This can be seen in Figure 5 and 6, where in some areas 
of the sample it is still possible to observe the grains. On the surface of the samples incubated 
in SBF with 0.1 % (v/v) of HS for the same period of time, dissolution features were mainly 
observed. Over the same period of time, no calcium phosphate deposits appeared on the 


















Figure 4 – An amorphous film on the HA surface after incubation in SBF with 0.1 % (v/v) 











Figure 5 – Apatite layer partially covering the Si-HA surface, after 7 days of incubation in 










Figure 6 – An apatite layer partially covering the Si-HA surface after 7 days of incubation in 












At day 10 a complete apatite layer had formed on the surface of the Si-HA incubated 
in SBF (Figure 7). This apatite layer appears to be more crystalline than the apatite layer 
observed after 7 days immersion, as shown by the shape of the crystals shown in Figure 8 
(a,b). After 14 days of incubation in SBF it was not possible to observe an apatite layer. Only 
after 28 days of incubation in SBF, calcium phosphate deposits were observed on the surface 
of the HA substrate (Figure 9 (a)). These deposits were not detected in the samples incubated 
in SBF with 0.1 % (v/v) HS, although an amorphous film was observed to partially cover the 










Figure 7 – A complete apatite layer on Si-HA afer incubation in SBF for a period of 10 days 










Figure 8 - Calcium phosphate crystals at Si-HA surface after incubation in SBF for a period 



















Figure 9 - (a) Calcium Phosphate deposits on the HA surface after 28 days of incubation in 
SBF (Scale bar 10 µm), and a thin film deposit on HA surface for the same period of time 
when incubated in SBF with 0.1% (v/v) HS (Scale bar 2µm) 
 
Discussion and Conclusion 
 
The composition of the protein layer formed on the surface of these calcium 
phosphates influences the biological response to the material after implantation [9]. The 
results indicate that when these proteins are present in higher concentrations (10 % (v/v) HS), 
the dissolution and consequent formation of the apatite layer is delayed. These results are in 
agreement with those reported in literature [10]. When the materials were incubated in SBF 
with 0.1 % (v/v) HS, the dissolution was higher than in the samples incubated in SBF with 10 
% (v/v) HS. This may be due to the lower coverage of the surface of the samples incubated in 
the different solutions, and also due to the different conformations of these proteins. The 
samples incubated in SBF with 10 % (v/v) HS may be completely covered by a protein layer, 
protecting the surface from dissolution which is required for the formation of the apatite layer. 
A lower concentration of proteins may decrease the competition between proteins and change 
the conformation of these proteins, influencing the formation of the calcium phosphate 
deposits. It is known that the adsorption of some proteins has a maximum at low 
concentration of HS, such as fibrinogen or albumin [13]. When fibrinogen is deposited on a 
glass surface, it has a maximum adsorption with 1 % (v/v) HS, although albumin, under the 
same conditions has a maximum adsorption with 6 % (v/v) HS [13]. Using the technique of 
AFM and ESEM it was possible to verify that changes on the Si-HA surface begin at day 1, 
a) b) 




with dissolution at the grain boundaries. This may be due to preferential dissolution of silicon, 
as no significant changes in the concentration of calcium or phosphorous were detected in the 
SBF solution. It has been already reported that when Si-HA is incubated in Tris buffer 
solution, there is a preferential dissolution of silicon [8]. The surface of Si-HA underwent 
significant changes more rapidly than the HA surface. The introduction of 0.8 wt% silicon in 
the HA lattice increases the bioactivity of the HA. These results are in agreement with the 
literature [14, 15]. Further studies are needed in order to fully understand the mechanisms by 
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Surface characterisation of silicon-substituted hydroxyapatite: A 




The adsorption of human serum proteins plays a key role on the biological response to 
a biomaterial in vivo, such as apatite layer formation and cell behaviour. Several factors may 
alter the adsorption of these proteins, namely the physical-chemical properties of the 
materials. We previously reported that the incorporation of silicon into the HA lattice induces 
a more negative surface charge, in this study it was shown that the incorporation of silicon 
increased the hydrophilicity of the HA material. In order to assess the effect of these proteins 
on the dissolution of the Si-HA material and apatite formation, several samples of Si-HA 
where incubated in serum-free SBF and in serum SBF. In serum-free SBF the incorporation 
of silicon (1.5 wt % Si) into the HA lattice decreased the time required for apatite formation 
when compared to phase pure hydroxyapatite. The images obtained by AFM and phase image 
AFM showed extensive dissolution on the samples incubated on serum-free SBF at early time 
points, on the other hand the samples incubated in serum SBF showed to be covered by 
protein layer. This result was confirmed by XPS analysis, which showed an increase in the 
nitrogen concentration on the surface of the samples. The ICP measurements confirmed that 
the protein layer slows down the ionic release to the surrounding solution. Consequently this 
delay will result in a delay on the formation of an apatite layer.  
 
Keywords: Proteins, Atomic Force Microscopy (AFM), Phase Atomic Force Microscopy 




 Since 1970´s several studies demonstrated the positive effect of silicon on bone 
mineralization [1-3]. More recently, Patel et al showed the beneficial role of the incorporation 
of silicon into the hydroxyapatite (HA) lattice in vivo [4], the silicon-substituted 
hydroxyapatite material enhanced bone regeneration. Although, the mechanism behind the 
enhanced bioactivity of the silicon-substituted hydroxyapatite (Si-HA) is still poorly 
understood. Due to the complexity of the in vivo model, several in vitro studies have been 





performed in order to clarify the mechanism behind the positive effect of silicon [5-11]. It has 
been shown that the incorporation of 0.8 wt % of silicon into the HA lattice decreases the time 
required for apatite formation in 64 % (28 days for phase pure HA to 10 days for 0.8 wt % Si-
HA), when incubated in simulated body fluid (SBF) at physiologic conditions [6].  
The ability of a biomaterial to form an apatite layer is considered to be an important 
characteristic for osseointegration [12]. Although, when a biomaterial is implanted there are 
several steps that will lead to the osseointegration, being the first event the adhesion of 
proteins to the surface, this step will take less than a second [13, 14], following the formation 
of a protein monolayer. Only after the adsorption of the protein layer cells reach the implanted 
site. Therefore, cells will mainly respond to this layer instead of the biomaterial surface itself 
[14]. The integrin receptors present in most cells recognize the adsorbed proteins, being this 
mechanism responsible for the bioreaction to an implant [15]. In the presence of a solid phase 
proteins in solution have the tendency to adsorb [16]. Proteins change their conformation to 
maximize the energy gain from adsorption, this adsorption will be irreversible if the 
conformational change required for desorption is energetically unfavourable [17]. Although, 
some proteins may be desorbed from the surface by other molecules in solution, as described 
by the “Vroman effect” [18]. This theory states that the more profuse and smaller proteins 
from blood plasma can be displaced by the fewer larger proteins that have higher affinities for 
the surface [18]. Several studies showed that determined proteins may induce (e.g. 
fibronectin) or inhibit (e.g. albumin) the nucleation of the calcium phosphate crystals [19], 
therefore a possible function of the specific crystal proteins could be to control the nucleation 
and growth of physiological apatite during the mineralization process [19]. In previous studies 
Botelho et al reported that the presence of human serum proteins in different concentrations 
delayed the formation of an apatite layer on 0.8 wt % Si-HA and HA [6]. 
The physicochemical properties of the material, such as surface chemistry, surface 
charge and surface energy, will influence protein adsorption and functionality, through 
changes in its orientation and conformation [16, 20, 21], and consequently cell behaviour [22-
24]. It has been shown that HA and Si-HA have different physicochemical properties, namely 
surface charge [5], the incorporation of silicon on the HA lattice induce a more negative 
surface charge.  
In order to better understand the biological behaviour of the Si-HA two additional 
physical-chemical properties were determined, surface wettability and interfacial tension. 
These properties can be determined through the measurement of contact angle, being the most 
common experimental technique the sessile drop [25]. In this method a droplet is placed very 





slowly on the surface of the material, originating three-phase equilibrium. The contact angle 
formed by the drop and the interfacial tension of the solid-vapour, liquid-vapour and solid-
liquid interface can be related through the Young´s [26] equation (Eq. 1): 
 
                                                                                                                                (eq. 1) 
 
where γLV is the interfacial tension of a liquid in equilibrium with its vapour,  γSV is the 
solid-vapor interfacial tension and γSL is the solid-liquid interfacial tension and θ represents 
the contact angle of a liquid drop on a solid surface. This equation has two unknowns 
variables, therefore another equation is requires. Several approaches have been proposed, for 
example the geometric mean method proposed initially by Scatchard and Hildebrand [27, 28] 
and later on adapted by Owens and Wendt´s [29], the harmonic mean proposed by Wu [30] 
and the van Oss, Good and Chaudhury method [31]. The Owens and Wendt´s method is the 
most used and it states that the interfacial tension between two phases in contact, particularly 
between a solid and a liquid can be described by the following equation (Eq.2),  
   
                                                                                                                                (eq. 2) 
   
This method assumes that the dispersive (γd) and polar (γp) intermolecular forces operate 
across the interface and therefore the total surface tension is the sum of the two components 
(Eq. 3). 
 
                                                                                                                                (eq. 3) 
 
The combination of equation 1 and 2 leads to a forth equation that will allow the 
determination of γSV and γLV,  
         
                                                                                                                                            (eq. 4) 
 
Using these equations and experimental values of contact angles measured with a pair of 
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In order to determine if there is a relationship between the incorporation of silicon into 
the HA lattice and the time required for the formation of an apatite layer, 1.5 wt % Si-HA was 
incubated in SBF for a period up to 10 days, at 37 ºC.  
To study the effect of human serum proteins (HS) on the surface dissolution and 
consequently apatite formation different compositions of Si-HA were incubated in SBF with 
HS (serum SBF). In this study several techniques were used: environmental scanning electron 
microscopy (ESEM), atomic force microscopy (AFM), phase imaging AFM, X-ray 
photoelectron spectroscopy (XPS) and inductively couple plasma spectroscopy (ICP).  
     
Material and Methods 
 
Materials Preparation 
The preparation of Si-HA was performed through an aqueous precipitation chemical 
route between calcium hydroxide, orthophosphoric acid and silicon tetraacetate as a source of 
silicate ions and it can be described by the following equation.  
 
( ) ( ) ( )( )( ) ( )( )xxx OHSiOPOCaOHxxSiOPOxCa −−−−−+ →−++−+ 24641044342 2610     (eq.5) 
 
Where, x is the number moles of silicon. A detailed protocol is fully described elsewhere [5, 
9, 32].  
 
X-ray diffraction (XRD) and X-ray fluorescence (XRF)  
To determine the phase purity of the precipitated material used in this study X-ray 
diffraction (XRD) was performed using a Philips PW1710 X-ray diffractometer (PANalytical 
Inc., Almelo, The Netherlands) Data were collected between 25º and 40o 2 θ using a step size 
of 0.02o and a count time of 2.5 seconds. Phase identification was carried out by comparing 
the peak positions of the diffraction patterns with ICDD (JCPDS) standards. The X-ray 
fluorescence was used to confirm the incorporation of 0.8 wt % Si, 1.2 wt % Si and 1.5 wt % 
Si into the HA lattice using a Philips PW1606 spectrometer.  
 
Contact Angle Measurements 
The powder containing the intermediate level of silicon 1.2 wt % Si-HA and HA were 
uniaxially pressed and sintered at 1300 ºC for 2 hours, with a heating rate of 2.5 ºC/min and 





cooled down at a rate of 10ºC/min. The samples were polished until a final Ra of (0.5 ± 0.1) 
µm. The contact angle was measured on the materials surface (HA and 1.2 wt % Si-HA) by 
the sessile drop method, at 25 ºC in a chamber saturated with a pool of liquid sample. Pictures 
of the drops were taken as a function of time, at regular intervals using a videocamera 
mounted on a microscope to record the drop image. The program used to analyse the profile 
of the drop was Axisymmetric Drop Shape Analysis-Profile (ADSA-P) and it was developed 
by Neumann and co-workers [33, 34]. The interfacial tension was assessed by the Owens-
Wendt using as testing liquids deionised water and diiodomethane (>99%, Merk Schuchardt), 
doubly distilled under vacuum. The polar and dispersive components of the surface tension of 
the liquids at 25ºC were taken from the literature [35], the γLV of water and diiodomethane are 
72 mJ/m2 (γd = 21.3 mJ/m2, γp = 50.7 mJ/m2) and 50.3 mJ/m2 (γd = 49.9 mJ/m2, γp = 0.4 
mJ/m2), respectively. 
 
Si-HA and human serum proteins interaction 
 Dense discs  
The powders containing the lower and upper levels of silicon, 0.8 wt % Si and 1.5 wt 
% Si, respectively, were uniaxially pressed into dense discs. The samples were incubated in 
different solutions: SBF (serum free-SBF) and SBF with 10 % (v/v) of HS (serum-SBF) (HD 
Supplies, UK) at 37ºC for different periods of time to analyse the effect of protein on the 
surface dissolution. The ratio of surface area per volume used was 0.1 cm-1. The surface of the 
materials was characterized before and after incubation by AFM and ESEM. AFM imaging 
was performed with a help a Digital Instruments NanoScope III. The topographic image on 
the AFM was obtained by tapping mode using the changes in the cantilever oscillation 
amplitude, but in the case of the phase image, the phase lag of the cantilever motion relative 
to the driving oscillator was also registered and used to generate images [17, 36-39]. ESEM 
signals were collected in low vacuum mode, with an off axis gaseous secondary electron 
detector.  
In order to access the presence of proteins on the ceramic surface, the atomic 
percentage of nitrogen was analysed by XPS. The Si-HA samples were incubated in SBF, 
SBF with 10 % (v/v) HS and in an additional solution with 0.1 % (v/v) of HS for 5 days. 
 
 Powders 
To determine the effect of human serum proteins on silicon release to the surrounding 
medium Si-HA powders were immersed in SBF, serum SBF (10 % (v/v) HS). The surface 





area was measured by the Brunauer-Emmett-Teller method (BET) (Micromeretics TriStar 
3000) and the ratio surface area per volume was increased 100 times (10 cm2/mL), and the 
silicon concentration in solution measured by inductively couple plasma spectroscopy (ICP). 
 
Statistical Analysis 
All results were statistically evaluated by ANOVA and post-hoc testing with 





 The XRD analysis did not detected secondary phases, such as tricalcium phosphate 
(TCP) or calcium oxide (CaO), indicating a phase pure material. The XRF results confirmed 
the presence of 0.8 wt % Si, 1.2 wt % Si and 1.5 wt % Si in the Si-HA material. 
 Contact angle measurements showed that Si-HA has an initial contact angle of (64.9 ± 
6.1°, n=10) that is lower than HA (71.8 ± 4.1°, n=10), although the differences observed did 
not reach statistical significance. As the water droplet sat on the surface of both materials the 
contact angle undergone a small decreased, although after that period of time the contact 
angle tended toward a constant value (Figure 1). When using the diiodomethane as a testing 
liquid, contact angles reached a plateau in a few seconds, (42.8 ± 5.8 °, n = 6) for HA and 
(44.1 ± 3.3 n = 6), for Si-HA (Figure 1). According to the OWRK approach it was possible to 
determine the interfacial tension of the substrates; 42.9 mJ/m2 ( dSVγ  = 35.1 mJ/m
2 and pSVγ = 
7.82 mJ/m2) for HA and 45.5 mJ/m2 ( dSVγ  = 33.8 mJ/m
2 and pSVγ = 11.80 mJ/m
2), for Si-HA. 
The dispersive component of the interfacial tension is predominant in both materials, although 






γ ) can be used as a quantitative indicator of hydrophilicity, so the Si-HA material 































Figure 1 - Variation of the contact angle with time for 1.2 wt % Si-HA and HA. 
 
The surface of the materials was analysed by ESEM, AFM and phase imaging AFM 
before incubation. Prior to incubation no specific features or deposits were observed, the 









Figure 2 – Environmental Scanning Electron Microscopy image of 1.5 wt % Si-HA before 
incubation. Similar image was obtained for 0.8 wt % Si-HA (data not shown). 
 
On the ESEM images it is possible to observe the formation of dissolution features 
(white arrow) on several grains, after incubation in serum free-SBF for a period of 1 day 
(Figure 3). These features grew in size and number with incubation time leading to the 
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Figure 3 – Environmental scanning electron microscopy images of 1.5 wt % Si-HA after 
incubation in SBF for 1 day, showing extensive dissolution features (white arrow). 
 
After 7 days a confluent apatite layer was observed at the surface of this material 
(Figure 4). Thin-film XRD (Th-XRD) corroborated this data (data not shown). The 
incorporation of higher concentration of silicon decrease the time required for the apatite 
formation in 30 % (from 10 days to 7 days) and when compared to HA in 75 % (from 28 days 









Figure 4 – Environmental scanning electron microscopy images of 1.5 wt % Si-HA after 
incubation in SBF for 7 days. 
The differences on the behaviour of the samples incubated in serum free-SBF and SBF 
with proteins started at day one; they are more evident on the AFM images. On the phase 
image it is clear that the surface has different characteristics, due to significant differences on 
the contrast (Figure 5). As reported in a previous paper the dissolution on 0.8 wt % Si-HA 
starts as early as day 1 [6]. Similar results were observed for 1.5 wt % Si-HA where extensive 
dissolution was observed at day 1 (data not shown). At day 2, the samples showed clear signs 
of dissolution, as it can be seen at the topographical AFM images and phase image AFM 











(Figure 5). Dissolution at the grain boundaries and on the surface of the grains was clear, it 




















Figure 5 – Atomic force microscopy and phase maging of (a,b) 0.8 wt % Si-HA and (c,d) 1.5 
wt % Si-HA after incubation in SBF for a period of two days. a,c – topographical images; c,d 
– phase image. 
 
Different features were observed on the samples surface when incubated in serum-
SBF. Through the ESEM imaging it was not possible to observe significant dissolution 
features on the surface of these samples. When these samples were analyzed by AFM and 
phase imaging AFM, the presence of a second layer was detected (Figure 6). The contrast 
observed on the surface shows that this layer has different characteristics from the underlying 
surface, which could indicate the presence of a protein layer on top of the samples. This layer 
may prevent the release of the ions into the surrounding medium and consequently delaying 
the formation of an apatite layer. At day 7 none of the substrates presented an apatite layer on 
























Figure 6 – Atomic force microscopy and Phase Imaging of 1.5 wt % Si-HA after incubation 
in serum- SBF for a period of one day. a – topographical image; b – phase image. 
 
In order to verify if the layer on the surface of the samples incubated on serum-SBF is 
a protein layer XPS analysis were performed. Proteins are biological macromolecules, formed 
by specific co-polymerization of up to 20 different amino acids [40]. The amino acids have a 
central or α carbon, to which four groups are bounded, a hydrogen, an amino group, a 
carboxyl group and a side chain usually designated by R. Nitrogen from the amino group 
(NH3+) and carbon for the carboxyl group (COO-) can be measured and used as an indicator 
of the presence of proteins. Although, in the case of the XPS technique there are some 
contaminations by carbon, so it is not possible to use this element to assess the presence of 
proteins. In this case a new solution was used SBF with a smaller concentration of human 
serum (HS) proteins (0.1% (v/v)). At the surface of both materials an increase in the atomic 
percentage of nitrogen was observed with the increase of proteins concentration, which 
indicates that this layer is indeed a protein layer (Table 1). The concentration of nitrogen 
detected on the surface of the samples incubated in serum free-SBF is related with the 
presence of tris-hydroxymethyl amino-methane buffer (TRIS) in the SBF solution that 
adsorbed on the surface of the sample. Therefore, higher concentrations of nitrogen can be 













Table 1- Atomic percentages of nitrogen at the surface of Si-HA after incubation for a 







   
In order to study the effect of proteins on silicon dissolution a different experiment 
was performed. This experiment comprised the suspension of Si-HA powders, in serum free- 
SBF and serum SBF. The powders had similar surface areas, 0.242 m2/g, 0.250 m2/g, for 0.8 
wt% Si-HA and 1.5 wt % Si-HA, respectively. The surface area per volume ratio used was 
100 cm2/mL and the ionic release was measured by ICP. Silicon was released from both 
substrates during the incubation period to the surrounding media. A higher content of silicon 
on the solution containing 1.5 wt % Si-HA was measured when compared to 0.8 wt % Si-HA 
(Figure 7a,b). The kinetics dissolution of the materials incubated in serum free-SBF and 
serum SBF was different. In the presence of proteins a slower rate was observed. This result 
confirms that the proteins layer on the surface of the material delays the diffusion of the ions 
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SBF 0.8 0.5 
SBF + 0.1 % (v/v) HS 6.5 9.1 
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Figure 7 - Curves of silicon release from a) 1.5 wt % Si-HA and b) 0.8 wt % Si-HA, after 
incubation in serum free-SBF and serum SBF. 
 
Discussion and Conclusion 
 
 In previous studies it was demonstrated that the incorporation of silicon into the HA 
lattice alters the surface charge of HA [5], leading to more negative values. Due to the 
importance of the surface properties on the interaction between biomaterials, physiological 
fluids, and the host tissue after implantation [41-43], it was important to further characterize 
the surface of Si-HA by determining its surface energy and wettability. Our results showed 
that the incorporation of silicon increased the hydrophilicity of HA, leading to a higher 
interfacial tension. Although these differences did not reach statistical significance, they 
corroborate the zeta-potential results due to the increase on the polar component on the Si-HA 
material, therefore the increase of the interfacial tension can be due to the presence of 
unsaturated Si-O bonds leading to the formation of Si-OH in the presence of an aqueous 
medium. Similar results are described in the literature for SiO2- containing material and phase 
pure HA [44-46].  
Another important property for osteointegration is the formation of an apatite layer. It 
has been reported that the incorporation of 0.8 wt % Si into the HA lattice decreased the time 
required for the formation of an apatite layer in 64% when incubated in SBF (28 days for HA 
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resulted in an additional decrease on the time required for the formation of the apatite (75 % 
when compared to phase pure HA). These results support the mechanism proposed for the 
enhanced bioactivity of Si-HA on previous reports, where it was stated that this increased is 
due to a combination of its high dissolution rate of the Si-HA material and its physical-
chemical properties. Its high solubility leads to a faster super-saturation of the serum free-
SBF, and therefore a faster precipitation of an apatite layer and the more electronegative Si-
HA surface can provide a preferential site for the nucleation of an amorphous calcium 
phosphate apatite layer than the HA surface, which can occur through the adsorption of Ca2+ 
ions on to the electronegative surface, resulting in an increase in surface charge and the 
attraction of phosphate groups [5].  
 The dissolution of Si-HA in the presence of serum-free SBF starts at early time points, 
on the AFM image the dissolution on the grain boundaries and grain are clear, therefore an 
apatite layer will form in a short period of time, as mentioned previously. Although, when a 
biomaterial is implanted in a living system, there are several proteins, enzymes and type of 
cells that will influence its behaviour [47], therefore, the dissolution-precipitation process is 
much more complex in vivo. In order to mimic the initial stages of the in vivo reactions the 
materials were incubated in serum-SBF to assess its effect on the dissolution and apatite 
formation. The dissolution kinetics of the materials incubated in serum SBF was slower when 
compared to the dissolution in serum free-SBF. At the same time point, no significant 
dissolution features were observed or apatite layer was visualized. The phase imaging AFM 
indicated the presence of a layer on top on these materials that could be a proteinaceous layer. 
The XPS analysis confirms this result, due to the increase on the concentration of nitrogen on 
the surface of the samples incubated in the presence of proteins.  
Several mechanism have been proposed to explain the mechanism behind the effect of 
proteins on the apatite formation, namely that proteins can bind to the surface of the ceramic 
and control secondary nucleation, affecting the dissolution reprecipitation process in the 
ceramic [47], according to Kaufmann et al the protein layer will protect the surface and 
prevent early dissolution [48]. The ICP results demonstrated that in the presence of proteins a 
release of silicon into the surrounding medium was lower when compared to the samples 
incubated in serum free-SBF. Therefore, the results presented here are in agreement with 
Kaufman et al, indicating that the presence of the protein layer will indeed protect the surface 
of the material, delaying the diffusion of the atomic species to the surrounding medium, 
delaying the supersaturation of the solution and consequent apatite layer.  
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The adhesion of bovine collagen type I, bovine serum albumin, bovine IgG, 1 % and 10 % 
(v/v) human serum to hydroxyapatite (HA), silicon-substituted hydroxyapatite (Si-HA) and 
tissue culture plastic were studied. The materials were incubated at 37 ºC for 30 minutes, after 
which the protein solution was removed and analysed. The adsorbed protein was evaluated by 
electrophoresis and immunoassay after extraction from the materials. The degree of adhesion 
was higher for collagen, followed by IgG and albumin on all materials. However there was no 
significant difference in the amount of collagen adsorbed onto the surface of each material 
and this was also the finding with albumin and IgG. These results suggest that the increased 
bioactivity seen with Si-HA is not only due to the degree of protein adhesion, but may 
possibly be due to changes in the conformation of the bound proteins. 
 
Keywords: Silicon-Substituted Hydroxyapatite, Human Serum Proteins, Bovine Collagen type 
I, Bovine Serum Albumin, Immunoglobulin G (IgG).  







 In vivo studies have demonstrated that silicate ions incorporated into crystal lattice 
significantly enhance the bioactivity of hydroxyapatite bone grafts [1-3]. In particular, high-
resolution transmission electron microscopy studies have shown notable differences in apatite 
deposits at the surface of HA and Si-HA implants. Organised collagen fibrils were observed 
at the Si-HA/bone interface after 6 weeks in vivo. In contrast, organised collagen fibrils were 
only observed after 12 weeks around HA implants. These findings suggest that the bone 
apposing Si-HA implants was at a more developed stage [4], and corroborate in vitro findings 
of enhanced osteoblast-like cell attachment on Si-HA ceramics [2, 3]. In an attempt to 
understand the mechanism of this enhanced bioactivity, several in vitro studies were 
performed. Plasma protein adsorption is one of the first events that occur after implantation 
[5]. We hypothesised that one of the reasons for the increased bioactivity could be altered or 
preferential protein adhesion.  
 To assess the adhesion of human serum proteins two different protein concentrations 
were used 1 % (v/v) and 10 % (v/v). To study preferential adhesion three proteins belonging 
to different groups were used; bovine serum albumin (BSA) a globular protein with an 
isoelectric point of approximately of 4.7 [6], immunoglobulin G (IgG) also a globular protein 
that can be characterised by its multi-domains showing strong structure-function relations for 
the different domains [7] with an isoelectric point of approximately 6.8 [6], and bovine 
collagen type I a glycoprotein with a triple-helical structure of collagen fibrils and an 
isoelectric point of approximately 8-9 [8]. 
 
Materials and Methods 
 
The preparation of phase pure HA and Si-HA is fully described elsewhere [9, 10]. The 
powders were uniaxially pressed into discs and sintered at 1300 ºC for 2 hours. Human AB 
serum was diluted in a phosphate buffer saline solution (PBS), to obtain a concentration of 1 
% (v/v) and 10 % (v/v). Albumin, IgG and collagen were diluted in PBS to obtain a 
concentration of 0.250 mg/mL. The dense discs were incubated in the protein solution (pH = 
7) for 30 min at 37 ºC, after which the solution was removed. The protein concentration 
before and after incubation was measured by two methods, biocinchoninic acid (BCA from 
Pierce) and NanoOrange from Sigma. Two further experiments were performed to assess the 
adhesion of collagen to the HA and Si-HA surface. Samples were incubated with 0.250 mg/ml 




























of bovine collagen type I. After rinsing the materials the adherent protein was removed by 
incubating the samples for 1 hour at 37º C with an SDS-buffer. The final solution was run on 
a 10% SDS-PAGE gel. The gel was stained with silver stain DAIICHI (Daiichi pure 
chemicals, Japan). The second experiment involved incubating the samples in two different 
solutions: 10 µg/ml of bovine collagen type I and 10 µg/ml of bovine collagen, type I with 10 
µg/ml of IgG (R&D Systems), for 30 minutes at 37 ºC, after which the protein solution was 
again removed. The adherent collagen was measured by ELISA, using goat anti-collagen type 
I as the first antibody and HRP-conjugated Avidin was used to detect the first antibody. The 
colour was developed using a TMB Peroxidase EIA substrate kit and the absorbance 




No significant difference between the adhesion of the proteins to the HA and Si-HA 
was observed. However the degree of adhesion was greater for collagen, followed by IgG and 
albumin (Figure 1a). The adhesion behaviour of the 1 % (v/v) and 10 % (v/v) of human serum 




































Figure 1 - Percentage of protein remain in solution for the different materials, measured by 
the BCA method (mean ± standard error of the mean; n=3.) 
 
To determine the total binding capacity, the mass of adherent protein was normalized 
by the surface area. As can be seen in figure 2, all materials demonstrated a higher binding 
affinity to collagen. A slight increase in the affinity of collagen was observed with the 
increase of the silicon content. No difference was observed in the adhesion of IgG, but in the 
case of the albumin a slight decrease was observed on the Si-HA compared to HA. For human 
serum proteins, again a slight decrease in adhesion was observed onto 1.5 wt % Si-HA. 
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Figure 2 - Total binding capacity (µg of adherent protein/surface area (mm2), a – collagen 
type I, IgG and albumin, b – 1 % (v/v) of HS and c – 10 % (v/v) HS (mean ± standard error of 
the mean; n=3.) 
 
 Similar results were observed when the samples were analyzed using the NanoOrange 
kit (data not shown). 
Due to the slight increase of collagen binding to the Si-HA material two experiments 
were carried out to investigate this further, as it can be seen in figure 3A.  
It appears to be a higher concentration of collagen adhering to 1.5 wt % Si-HA, 
although upon repeating this result was not consistent, as seen in figure 3B. A similar result 
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Figure 3 - Two SDS-PAGE gels with different samples prepared in the same way: (A) -a –
molecular weight markers, b – Collagen standard, c- Collagen removed from Tissue culture 
plastic d - Collagen removed from 1.5 wt % Si-HA, e – Collagen removed from 0.8 wt % Si-
HA and f - Collagen removed from HA; B - a – Collagen standard, b- Collagen removed from 




 The pattern of adsorbed proteins observed in the study could be explained by the 
electrostatic interactions between the proteins and the substrates used. The three proteins 
studied have different structures and different isoelectric points, therefore the overall net 
charge of these proteins will be different at pH 7. Collagen would have an overall positive 
charge, IgG a slight negative charge and albumin a more negative charge. As reported in 
previous studies, the surface charge of HA and Si-HA is negative [11], therefore the 
electrostatic interactions between the materials and the protein is greater if the protein has an 
overall positive charge, and could be one of the reasons for the higher affinity of collagen to 
the different substrates, followed by IgG and albumin as was observed. Muller et al also 
reported a higher adhesion of albumin and IgG to a positively charged surface, although IgG 
presented a lower adhesion due to its lower negativity. In that study a basic protein, lysozyme, 
demonstrated higher adhesion to a negatively charged substrate [12]. The adhesion of proteins 
from the different concentrations of human serum was not conclusive and further studies are 
required. In an attempt to quantify the adhesion of collagen to Si-HA and HA, two further 
methods were used, SDS-PAGE and ELISA. No consistent differences in the adsorption of 
collagen to the HA and Si-HA surface were observed. We had hypothesized that the increase 
in bioactivity of Si-HA could be due to a higher adhesion of proteins. These results suggest 
that the increase bioactivity seen with Si-HA is not only due to the degree of protein adhesion. 
Although the composition of the protein layer formed in vivo is still poorly understood, it has 
been reported that the protein pattern on calcium phosphates surfaces in vivo is different from 
the one obtained in vitro. This pattern also changes with implantation time, in part due to 
B 
 
          c          b          a 





cellular proteolytic activity and secretion of proteins by cells [13]. An alternative theory for 
the increased bioactivity of Si-HA is related to changes in the conformation of proteins, as it 
is known that the activity and specificity of a protein is related to its conformation. In addition 
Reffit et al demonstrated a positive effect of soluble silicon in human cells [15]. In previous 
studies we have demonstrated that there is a preferential release of silicon into the incubation 
solution [11], therefore the enhanced bioactivity may also be due to a direct effect of silicon 




 These results suggest that the increased bioactivity seen with Si-HA is not only due 
to the degree of protein adhesion. It may be due to changes in the conformation of proteins or 
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 In vivo studies carried out by Nelesh Patel et al using a lapine and ovine model 
demonstrated the positive effect of silicon-substituted hydroxyapatite (Si-HA) on bone 
regeneration. The two main types of cells involved in bone regeneration are the osteoblasts 
and osteoclasts. Due to the complexity of the in vivo system it was not possible to determine 
the mechanism behind the enhanced bone regeneration. So, we performed several in vitro 
tests using human osteoblasts and osteoclasts. 
  
 Human osteoblasts were seeded on dense HA and two compositions of Si-HA (0.8 wt 
% Si-HA and 1.5 wt % Si-HA). The effect of the incorporation of silicon on the HA lattice on 
osteoblasts was assessed by the measurement of different osteoblastic markers such as: 
collagen type I (COL I), alkaline phosphatase (ALP), osteocalcin (OC) and protein 
expression, at different time points. 
 The cells seeded on the three substrates adhered, proliferate and expressed different 
osteoblastic markers. The incorporation of 0.8 wt % of silicon into the HA lattice induced 
higher proliferation of human osteoblast and protein expression. Although, in the presence of 
a higher concentration of silicon (1.5 wt %) the cells responded with an increase on the ALP 
expression, indicating that the cells were differentiating faster.  
 
 Osteoclasts precursors were seeded at the surface of the 3 materials. Several 
osteoclasts markers such as, actin rings, several nuclei, TRAP and vitronectin receptors were 
measured. The increase on the concentration of calcium and phosphorous in the medium 
culture was used as an indicator of activity and resorption. 
 HA and Si-HA allowed the differentiation of osteoclasts precursors (peripheral 
mononuclear blood cells and monocytes CD 14+) to mature osteoclasts. All the cells 
expressed osteoclasts markers. Significant differences on the concentration of the calcium and 
phosphorous on the medium from the Si-HA samples seeded with osteoclasts were detected, 
indicating the osteoclasts are active and resorbing, especially on 1.5 wt % Si-HA. 
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Two different microscopy techniques were used to investigate the response of human 
osteoblast cells to hydroxyapatite (HA) and silicon substituted hydroxyapatite (Si-HA), 
namely, fluorescence and confocal microscopy. The changes in the surface of HA and Si-HA, 
after incubation for different periods of time in simulated body fluid, were assessed using 
atomic force microscopy and environmental electron scanning microscopy. Cell proliferation 
was higher on Si-HA compared to HA. In addition more focal points of adhesion were seen 
on Si-HA than on HA. Using atomic force microscopy and environmental scanning electron 
microscopy it was possible to observe changes in the surface of both materials, namely 
dissolution features and the formation of an apatite layer. These findings support the results of 
a previous study, which showed that Si-HA had a higher dissolution with the preferential 
release of silicon into the medium and this fact may account for the changes observed in the 
cell behaviour.  
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In the 1970´s several groups demonstrated that bone mineralization requires a 
minimum concentration of soluble silicon [1-4]. Hench reported that the deterioration in the 
proliferation and function of osteoblasts due to osteopenia and osteoporosis is related to the 
loss of biologically available silicon [5] and Keeting et al reported that, bone cells in culture 
proliferate more rapidly in the presence of soluble silicon [6]. A recent study by Reffit et al 
demonstrated that physiological concentrations of soluble silicon stimulate collagen type I 
synthesis in human osteoblast-like cells and promote osteoblastic differentiation [7]. These 
studies clearly demonstrate the possible advantage of incorporation of silicon into the lattice 
of biomaterials intended for applications in bone tissue regeneration. Therefore to take 
advantage of the positive biological effect of silicon, Si-substituted hydroxyapatite (Si-HA) 
has been developed using a chemical precipitation route [8, 9]. Patel et al demonstrated that 
the in vivo bioactivity of hydroxyapatite is significantly enhanced with the addition of silicate 
ions into the lattice of hydroxyapatite [10]. Gibson et al [11] also demonstrated that Si-HA 
increases the metabolic activity of human osteosarcoma cells. The aim of this work was to 
assess the effect of Si-HA on human osteoblast (HOB) cells and to correlate these findings 
with the rate of dissolution of the Si-HA. The techniques used to analyse the effect of silicon 
on dissolution of the material and on the cells were: confocal laser scanning microscopy 
(CM), fluorescence microscopy (FM), environmental scanning electron microscopy (ESEM) 
and tapping mode atomic force microscopy (AFM). 
 
Materials and Methods 
 
The preparation of phase pure HA and Si-HA is fully described elsewhere [8, 9]. The 
powders were uniaxially pressed to discs and sintered at 1300 ºC for 2 hours. The HOB cells 
were grown in McCoy’s 5A modified medium, supplemented with 10 % (v/v) foetal calf 
serum, 30 µgml-1 vitamin C, and 1 % (v/v) L-Glutamine at 37 ºC. Cells of passage number 5 
were seeded onto two different materials, HA and 0.8 wt% Si-HA at a density of 10 000 
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cells/cm2. After 3 and 7 days of culture, the cells were fixed in 4 % formaldehyde/phosphate 
buffer saline solution, pH 7.4 at room temperature for 15 min.  
The staining procedure is described elsewhere [12]. After staining the samples were 
mounted with Vectashield fluorescent mountant and viewed using both FM and CM. At each 
time point the lactate dehydrogenase (LDH) release was determined, using an enzyme assay 
kit (Promega, UK). LDH is a cytosolic enzyme present within all mammalian cells [13]. If the 
cell membrane is damaged there is a leakage of LDH into the medium, through this method is 
possible to have an accurate measure of cell membrane integrity and cell viability [14]. To 
determine the changes on the surface of HA and Si-HA, samples of both materials were 
incubated in simulated body fluid (SBF), at 37 ºC, for different periods of time. Changes were 
assessed by AFM and ESEM. AFM imaging was performed using a Digital Instruments 
NanoScope III and ESEM signals were collected in low vacuum mode, using an off axis 




The number of cells on the 0.8 wt% Si-HA was significantly higher than on phase pure 
HA, which could indicate that the silicon enhances the proliferation of HOB cells (Figure 1a), 
and there was no significant variation in the LDH release with time. When the LDH was 
expressed per cell, this parameter was significantly lower on Si-HA than on HA, and this 















































HA 0.8 w t% Si-HA
a) 


















Figure 1 – Variation of the number of cells (a) and LDH/Cell release (b) on phase pure 
HA and Si-HA with time, (mean ± standard deviation, n=3). 
      
Using FM it was possible to view the distribution and number of cells on the HA and Si-
HA. The number of HOB cell on the Si-HA surface appeared to be higher and more closely 





















The cell cytoskeleton and vinculin in focal adhesion complexes were visualized using 
confocal microscopy to image the cells on the different materials. At day 3, cells were spread 
Figure 2 – FM images of HOB onto HA (a) and Si-HA (b) after 3 days of incubation. 
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on the substrates as shown in Figure 4 a,b. Although at day 7 the cells seemed to be less 
spread on both materials (Figure 5 a,b). There appeared to be more focal points of adhesion 





















Figure 5 – CM image of HOB on HA (a) and Si-HA (b) after a period of 7 days of 
incubation. 
 
Both AFM and ESEM revealed that the dissolution of the Si-HA started earlier than the 
dissolution of HA. After 7 days of incubation the Si-HA surface was partially covered by an 
apatite layer (Figure 6 b), indicating, that there had been extensive dissolution of Si-HA at 
earlier time points [15], while for HA significant changes were only detected after 14 days of 
incubation (results not shown). AFM was used to observe small features in the surface of both 
materials. At day 1, dissolution features were visible at the surface of Si-HA, but not on the 
HA surface (Figure 7 a,b) and it was not possible to observe significant dissolution features 






























These results show an increase in proliferation and an increase in the number of viable 
HOB grown on Si-HA compared to HA. These results complement those of Gibson et al [11], 
who showed that Si-HA increase the activity of osteoblast-like cells. The adhesion of cells to 
a substrate involves extracellular matrix proteins, cell membrane proteins and cytoskeleton 
proteins which interact together to induce signal transduction, promoting the action of 
transcription factors and consequently regulating gene expression [16]. The external face of 
focal contacts present specific proteins such as integrins, these molecules bind to specific 
ligands. Bone cells can adhere to the substrate through α2β1 integrin that binds to collagen 
[16]. According to the literature, there is a preferential dissolution of silicon in the Si-HA and 
we have shown early dissolution of this material, so there will be soluble silicon in the 
medium available to cells [17]. Reffit et al [7] showed that soluble silicon increases the 
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points of adhesion, observed on the HOB cell cultured on the Si-HA allowing the cells to 




 Si-HA increases the proliferation of human osteoblast cells, resulting in more viable 
cells on the surface compared to HA. The increase in the number of focal points of adhesion 
may be due to the release of silicon to the medium stimulating the production of collagen by 
HOB cells. However the mechanism by which the silicon increases the collagen production 
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Human osteoblasts were cultured on hydroxyapatite (HA) and 0.8 wt % and 1.5 wt % 
silicon substituted hydroxyapatite (Si-HA) discs. The influence of these substrates on cell 
behaviour in vitro was assessed by measuring total protein in the cell lysate and the 
production of several phenotypic markers: collagen type I (COL I), alkaline phosphatase 
(ALP), osteocalcin (OC) and the formation of bone mineral. After 7 days β-glycerophosphate 
and physiological levels of hydrocortisone were added to the culture medium to stimulate cell 
differentiation and mineral production. There was a significantly higher production of ALP on 
1.5 wt % Si-HA at day 7 following which, the addition of hydrocortisone promoted the 
differentiation of cells on the other two substrates. Hydrocortisone addition also decreased the 
production of OC. During the period when hydrocortisone was present no significant 
difference in behaviour was seen between cells on Si-HA and HA however, following 
removal of hydrocortisone, cells responded to 0.8 wt % Si-HA with a significant increase in 
protein production. Using fluorescence microscopy nodular structures labelled with 
tetracycline were observed on the surface of all substrates after 21 days. These structures were 




deposited on areas of high cell density but were not related to the presence or level of silicon 
in the substrate. These results indicate that human osteoblasts are affected by the presence of 
silicon in the HA substrate and that the timing of these effects may be dependent upon the 
level of silicon substitution. 
 





Calcium phosphates when implanted in vivo create a functional interface with the host 
tissue [1-4] and this has led to an increased interest in the materials for clinical use. This 
behaviour results from several physicochemical reactions at the interface, namely protein and 
cell adhesion, that will ultimately result in the deposition of a calcified matrix. One of the 
most common materials used as a bone graft is hydroxyapatite (HA). Although, it has been 
demonstrated that HA has the ability to form an apatite layer and promote mineralization in 
both in vitro [5] and in vivo environments [6], the process is relatively slow, hence the 
material may be ineffective in the treatment of complex orthopaedic conditions, for example 
in fracture repair non-union or in proximity to a spinal fusion. In an attempt to increase the 
bioactivity of HA, silicon ions were incorporated into the HA lattice [7, 8].  
Silicon biochemistry and its involvement in several metabolic pathways it has been 
study for several years. It has been reported that in 1878 Louis Pasteur said “Effects of silicic 
acid are destined to play a great and major role in therapy” [9]. Several reports mentioned 
the positive effect of silicon in several situations, such as DNA synthesis, protein synthesis, 
atherosclerosis and bone formation and development [9-17]. In 1972, Carlisle, Schwarz and 
Milne et al reported for the first time that a silicon deficiency diet in chicks and rats, led to 
abnormally shaped bones and defective cartilaginous tissue, but that these effects could be 
corrected by the incorporation of silicon in their diet [9, 15-17]. These and further studies 
indicated that silicon might play an important role in connective tissue metabolism especially 
in bone and cartilage [18-20]. Others studies showed that silicon can have an effect on gene 
activity [21-23]. Baxter et al and Finkelstein et al suggested that in animal cells some DNA-
binding proteins might be implicated in the regulation of gene expression [10, 12]. Voronkov 
demonstrated that nucleic acids contain silicon atoms. In DNA one atom of silicon 
corresponds to an average of 20-30 atoms of phosphorous, and in the RNA this ratio changes 




to 25-45 atoms. Indicating that silicon has a key role in the structure of nucleic acids, in the 
mechanism of protein biosynthesis, and in the transmission of hereditary information [22]. 
Keeting et al showed that Zeolite A, a particulate material containing silicon, stimulates the 
proliferation and differentiation of osteoblast-like cells in culture [24]. A recent study by 
Reffit et al demonstrated that physiological concentrations (10 – 20 µΜ) of soluble silicon 
stimulate collagen type I synthesis in human osteoblast-like cells and promote osteoblast 
differentiation [19]. In vivo, Patel et al have demonstrated that the bioactivity of HA is 
significantly enhanced by the addition of silicate ions into the lattice. [6]. In vitro studies by 
Gibson et al [25] demonstrated that silicon-substituted hydroxyapatite (Si-HA) increased the 
metabolic activity of human osteosarcoma cells and Botelho et al [26] demonstrated an 
increase in the adhesion of human osteoblasts when cultured on Si-HA. It has been 
demonstrated that an increase in silicon content in the HA lattice results in enhanced 
bioactivity, resulting in a more rapid apatite formation [27]. 
The aim of this work was to study the effect of silicon-substituted hydroxyapatite on 
the differentiation of human osteoblasts (HOBS) and on their ability to induce mineralization. 
Therefore, HOBS were cultured on discs of phase pure HA, 0.8 wt % and 1.5 wt % Si-HA. 
Cell proliferation and differentiation markers were followed with time.  
 
Materials and Methods 
 
Materials preparation 
HA, 0.8 wt % and 1.5 wt % of Si-HA were prepared according to the method 
described by Gibson et al [8]. Using an aqueous precipitation chemical reaction, between 
calcium hydroxide and orthophosphoric acid solutions. Silicon tetraacetate was incorporated 
into the reaction mixture as a source of silicate ions. The HA and Si-HA powders were 
uniaxially die pressed and sintered at 1300 ºC for 2 hours. 
 
Cell culture  
Human osteoblast cells (HOBS) were isolated from trabecular bone from patients 
undergoing hip joint replacement surgery (PromoCell GmbH). HOBS were grown in 
McCoy´s medium supplemented with 10 % (v/v) of foetal calf serum (FCS), 1 % (v/v) L-
glutamine-penicillin-streptomycin (200 mM glutamine, 10,000 units/ml penicillin and 10 
mg/ml streptomycin) and 30 µg/ml of vitamin C (growth medium). All cell culture reagents 




were obtained from Invitrogen, Paisley, UK and all other chemicals from Sigma, Poole, UK 
except where indicated. Cells were seeded (8000 cells/cm2) onto HA and Si-HA discs and 
cultured in growth medium. The medium was changed every two days. From day 7, 7.5 mM 
of β-glycerophosphate and 200 nM hydrocortisone were added at each medium change until 
day 25, from this day until the end of the culture only growth medium was added.  
 
Tetracycline and labelling of cell nuclei 
Nine µg/ml of tetracycline was added to the medium, 24 hours prior the termination of 
the culture, to visualize mineral nodule formation.  
At each time point, cells were fixed in 4 % formaldehyde/phosphate buffer saline 
solution, pH 7.4 at room temperature for 15 min and stained with 4`,6 – diamidino-2-
phenylindole (DAPI) to visualize cell nuclei.  
 
Measurement of total protein  
At day 1, 3, 7, 10, 14, 21 and 27 the samples were analysed for total protein, using the 
bicinchoninic acid method (BCA, Merck, Poole UK). 
 
Measurement of collagen type I (COL I) and osteocalcin (OC) 
Culture medium was harvested at each medium change on days 1, 5, 7, 10, 12, 14, 18, 
21, 25 and 27 days. Quantification of collagen type I synthesis was performed on each sample 
by measuring the amount of carboxy-terminal propetide of type I collagen (CICP) released 
into the culture medium by an immunoassay (Metra™ CICP EIA kit, Quidel, Dorking, U.K.). 
Osteocalcin in the medium was also measured by an enzyme immunoassay (Metra™ 
Osteocalcin EIA kit, Quidel) at the same time points.  
 
Cellular alkaline phosphatase (ALP) 
Alkaline phosphatase was measured at day 1, 3 7, 10, 14, 21 and 27. The medium was 
removed, the samples were rinsed with phosphate buffer saline solution (PBS) and attached 
cells lysed by adding 500µl PBS and 500µl 1% (v/v) Triton X-100/PBS, followed by two 
freeze-thaw cycles of 10 min each at -70°C and 37°C. The ALP activity was assessed 
colourimetrically by monitoring the release of p-nitrophenol phosphate from p-nitrophenol 
phosphate as described by Sabokar et al [28]. The ratio of ALP/COL1 was used as a measure 
of differentiation. 





Statistical analysis  
All results were statistically evaluated by ANOVA and post-hoc testing with 






The measurement of total protein can be related to cell number, until the culture 
reaches confluence. After 7 days, at the seeding concentration used in this study, the cells 
were approaching confluence. Using confocal laser scanning microscopy it was possible to 
visualize the cells fully spread (Figure1). We have therefore used total protein to correct for 
cell number at early time points. At day 1 and day 3 the level of protein was below the 
sensitivity of the analytical method used. The HOBS seeded on all materials expressed a 
significantly higher concentration of proteins at day 27 compared to day 7 (p<0.006). 
Comparing the three materials at day 7 the cells seeded on 0.8 wt % Si-HA expressed higher 
concentration of protein, but this did not reach statistical significance. At day 27 the protein 
concentration was significantly higher on 0.8 wt % Si-HA in comparison with the other two 




























Figure 1 a-c) – Confocal laser scanning microscopy of human osteoblasts seeded on HA (a), 













Figure 2 – Total protein (µg/mL) measured at different time points. (* statistical difference 
between time points, ** between materials; p<0.05; n=3). 
 
Collagen type I production (COL I)  
The release of C-terminal collagen propetide (CICP) provides a stoichiometric 
representation of the production of collagen; therefore these results can be expressed as COL I 
production.  
An overall increase in the concentration of COL I release into the medium, with time 
was detected (Pearson correlation coefficient R = 0.876, p<0.001 for HA; R = 0.925, p<0.001 




























increase in collagen at later time points that could be related to the lack of hydrocortisone in 
the medium (Figure 3a). A higher production of COL I was observed at day 1 for Si-HA 
materials when comparing the values of COL I production per total protein (due the low 
sensitivity of the BCA method at day 1 the value of total protein used was the lower limit of 
the method), but these differences were not significant. The levels expressed by the cells at 
day 14 are significantly lower than those measured at day1 (p<0.002 for HA; p<0.000 for 0.8 



















Figure 3 – a ) COL I release to the medium at different time points (n=2); b) expression of 
COL I per total protein in two time points of the culture (* statistical difference between time 
points, n=3). 
 
Alkaline phosphatase release (ALP) and ALP/COL I  
The level of ALP at day 1 and 3 were below the detection limit of the analytical 
method used. The level of ALP expressed by the HOBS seeded on the different materials for 
day 21 and 27 was significantly higher than the levels at day 7 (p<0.002 for all materials), 




















































seeded on 1.5 wt % Si-HA was similar throughout the culture period and higher at day 7 than 
on the other two substrates.  
The ALP/COL I ratio can be used as a measurement of differentiation. A significant 
increase in the ALP/COL I (Figure 4b) ratio was observed between days 7 and 21, for HA and 
0.8 wt % Si-HA (p<0.001), but not for 1.5wt % Si-HA. When comparing the three materials 
at day 7 the ratio ALP/COL I on 1.5 wt % Si-HA was significantly higher (p<0.001), 
indicating greater differentiation. Once the HOBS were no longer under the influence of 
hydrocortisone, a decrease on the ALP/COL I was observed, that can be due to the increase in 






















Figure 4 –Production of ALP a) with time; and b) variation of the ratio ALP/COL I with time. 




















































Osteocalcin release (OC) 
  The level of OC in culture medium before adding it to the cells was 10.3 ng/ml. At the 
earlier time points no release of OC into the medium was detected. At day 7 a significant 
increase was observed (p<0.001), which indicates the beginning of a post-proliferative stage. 
After the introduction of hydrocortisone to the medium the values of OC decreased below the 
baseline value. Due to the onset of mineralization at day 21 the addition of hydrocortisone and 
β-glycerophosphate was stopped at day 25, there was no need for further stimulation of the 
culture to mineralize. The lack of hydrocortisone in the medium induced a significant increase 
in the OC levels by day 27, except for 1.5 wt % Si-HA (Figure 5).  With the exception of day 
7, higher levels of OC release were observed on cells seeded on 0.8 wt % Si-HA. The levels 











Figure 5 – OC release to the medium at different time points. (* statistical difference between 
time points; p<0.05; except for 1.5 wt % Si-HA           baseline; n=2). 
 
Mineral nodular formation  
At days 7 and 14 no mineral deposits were visualized on the surface of any of the 
materials. At day 21 the first deposits were observed on all materials. These deposits 
coincided with the areas of high cell density. At day 27 a larger number of deposits were 
observed (Figure 6). No difference in the pattern or timing of mineralization was seen 



































Figure 6 - a) Mineral deposits labelled with tetracycline on the surface of 0.8 % wt Si-HA 
and (b) 1.5 wt % Si-HA after 28 days; c) cell nuclei stained with DAPI and the mineral 
deposits (arrow) on the surface of 0.8 wt % Si-HA and (d) on 1.5 wt % Si-HA. Similar 




In this paper we have demonstrated that HA and Si-HA substrates support HOBS 
proliferation and differentiation for up to 27 days. In all cultures the HOBS expressed the 
phenotype markers, COL I, ALP and OC. These markers can be used to identify the different 
stages of osteoblast differentiation [29]. Although the mechanism behind this process is not 
fully understood, it is known to be a multistep process [30]. All the steps are characterized by 
changes in gene and protein expression. It is known that endogenous systemic glucocorticoids 
are involved in bone formation and remodelling [31, 32], so to mimic the physiologic 
conditions, hydrocortisone (200nM) was added to the growth medium. β-glycerophosphate 
(7.5 mM) was used to stimulate the production of mineral.  
The Si-HA substrates showed a higher cell number (0.8 wt %) and ALP production 
(1.5 wt %) when compared to HA. The higher ALP/COL I ratio at day 7 on 1.5 wt % Si-HA 
indicate that the HOBS were differentiating faster. Although, silicon is present in both Si-HA 
substrates an earlier release from 1.5 wt % Si-HA could be the stimulus to more advanced 
differentiation. The higher cell numbers on 0.8 wt % Si-HA, although statistically not 
significant, is in agreement with previous studies where we demonstrated higher adhesion on 
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0.8 wt % Si-HA than on HA and 1.6 wt % Si-HA [26], and also with the results reported by 
Gibson et al, who showed a higher metabolic activity of osteosarcoma cells when seeded on 
0.8 wt % Si-HA when compared with HA [25].  
The high levels of ALP and OC, before the addition of hydrocortisone are in 
accordance with the behaviour of HOBS from older donors in culture [33]. The cells used in 
this study were from donors between 55 and 65 years of age. These cultures are more 
differentiated than those from young donors at an equivalent passage [33]. Only post-
proliferative HOBS produce OC, therefore an increase in OC at day 7 could be related to this 
stage [33, 34]. The production of OC was affected by the presence of hydrocortisone, a 
decrease on the OC expression was observed as soon as hydrocortisone was added to the 
medium (day 7) and increased at day 27 when the addition was stopped. It is well established 
that the presence of glucocorticoids influence osteoblast behaviour [35, 36]. These molecules 
induce differentiation of HOBS, but also inhibit some functions of differentiated osteoblasts. 
They induce the mature cells to mineralize and produce multilayered bone nodules [36, 37]. 
Glucocorticoids not only affect cell proliferation, but can also suppress type I collagen gene 
expression by decreasing the rates of transcription and destabilizing  α1 collagen messenger 
ribonucleic acid (mRNA); they also decrease the expression of OC [35, 36] Osteocalcin and 
osteopontin are generally considered inhibitors of matrix mineralization [38]. In this 
experiment the OC production could not be used as a marker for mineralization, due to the 
inhibitory effect of hydrocortisone. After 21 days, it was possible to observe mineral deposits 
on the surface of the 3 materials. These deposits coincided with areas of high cell density, 
indicating that was a cell mediated process. The tetracycline label allowed visualization of 
mineralization, being the major advantage of this label over common calcium stains such as 
Alizarin Red and Von Kossa, its ability to distinguish physiological mineral from dystrophic 
mineral [39]. Mineral nodule formation increased with time but was similar in extent on all 
three substrates.  
The results presented in this study do not allow the exact mechanism behind the 
response to silicon substituted HA materials to be described. However, they help in the 
formulation of further hypotheses. Several studies have demonstrated the positive effect of 
silicon in bone formation [6, 15-19] and more recently Reffit et al demonstrated a positive 
effect of soluble silicon on COL I synthesis, ALP and OC production and also an increase on 
the levels of mRNA of ALP and OC, after 3 days [19]. In previous studies we showed that 
there is a preferential release of silicon at early time points to the surrounding media, that can 
stimulate the human osteoblasts to proliferate and differentiate faster than on HA [40]. And 




also it was demonstrated that the Si-HA has different surface properties, namely a more 
negative surface charge that can influence the adhesion of proteins. Therefore, the higher 
cellular adhesion and consequent proliferation on 0.8 wt % Si-HA and 1.5 wt % Si-HA, 
maybe due to the synergetic effect of silicon and its physical-chemical properties.  
The human osteoblasts did not respond in the same way to both materials. The higher 
dissolution of silicon from 1.5 wt % Si-HA stimulates cells seeded on this substrate at early 
time points leading to earlier differentiation than on the other two materials at day 7, as it can 
be seen by the high expression of ALP. Other studies showed that a stable collagenous matrix 
is important for the progression of osteoblastic differentiation and is a prerequisite for an 
increase in ALP expression [41-45]. Although, 0.8 wt% Si-HA has the ability to adsorb 
higher concentration of total human serum proteins, 1.5 wt% Si-HA has higher binding 
affinity to COL I [46]. Therefore, the high expression of ALP by the HOBS seeded on the 1.5 
wt% Si-HA may be due to a synergetic effect of silicon release and the presence of a stable 
collagenous matrix. The effects of silicon release from Si-HA on human osteoblasts over 
prolonged periods of time have not been previously demonstrated and our results show that in 
the presence of hydrocortisone the differences between the materials in ALP, COL I and OC 
production are diminished. However, at later time points there is the onset of mineralization 
and with the removal of hydrocortisone, the cells on 0.8 wt % Si-HA appear to respond by 
increasing protein production. We suggest here that there is continuing release of silicon from 
the Si-HA substrate at the later time points, whilst the percentage of silicon release from 1.5 
wt % is higher than on 0.8 wt% and it was expected that this would result in a higher 
production of proteins however, this was not seen. Reffit et al demonstrated a similar pattern; 
at higher silicon concentrations the positive effect of silicon is diminished. This dose-
dependant effect on bone cells has also been reported with other trace elements [47]. Gibson 
et al also found a similar result, the osteosarcoma cells seeded on 0.8 wt % Si-HA showed a 
higher metabolic activity than the cells seeded on 1.6 wt % Si-HA [25]. Therefore, there is an 





The effects of silicon release from Si-HA on human osteoblasts over a long period of 
time have not been previously demonstrated. Our results show that the presence of 
hydrocortisone diminished the positive effect of silicon with the removal of hydrocortisone, 




the cells on 0.8 wt % Si-HA appear to respond by increasing protein production. The 
formation of bone mineral was observed on all materials after 21 days. The cells seeded on 
the three substrates expressed osteoblast markers and significant differences were detected at 
early time points on the Si-HA material. The level of osteoblasts markers on 1.5 wt % Si-HA 
was constant with time. In general the level of osteoblast markers expressed by 0.8 wt % Si-
HA was higher than on 1.5 wt % Si-HA. Further studies are required to fully understand the 
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In healthy bone, resorption and synthesis are in perfect coordination. In previous 
studies we demonstrated that the incorporation of silicon into the hydroxyapatite lattice 
enhances the proliferation and differentiation of human osteoblasts. Therefore, the aim of this 
study was to demonstrate the effect of silicon-substituted hydroxyapatite (0.8 wt % Si-HA and 
1.5 wt% Si-HA) on the differentiation of mononuclear cells into osteoclasts, using two 
different starting cultures, peripheral blood mononuclear cells (PBMC) and monocytes 
expressing the CD 14 antigen (CD14+). Through this study, it was possible to demonstrate 
that Si-HA allows the differentiation of mononuclear cells into mature osteoclasts, 
independently of the starting culture, PBMC or CD14+. Most of the cells on the surface of the 
materials expressed osteoclastic markers: actin rings, several nuclei and positive for tartrate-
resistant acid phosphatase (TRAP) and vitronectin receptor. In the presence of osteoclasts a 
higher release of calcium and phosphate to the medium from the 1.5 wt % Si-HA substrate 
was detected when compared to the HA substrate, therefore these results indicate higher 
osteoclastic resorptive activity on the 1.5 wt % Si-HA surface. 
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Silicon-substituted hydroxyapatite can be resorbed by cellular mechanisms and have a 
stimulatory effect on osteoclasts, although the underlying mechanism is still poorly 
understood.  
 





 The ideal bone graft for many applications would be a material that can both be 
resorbed and induce bone formation, hence being completely replaced by new bone. Bone is a 
dynamic organ due to its constant remodelling. This process can be divided in two main steps; 
resorption, where the “old” bone is resorbed by the osteoclasts and synthesis, where the 
osteoblast lays down new layers of bone [1]. 
  In healthy bone, resorption and synthesis are in perfect coordination. Disruption to the 
balance between resorption and formation can lead to osteoporosis that is characterized by the 
loss of bone mass [2] and osteopetrosis resulting from a failure of osteoclasts to resorb bone 
[3]. The osteoclast is the only cell capable of resorbing mature bone. It is a tissue-specific 
macrophage polykaryon created by the differentiation and fusion of monocyte/macrophage 
precursors cells [4]. The resorption takes place under the ruffled border, where protons and 
proteases are secreted, leading to the formation of resorption lacunae [4].  
In the last decade there has been a breakthrough in the understanding of 
osteoclastogenesis, due to the discovery of the receptor activator of nuclear factor kβligand 
(RANKL) in 1998. It was identified as an osteoblast-produced ligand, which promotes 
osteoclast differentiation [4, 5]. RANK is a type I transmembrane receptor of the TNF 
receptor superfamily that was identified in a dendritic cell cDNA library [6]. Several studies 
showed that it is possible to generate osteoclasts in vitro from peripheral mononuclear blood 
cells (PBMC) using RANKL and macrophage colony stimulating factor (MCSF), a 
polypeptide growth factor [7, 8]. Quinn et al suggested that osteoclasts are derived from 
monocytes that expressed the macrophage-associated antigen CD 14 (CD14+). These results 
were supported by Massey et al, who showed that CD 14 + cells from PBMC showed 
enhanced osteoclastic bone resorption in co-cultures with UMR 106 rat osteoblast-like cells 
[9]. The use of co-culture is related to the ability of osteoblast/stromal cells to produce the 
two haematopoietic factors needed for osteoclastogenesis, RANKL and MCSF [4].  
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The use of soluble RANKL and MCSF allows the formation of mature osteoclasts in 
vitro directly from osteoclast precursors, eliminating the need of a co-culture system (PBMC 
and UMRS 106 rat osteoblast like cells). The major advantage of this method is that only one 
cell type is used and the final osteoclast culture is free of osteosarcoma cells [5]. RANKL and 
MCSF induce gene expression for tartrate-resistant acid phosphatase (TRAP), cathepsin K 
(CATK), calcitonin receptor and αvß3-integrin (vitronectin receptor) which are characteristic 
of mature osteoclasts [4]. Therefore, in vitro osteoclasts can be identified by TRAP staining (a 
characteristic shared with macrophages), multinuclearity, formation of an actin ring structure, 
a polar cell body during resorption and by the presence of avß3 integrin [5, 10]. This integrin 
belongs to the superfamily of adhesion proteins, named as “vitronectin receptor” because it 
binds to the plasma protein vitronectin [10]. In osteoclasts, avß3 is the predominant integrin 
quantitatively and functionally, and it can mediate the recognition of several RGD bone 
matrix proteins [10]. 
The biomaterials are designed to fulfil a purpose, in the case of bone regeneration; 
they should stimulate the proliferation and differentiation of osteoblast cells, leading to the 
formation of “new bone”. And they also should be resorbed by cellular mechanism to keep 
the normal balance between bone formation and resorption. It has been shown that is possible 
to assess the resorbability of biomaterial by cellular mechanisms in vitro [1, 11, 12]. Schiling 
et al reported that PMMA can not be resorbed by osteoclasts as no resorption pits were 
visualized, although these features were present on the surface of calcium phosphate materials 
indicating the its resorbability by osteoclasts [1]. Doi et al reported that the incorporation of 
carbonate ions increased the osteoclast resorption in vitro [11]. Patel et al reported similar 
results in vivo, in this case the incorporation of carbonate ions to the HA lattice increased the 
number of multinucleated phagocytic cells resembling osteoclast, in close proximity or 
directly on the surface of carbonate hydroxyapatite, indicating that this material was resorbed 
by cellular mechanisms under physiologic conditions [13].  
In previous studies we demonstrated that the incorporation of silicon into the HA 
lattice increases osteoblast proliferation and differentiation [14] and Gibson et al reported that 
the presence of this ion increases the metabolic activity of osteoblast-like cells in vitro [15]. 
Patel et al showed an increase in bone apposition/ingrowth related to the concentration of 
silicon incorporated into the HA lattice, although no osteoclast like cells were observed on the 
surface or proximity of this material [13]. Therefore, the aim of this study was to assess the 
effect of silicon incorporation into hydroxyapatite (HA), on the differentiation of 
mononuclear cells into mature osteoclasts, using two different precursor populations; PBMC 
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and monocytes expressing the CD 14 antigen and to determine if this material can be resorbed 
by osteoclasts.  
  
Material and Methods 
 
Hydroxyapatite (HA) and silicon-substituted hydroxyapatite (Si-HA) were prepared by 
a chemical precipitation route; the protocol is fully described elsewhere [16-18]. Sintered 
powders of the HA and Si-HA materials were prepared by compacting the as-precipitated 
powders and sintering at 1300ºC. The samples were sterilized by heat, 180 º C for a period of 
2 hours. 
  Two different osteoclasts precursors were used; peripheral blood mononuclear cells 
(PBMC) and CD 14 positive monocytes (CD14+), as described below. 
 
Peripheral blood mononuclear cells 
 The peripheral blood mononuclear cells were isolated from a buffy coat obtained from 
the blood of healthy donors. Buffy coat cells were diluted in phosphate buffer solution (PBS) 
and transferred to tubes containing Histopaque-1077® (Sigma-Aldrich, Poole, UK), that 
allows the separation of erythrocytes, neutrophils, platelets and PBMC by density and the 
protocol is fully described elsewhere [19]. The end product is a mix culture of monocytes, 
platelets and lymphocytes. 
  The cells were suspended in α – MEM medium with 10 % (v/v) human AB serum, 1 
% (v/v) Glutamine and 30 µg/mL vitamin C (attachment medium). They were seeded at a 
concentration of 2 x 106 cells/mL and allowed to attach for 2 hours, at 37 ºC in a 5 % CO2 
atmosphere. After this period the non-adherent cells were washed off and 250 µL of 
attachment medium containing 25 ng/mL of MCSF and 30 ng/mL of RANKL was added. 
Experimental samples will be referred to as HA OC; 0.8 wt % Si-HA OC and 1.5 wt % Si- 
HA OC. After 2 hours of attachment a set of samples (n=3, for each material) was stained 
with toluidine blue to visualize the nucleus. The cells were visualized using a light 
microscope.  
The medium was changed every three days for a period of 21 days and analyzed for 
calcium (Ca2+) and phosphate (PO43-) using a colorimetric assays, calcium flex® reagent 
cartridge and phosphorous® reagent cartridge from Dade Behring, respectively.  
Two different controls were used: a) the samples without cells were incubated only in 
attachment medium (referred to as HA, 0.8 wt % Si-HA and 1.5 wt % Si-HA) and, b) the 
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samples were incubated with 2 x 106 cells/mL of PBMC, but only in attachment medium, 
without cytokines (designated as HA PBMC; 0.8 wt % Si-HA PBMC and 1.5 wt % Si-HA 
PBMC).  
Following 21 days of culture the medium was removed and the samples washed with 
phosphate buffer saline solution (PBS), after which the cells were fixed for 5 minutes in 4 % 
paraformaldehyde and stained for TRAP [20]. The substrate was naphtol AS-BI phosphate 
(Sigma-Aldrich, Poole, UK). Tartrate resistance was assessed in the presence of 0.05 M 
sodium tartrate.  
 
CD 14+  
The first step to obtain a pure culture of CD14 + is the same as described above, but 
with the addition of a magnetic separation step. After centrifugation with histopaque the cells 
were labelled with magnetic microbeads® presenting anti-CD 14 antibodies and placed in a 
magnetic column (Miltenyi Biotec Ltd., Bisley, UK), where the CD14+ cells were retained by 
the column. Following removal from the magnetic source the column was washed with a 
Macs Buffer® (Miltenyi Biotec) and the CD14+ cells were collected. The cells were seeded at 
2 x 106 cells/mL and incubated for a period of 2 hours in attachment medium at 37 º C in a 5 
% CO2 atmosphere. After this period the non-adherent cells were washed off and 250 µL of 
attachment medium containing 25 ng/mL of MCSF and 30 ng/mL of RANKL was added for a 
period of 21 days, (the experimental samples will be referred to as HA OC; 0.8 wt % Si-HA 
OC and 1.5 wt % Si-HA OC). Two different controls were used a) the cells were seeded at 2 x 
106 cells/mL with attachment medium but no added cytokines (referred to as HA NC; 0.8 wt 
% Si-HA NC and 1.5 wt % Si-HA NC), b) the cells were also seeded at 2 x 106 cells/mL with 
attachment medium plus 25 ng/mL of MCSF (samples designated as HA MCSF; 0.8 wt % Si-
HA MCSF and 1.5 wt % Si-HA MCSF).  
The medium was changed every seven days for a period of 21 days and analyzed for 
calcium (Ca2+) and phosphate (PO43-) using a colorimetric assay.  
After 21 days, the cells were fixed in 4 % paraformaldehyde/phosphate buffered saline 
solution, pH 7.4 at room temperature for 15 min. Using imunocytochemistry the cells were 
stained with Phalloidin FITC (1µg/mL), which binds to F-actin. The “vitronectin receptor” 
was identified using a primary mouse antibody against avß3, and a secondary antibody 
conjugated to TRITC to demonstrate vitronectin receptors (681µg/mL). The nuclei were 
stained using 4`,6 – diamidino-2-phenylindole – DAPI (20µg/mL). The fluorescent stains 
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were visualised using fluorescence microscopy (FM) and confocal laser scanning microscopy 
(CLSM).  
 
Statistical analysis  
All results were statistically evaluated by ANOVA and post-hoc testing with 





Peripheral blood mononuclear cells 
After 2 hours of incubation mononuclear cells attached at the surface of all materials. 





















Figure 1- Distribution of the adherent PBMC on the HA (a), 0.8 wt% Si-HA (b) and 1.5 wt% 
Si-HA (c) after 2 hours of incubation. i) platelets and ii) the nucleus of mononuclear cells 
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On the HA surface the cells were sparser than on Si-HA (Figure 2). Although, the 
difference of adherent cells between the materials did not reach statistical significance. These 
results support previous ones where a similar trend was observed regarding the adhesion of 
human osteoblasts, the 0.8 wt % Si-HA promoted greater adhesion and proliferation of human 
osteoblasts compared to HA [14]. Further research showed that 0.8 wt % Si-HA not only 
shows higher osteoblast adhesion when compared to HA but also when compared to 1.5 wt % 








Figure 2 – Number of adherent PBMC per mm2 after 2 hours of incubation. 
 
 
After a period of 21 days the culture was terminated. The cells on the surface of the 
three materials showed typical features of osteoclasts, they were multinucleated (white arrow) 













Figure 3 - Multinucleated, TRAP positive cells on the surface of a) HA; b) 0.8 wt % Si-HA 
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To evaluate the resorption ability of the osteoclasts the calcium and phosphate release 
to the medium was measured in the three experimental conditions.  
The calcium release from HA to the medium was similar in all the three experimental 
conditions (Figure 4a); HA in attachment medium, HA PBMC and HA OC. Although, a slight 
increase in the phosphate concentrations was observed from the samples containing 
osteoclasts at day 19 (Figure 4b), it was not statistical significant and furthermore, the trend of 
phosphate release between the controls and the experimental samples is exactly the same. 
Therefore, it is not possible to conclude that the slight increase in phosphate release is due to 



















Figure 4 – Calcium (a) and phosphate (b) concentration in the medium at different points 
concentration, for the HA controls and the HA with osteoclasts (n=3). 
 
The behaviour of the osteoclasts on the 0.8 wt % Si-HA surface differs from HA, in 
this case at day 19 a slight increase on the calcium content in the medium with osteoclasts 
was detected, although it did not reach a statistical significance (Figure 5a). While the 
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observed with the controls 0.8 wt % Si-HA – 1.10 mmol/L, p<0.007; 0.8 wt % Si-HA PBMC 
– 1.11 mmol/L, p<0.045 and 0.8 wt % Si-HAOC – 1.42 mmol/L (Figure 5b). This, could 






















Figure 5 – Calcium (a) and phosphate concentration (b) in the medium at different points 
concentration, for the 0.8 wt % Si-HA controls and the 0.8 wt % Si-HA sample with 
osteoclasts. (* - statistical different p<0.05, n=3) 
 
The calcium concentration in the medium from the experimental sample 1.5 wt % Si-
HA OC, at day 19, was significantly higher when compared to the control samples (Figure 
6a), 1.5 wt % Si-HA – 1.88 mmol/L p<0.002; 1.5 wt % Si-HA PBMC – 1.89 mmol/L p<0.003 
and 1.5 wt % Si-HAOC – 2.39 mmol/L. A similar result was observed for the phosphate 
(Figure 6b), 1.5 wt % Si-HA – 1.10 mmol/L p<0.001; 1.5 wt % Si-HA PBMC – 1.11 mmol/L 
p<0.001 and 1.5 wt % Si-HAOC – 1.42 mmol/L. Once again this result could indicate that the 
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Figure 6 – Calcium (a) and phosphate (b) concentration in the medium at different points 
concentration, for the 1.5 wt % Si-HA controls and the 1.5 wt % Si-HA sample with 
osteoclasts.  (* - statistical difference p<0.05, n = 3) 
 
 When comparing the samples with osteoclasts from the three materials at day 19, an 
increase in calcium and phosphate concentration in the medium with the increase of the 
silicon content. A statistical difference between HA and 1.5 wt % Si-HA (calcium p<0.007; 
phosphate p<0.001) was detected. Although, no statistical significant difference was observed 
between 0.8 wt % Si-HA and HA or between the two compositions of Si-HA.  
 
CD14+ 
 A similar analysis protocol was followed with the CD 14 + cultures, although in this 
case the osteoclast markers, actin rings and vitronectin receptor were assessed in addition to 
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 After 21 days, most of the cells present at the surface of the 3 materials were TRAP 
positive and multinucleated. The localization of actin distribution using FITC – labelled 
phalloidin demonstrated the characteristic actin ring on the surface of HA and Si-HA. Very 
few cells differentiated on the controls surface (NC or MCSF) or formed actin rings, as it can 
be seen in the images of fluorescence microscopy (Figure 7). One the other hand, most of the 
cells on the surface of the experimental samples presented actin rings, although some of them 
had discontinuities. They were positive for vitronectin (Figure 8) and several nuclei were 






















Figure 7 – Fluorescence microscopy showing few cells with actin rings (white arrow). a – 
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Figure 8 – Fluorescence microscopy image of the actin rings and vitronectin of 
multinucleated cells (osteoclasts), on the HA surface, after 21 days. a – actin ring; b – 
vitronectin; c- co-localization of the vitronectin receptor and actin ring; d – nuclei, 
discontinuities (white arrow) 
 
Similar results were obtained for Si-HA; the cells were multinucleated, presented actin 
rings, most of them complete and they also presented podosomes rich in vitronectin. The cells 
showed to be positive for vitronectin and were multinucleated. On both compositions a large 


















Figure 9 – A detail of the osteoclast on the surface of 0.8 wt % Si-HA (a,b,c) and 1.5 wt % 
Si-HA (d,e,f) after 21 days. a,d – actin rings; b,e – vitronectin; c,f – nuclei. 
 
As mentioned before osteoclasts are actively migrating cells, and they can form 
microfilaments called podosomes, which are rich in vitronectin receptor αvβ3. The 
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more detail by CLSM (Figure10). This fact could indicate that the osteoclasts are entering the 
resorption phase. It can be seen in the CLSM images that some cells on the surface on Si-HA 
formed podosomes (Figure 10 c,d white arrows). The localization of the microfilaments 
showing the actin ring is very important, because they reflect the osteoclast phases, migration 


























Figure 10 – Confocal laser microscopy images of the actin rings and vitronectin receptors of 
multinucleated cells – osteoclasts, on the 0.8 wt % Si-HA(a,c) and 1.5 wt % Si-HA (b,d) 
surfaces, after 21 days. a,b  – actin rings; c,d – vitronectin (white arrow indicate podosomes) 
 
The results obtained regarding the calcium and phosphate release were similar to these 
described previously for the PMBCs. The calcium and phosphate concentrations were 
analysed at every medium change until the final day of culture.  
In this case earlier phosphate release into the medium of HA OC was observed, as 
soon as day 8 (Figure 11a). At day 21 a slight increase in the phosphate into the medium 
containing osteoclasts. A similar trend was observed for calcium, HA NC – 1.88 mmol/L; HA 
MCSF – 1.88 mmol/L and HA OC – 1.97 mmol/L (Figure 11b). Even though, none of these 


























Figure 11 – Phosphate (a) and calcium (b) concentration in the medium at different points 
concentration, for the HA controls and the HA sample with osteoclasts (n = 3). 
 
 A higher concentration of phosphate was observed at day 8, 15 and 21 from the 
samples containing 0.8 wt % Si-HA OC, but when compared to the controls these were not 
statistically significant (Figure 12a). Once again, a higher release of calcium was observed by 
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Figure 12 – Phosphate (a) and calcium (b) concentration in the medium at different points 
concentration, for the 0.8 wt % Si-HA controls and the 0.8 wt % Si-HA sample with 
osteoclasts 
 
In the case of 1.5 wt % Si-HA the release of phosphate was significantly higher at day 
15, when compared with the controls (Figure 13a); 1.5 wt % Si-HA NC - 1.07 mmol/L, 
p<0.014; 1.5 wt % Si-HA MCSF – 1.06 mmol/L p<0.011 and 1.5 wt % Si-HA OC – 1.27 
mmol/L. While, the increase observed at the same time point for calcium it did not reach 
statistical significance (Figure 13b). At day 21 the calcium and phosphate content in the 1.5 
wt % Si-HAOC medium was significantly higher than the controls (calcium – 1.5 wt % Si-
HA NC – 1.77 mmol/L, p<0.001; 1.5 wt % Si-HA MCSF – 1.86 mmol/L, p<0.001; and 1.5 wt 
% Si-HA OC – 2.58 mmol/L; phosphate – 1.5 wt % Si-HA NC – 1.06 mmol/L, p<0.001;  1.5 
wt % Si-HA MCSF – 1.17 mmol/L, p<0.001; 1.5 wt % Si-HA OC – 1.57 mmol/L). These 

































































Figure 13 – Phosphate (a) and calcium (b) concentration in the medium at different points 
concentration, for the 1.5 wt % Si-HA controls and the 1.5 wt % Si-HA sample with 
osteoclasts. (* - statistical difference p < 0.05, n = 3) 
 
Once again the calcium and phosphorous concentration of the experimental samples 
increased with the increase in silicon content. When comparing the three materials, the 
calcium and phosphate content in the medium of 1.5 wt % Si-HA OC at day 21 was 
significantly higher than for HA OC and 0.8 wt % Si-HA OC (calcium - HA OC p<0.001; 0.8 
wt % Si-HA OC p<0.001; phosphate - HA OC p<0.001; 0.8 wt % Si-HA OC p<0.015). No 





 Through this study, it was possible to demonstrate that HA and Si-HA allows the 
differentiation of PBMC and CD 14 + selected mononuclear cells into mature osteoclasts. 
Most of the cells on the surface of the materials expressed osteoclastic markers: actin rings, 
multinuclearity, expressed TRAP and presented vitronectin receptors. Although, some of 
these markers are expressed by other cell types such as macrophages, according to Monchau 
et al the formation of an actin ring is the best in vitro method to confirm the osteoclastic 
phenotype [21]. In the fluorescence images it was possible to see the podosomes. It is through 
this structure that osteoclasts adhere to the surface, which originates in an intramembranous 
integrin (αvβ3). These molecules act as an intermediate between the extracellular matrix 
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integrins through complex focal adhesion contacts containing several proteins in a ring shape 
at the periphery of the cell [22, 23]. In the fluorescence images it was possible to observe this 
structure, the actin ring, in the experimental samples. It is under this actin ring that the 
osteoclast makes a tight contact with the surface, followed by the secretion of protons and 
proteases, that will dissolve the bone crystals or the ceramic samples, as in this in vitro study 
[22, 23]. The resorption products are endocytosed from the ruffled border and then 
transcytosed and released at the functional secretory domain in the top of the osteoclast basal 
membrane [24, 25]. Some of the actin rings presented discontinuity, which could be due to the 
change in the osteoclast phase, resorption to migration or a decrease in the cellular activity 
[21]. When the osteoclast is changing from the non-resorbing to the resorbing stage a large 
reorganization takes place, in the first stage of the resorption cycle actin and vinculin are 
distributed throughout the podosomes. In the next stages these structures coalesce to a specific 
area of the osteoclast and the actin and vinculin stains dissociate. These changes are important 
because they reflect the cells interaction with the extracellular environment [26]. 
To ensure that the calcium and phosphate measured in the medium was related to the 
osteoclastic activity and not related to either acellular degradation or non-osteoclast cell 
activity several controls were performed. Each ceramic was simultaneously exposed to culture 
medium alone (without cells) and with cells but no cytokines (first experiment) and on the 
second experiment a different control was added; the samples were incubated with cells plus 
MCSF, to verify that resorption occurs only in the presence of osteoclasts. In this second 
control only MCSF was added and no RANKL, to avoid the differentiation of osteoclasts 
precursors into mature osteoclasts. Several studies have demonstrated the importance of 
RANKL for the differentiation and activation of osteoclasts precursors. It has been 
demonstrated that RANKL is fundamental for osteoclastogenesis and that this phenomenon 
can be affect by several factors, namely MCSF, interkukin-1, transforming growth factor-β, 
tumour necrosis factor-α, interlukin-6, vitamin D3 and parathyroid hormone. Although, all 
these cytokines are very important, they cannot induce the differentiation of osteoclasts 
precursors alone [27-31]. The ability of TNF-α to induce osteoclastogenesis is still 
controversial, it has been shown that TNF-α, can induce osteoclastogenesis, but by the 
stimulation of osteoblast/stromal cells to produce RANKL [32] or  if this cytokine acts 
directly on osteoclasts precursors at least a small amount of RANKL must be present [32]. 
RANKL has the ability to induce osteoclastogenesis in the presence of MCSF [28]. RANKL 
acts on osteoclasts precursors through a membrane receptor, RANK (receptor activator of NF-
κβ) activating osteoclastogenesis, although if binds to the decoy receptor osteoprotegerin 
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(OPG) osteoclastogenesis will be inhibit [28]. It has been established that MCSF is involved 
in the proliferation and survival of osteoclast progenitors and osteoclasts, but it does not 
stimulate their resorbing activity [7, 33].  
 The analyses of the culture medium from the experimental samples showed significant 
differences. 1.5 wt % Si-HA had higher concentrations of calcium and phosphate in the 
medium from the samples containing osteoclasts when compared between the three materials 
and the controls, with the exception of 1.5 wt % Si-HA and 0.8 wt % Si-HA using PBMC as a 
starting culture, which indicates that the osteoclasts were active and resorbing on 1.5 wt % Si-
HA. Similar increases in the calcium and phosphate in the medium was reported by Zhang et 
al, when he seeded mature osteoclasts on the surface of bioglass [34]. In the case of 0.8 wt % 
Si-HA a higher increase in phosphate was observed in both cultures. No significant difference 
was observed between HA and 0.8 wt % Si-HA. The difference between the results obtained 
in the two starting cultures, PBMC and CD14+, could be due to the presence of a mixed 
population of cells in the case of PBMC, only a small fraction of which are CD14+.  
From these results it seems that HA is likely to be less resorbable in vitro, although 
other studies have shown evidences of resorption on HA [35, 36]. Several factors can 
influence the osteoclastic resorption, such as: sintering temperature, porosity, grain size and 
experimental conditions [11, 36]. 
It seems that there is an increased resorption from the Si-HA materials compared to 
HA. Similar results were obtained by Langstaff et al where it was demonstrated that a silicon-
stabilized calcium phosphate coating and bulk ceramic showed evidence of osteoclast 
resorption, while no evidence of cellular resorption was observed on the HA samples [12]. 
Although Patel et al did not reported the presence of osteoclast-like cells in vivo [13], we 
were able to demonstrate that Si-HA material can be resorbed by cellular mechanisms and 
that silicon has a positive effect on osteoclast activity, although the mechanism behind this is 
still unknown and further studies are required. 
 The primary objective for synthetic bone substitute research is the development of an 
implantable material which combines initial rapid healing with the subsequent capability to be 
progressively resorbed by osteoclasts during normal continuous tissue remodelling [12]. So, 











 HA and Si-HA allow the differentiation of osteoclast precursors into mature 
osteoclasts. A higher release of calcium and phosphate into the medium from the 1.5 wt % Si-
HA OC indicates higher osteoclast activity. Therefore, Si-HA can be resorbed by osteoclasts. 
 Silicon can have a stimulatory effect on osteoclasts, although the underlaying 




The authors would like to acknowledge to Fundação para a Ciência e Tecnologia 
(FCT) for CM Botelho’s grant (ref. SFRH/BD/6173) and the project entitled “Coatings with 




1. Schilling A, Linhart W, Filke S, Gebauer M, Schinke T, Rueger J, et al. Resorbability of 
bone substitute biomaterials by human osteoclasts. Biomaterials 2004;25(18):3963-3972. 
 
2. Miller P, Baram D, Bilezkian J, Greenspan S, Lindsay R, Riggs B, et al. Practical clinical 
application of biochemical markers of bone turnover - Consensus of an Expert Panel. Journal 
of Clinical Densitometry 1999;2(3):323-342. 
 
3. Flanagan A, Massey H, Wilson C, Vellodi A, Horton MA, Steward C. Macrophage colony-
stimulating factor and receptor activator NF-kappa B ligand fail to rescue osteoclast-poor 
human malignant infantile osteopetrosis in vitro. Bone 2002;30(1):85-90. 
 
4. Boyle W, Simonet W, Lacey DL. Osteoclast differentiation and activation. Nature 
2003;423(6937):337-342. 
 
5. Susa M, Luong-Nguyon NH, Cappellen D, Zamurovic N, Gamse R. Human primay 
osteoclasts in vitro generation and applications as a pharmacological and clinical assay. 
Journal of Translational Medicine 2004;2:6. 
 
6. Anderson D, Maraskovsky E, Bilingsley W, Dougal W, Tometsko M, Roux E, et al. A 
homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell 
function. Nature 1997;390(6656):175-179. 
 
7. Matsuzaki K, Udagawa N, Takahashi N, Yamaguchi K, Yasuda H, Shima N, et al. 
Osteoclast differentiation factor (ODF) induces osteoclast-like cell formation in human 
In Vitro Biological Characterisation - Chapter 4 
 
 158
peripheral blood mononuclear cell cultures. Biochemical and Biophysical Research 
Communications 1998;246(1):199-204. 
 
8. Quinn J, Elliot J, Gillespie M, Martin T. A combination of osteoclast differentiation factor 
and macrophage-colony stimulating factor is sufficient for both human and mouse osteoclast 
formation in vitro. Endocrinology 1998;139(10):4424-4427. 
 
9. Massey H, Flanagan A. Human osteoclasts derive from CD14-positive monocytes. British 
Journal of Haematology 1999;106(1):167-170. 
 
10. Horton M. The αvβ3 integrin ''vitronectin receptor''. The International Journal of 
Biochemistry & Cell Biology 1997;29(5):721-725. 
 
11. Doi Y, Shibutani T, Moriwaki Y, Kajimoto T, Iwayama Y. Sintered carbonate apatites as 
bioresorbable bone substitutes. Journal of Biomedical Materials Research. 1998;39:603-610. 
 
12. Langstaff S, Sayer M, Smith T, Pugh S. Resorbable bioceramics based on stabilized 
calcium phosphates. Part II: evaluation of biological response. Biomaterials 2001;22(2):135-
150. 
 
13. Patel N, Gibson IR, Hing KA, Damien E, Revell PA, Best SM, et al. A comparative study 
on the in vivo behaviour of hydroxyapatite and silicon-substituted hydroxyapatite granules. 
Journal of Materials Science: Materials in Medicine 2002;13:1199-1206. 
 
14. Botelho CM, Brooks RA, Best SM, Lopes MA, Santos JD, Rushton N, et al. Biological 
and physical-chemical characterization of phase pure hydroxyapatite and silicon-substituted 
hydroxyapatite by different microscopy techniques. Key Engineering Materials 2004;254-
256:845-849. 
 
15. Gibson IR, Hung J, Best SM, Bonfield W. Enhanced in vitro cell activity and surface 
apatite layer formation on novel silicon-substituted hydroxyapatites. In: Ohgushi H, Hastings 
GW, Yoshikawa T, editors. Bioceramics 12; Nara, Japan: World Scientific Publishing Co. 
Pte. Ltd; 1999. p. 191-194. 
 
16. Jha LJ, Best SM, Santos JD, Gibson IR, Bonfield W, Jha LJ, Best SM, Santos JD, Gibson 
IR, Bonfield WJha LJ, Best SM, Santos JD, Gibson IR, Bonfield W; Silicon-substituted 
apatites and process for the preparation thereof. Worldwide patent PCT/GB97/02325. 1999. 
 
17. Gibson I, Best SM, Bonfield W. Chemical characterization of silicon-substituted 
hydroxyapatite. Journal of Biomedical Materials Research. Part B, Applied Biomaterials 
1999;44(4):422-428. 
 
18. Botelho CM, Lopes MA, Gibson IR, Best SM, Santos JD. Structural analysis of Si-
substituted hydroxyapatite: zeta potential and X-ray photoelectron spectroscopy (XPS). 
Journal of Materials Science: Materials in Medicine 2002:1123-1127. 




19. Winchester RJ, Ross G. Methods for enumerating lymphocyte populations. In: Rose NR, 
Friedman H, editors. Manual of clinical immunology. Washington DC: American society for 
microbiology; 1976. p. 64-76. 
 
20. Burstone MS. Histochemical demonstration of acid phosphatases with naphthol AS-
phosphate. Journal of National Cancer Institute 1958;21:423-539. 
 
21. Monchau F, Lefevre A, Descamps M, Belquin-myrdyez A, Laffargue P, Hildebrand HF. 
In vitro studies of human and rat osteoclast activity on hydroxyapatite, beta-tricalcium 
phosphate, calcium carbonate. Biomolecular engineering 2002;19(2-6):143-152. 
 
22. Chambers TJ. The regulation of osteoclastic development and function. Ciba Foundation 
Symposium 1988;136:92-107. 
 
23. LakkaKorpi P, Tuukkanen J, Hentunen J, Jarvelin K, Vaananen K. Organization of 
osteoclast microfilaments during the attachment to bone surface in vitro. Journal of Bone and 
Mineral Research 1989;4(6):817-825. 
 
24. Nesbitt S, Horton MA. Trafficking of matrix collagens through bone-resorbing 
osteoclasts. Science 1997;276(5310):266-269. 
 
25. Salo J, Lehenkari P. Removal of osteoclast bone resorption products by transcytosis. 
Science 1997;276(5310):270-273. 
 
26. Vaananen K, Horton MA. The osteoclast clear zone is a specialized cell extracellular 
matrix adhesion structure. Journal of Cell Science 1995;108:2729-2732. 
 
27. Kong YY, Feige U, Sarosi I, Bolon B, Tafuri A, Morony S, et al. OPGL is a key regulator 
of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 
1999;402:304-309. 
 
28. Wittrant Y, Thepleyre S, Couillaud S, Dunstan C, Heymann D, Rédini F. Relevance of an 
in vitro osteoclastogenesis system to study receptor activator of NF-kappa B ligand and 
osteoprotegerin biological activities. Experimental cell research 2004;293(2):292-301. 
 
29. Heymann D. gp130 cytokine family and bone cells. Cytokine 2000;12(10):1455-1468. 
 
30. Heymann D, Gouin F, Passuti N, Daculsi G. Cytokines, growth factors and osteoclasts. 
Cytokine 1998;10(3):155-168. 
 
31. Burgess T, Qian Y, Kaufman S, Ring B, Van G, Capparelli C, et al. The ligand for 
osteoprotegerin (OPGL) directly activates mature osteoclasts. The Journal of Cell Biology 
1999;145(3):527-538. 
In Vitro Biological Characterisation - Chapter 4 
 
 160
32. Teitelbaum S. Bone resorption by osteoclasts. Science 2000;289(5484):1504-1508. 
 
33. Udagawa N, Takahashi N, Jimi E, Matsuzaki K, Tsurukai T, Itoh K, et al. 
Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast 
differentiation factor/RANKL but not macrophage colony-stimulating factor. Bone 
1999;25(5):517-523. 
 
34. Zhang YM, Cai YR, Monchau F, Lefevre A, Zhao YM, Hildebrand HF. Biodegradation 
of synthetic bioglass with different crystallinity in vitro. In: 7th World Biomaterials Congress; 
2004; Sydney; 2004. p. 1904. 
 
35. Gomi K, Lowenberg B, Shapiro G, Davies JE. Resorption of sintered synthetic 
hydroxyapatite by osteoclasts in vitro. Biomaterials 1993;2:91-96. 
 
36. De Bruijin JD, Bovel YP, Davies JE, Van Blitterswijik CA. Osteoclastic resorption of 
calcium phosphate is potentiated in postosteogenic culture conditions. Journal of Biomedical 






General Discussion and Main Conclusion  
General Discussion and Main Conclusion – Chapter 5 
 162
Discussion and Main Conclusion 
 
 In this thesis we proposed to assess the effect of silicon incorporation into the 
hydroxyapatite (HA) lattice, focusing mainly on the biological response to the material in 
vitro.  
 Previous studies showed that the incorporation of silicon into the HA lattice induced 
few structural changes, namely on the lattice parameters, a decrease in the a axis and an 
increase on the c axis and also an increase on the distortion index of the phosphate (PO43-) 
group, indicating that the PO43- group is replaced by the silicate (SiO44-) group. The presence 
of silicon into the structure of HA did not induce the formation of secondary phases, or 
influence the crystallinity of the material [1]. It was also shown that the silicon-substituted 
hydroxyapatite (Si-HA) has an enhanced bioactivity in vitro [2] an in vivo [3-5].  
Looking at the previous studies the main question was: how does silicon affects the 
biological response to HA? The complexity of the in vivo system makes it difficult to 
determine the mechanism behind the enhanced bioactivity. Therefore, the study reported in 
this thesis focused on different in vitro tests, principally on the interaction of silicon-
substituted hydroxyapatite (Si-HA) with proteins and human bone cells. 
The formation of an apatite layer is considered to be an important factor for 
osseointegration, being related to the materials dissolution kinetics and its physical-chemical 
properties. So, in this work we started by characterising the Si-HA on a physical-chemical 
point of view. Our results showed that the Si-HA material has a higher electrophoretic 
mobility than HA, resulting in a more negative zeta potential. The Fourier transformed infra-
red analysis (FTIR) and X-ray photoelectron spectroscopy (XPS) clearly support the 
substitution mechanism proposed by Gibson et al [1], according to the author the SiO44- group 
substitutes for the PO43- group and due to a charge balance some hydroxyl (OH-) groups are 
lost. The binding energy at 101 eV (Si-O bonding) confirms conclusively that silicon exists as 
a tetrahedral silicate (SiO44-), rather than as a polymeric or as a SiO2 form. This finding 
supports the analogy between silicon or silicate substitution and the well-characterized 
carbonate (CO32-) substitution of PO43- groups in HA. The decrease of the peak at 631 cm-1 on 
the FTIR spectra confirms the loss of the OH- group due to the charge balance. The bands at 
888 cm-1 and 504 cm-1, also confirmed the presence of a SiO44- group. The incorporation of 
silicon increased the hydrophilicity of the material and consequently its interfacial tension, 
through an increase on its polar component. Although, the difference on the hydrophilicity 
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between the HA and Si-HA did not reach statistical significance, they corroborate the zeta 
potential results. Therefore, the increased hydrophilicity may be due to the presence of 
unsaturated Si-O bonds leading to the formation of Si-OH bonds in the presence of an 
aqueous medium.  
The Si-HA material has a higher dissolution rate when compared to HA. When 
incubated in SBF, the incorporation of silicon into the HA lattice decreased the time required 
for the formation of an apatite layer in 64% and 75%, for 0.8 wt% Si-HA and 1.5 wt% Si-HA, 
respectively. Similar results were reported by Gibson et al [1] and Thian et al [6]. Following 
the analysis of our results we proposed that the formation of an apatite layer on the surface of 
Si-HA is a combination of two factors, dissolution and surface charge. The greater solubility 
of Si-HA causes a faster super-saturation of the SBF solution followed by a faster 
precipitation of an apatite layer from super-saturated SBF. In addition, the surface properties 
of the HA and Si-HA ceramics may control the time scale for the change from dissolution to 
apatite precipitation. The more electronegative Si-HA surface provides a preferential site for 
nucleation of an amorphous calcium phosphate apatite layer than the HA surface. This can 
occur via the adsorption of calcium (Ca2+) ions onto the electronegative surface, resulting in 
an increase on the surface charge and the attraction of PO43- groups. 
Using atomic force microscopy (AFM) and AFM phase imaging it was possible to 
observe that there is a preferential dissolution at the grain boundaries of the Si-HA material. 
Energy dispersive X-ray (EDX) and XPS analysis showed that silicon is preferentially 
dissolved from the material surface to the surrounding media. Gibson et al [1] reported that 
silicon substitution caused a substantial increase on the distortion index of the PO43- group 
and a decrease on the number OH- groups. It is possible that these disturbances and the 
vacancies at the OH- site may lead to higher susceptibility for SiO44- to be released from the 
structure. Porter et al demonstrated that the incorporation of silicon into the HA lattice 
increased the number of grain boundaries and triple junctions. The Si-HA sample containing 
higher concentration of silicon (1.5wt%) has a less crystalline phase on the triple junctions [7]. 
Therefore, we proposed that silicon is preferentially located at the grain boundaries.  
As mentioned previously the formation of an apatite layer is considered to be an 
important step for osseointegration and in the in vivo environment there is the presence of 
several biological molecules such as proteins. So, we studied the effect of human serum 
proteins on the formation of the apatite layer. Our results showed that the presence of proteins 
delayed the formation of an apatite layer in all substrates. Through, the AFM phase imaging it 
was possible to see a layer with different characteristics from the ceramic material on the 
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surface of the samples incubated with human serum proteins. The XPS analysis confirmed 
that this layer was a protein film due to the increase on nitrogen content. We hypothesised 
that the protein layer prevents the diffusion of ions from the surface of the material to the 
surrounding medium. This hypothesis was confirmed by inductively couple plasma 
spectroscopy (ICP), since we demonstrated that in the presence of human serum proteins a 
lower concentration of silicon was released to the medium from 0.8 wt% Si-HA and 1.5 wt% 
Si-HA. 
It has been reported in the literature that cells respond mainly to the proteinaceous 
layer on the surface of the material rather than to the biomaterial itself [8]. So, the adhesion of 
total human serum proteins and individual proteins to Si-HA was studied. 0.8 wt% Si-HA has 
a higher binding capacity for total human serum proteins when compared to HA and 1.5 wt% 
Si-HA. IgG, albumin and collagen type I have different binding affinities to the materials. 
Collagen type I has higher binding affinity to Si-HA and its affinity increased with the 
increase of the silicon content. IgG has lower affinity to the materials, followed by albumin. 
The pattern of adsorbed proteins observed in this study can be explained by electrostatic 
interactions between the proteins and the substrates. The three proteins studied have different 
structures and different isoelectric points, therefore the overall net charge is different at pH 7, 
collagen type I has an overall positive charge, IgG has a slight negative charge and albumin 
has an even more negative charge. As mentioned previously the surface charge of Si-HA is 
more electronegative than HA, so the electrostatic interaction between the Si-HA and a 
protein is greater if a protein has an overall positive charge as in the case of collagen type I, 
followed by a lower binding affinity of IgG and albumin. In the case of the adhesion of a 
complex mixture of proteins there are other factors that can influence the adhesion such as, 
spatial charge distribution and the “Vroman effect”.  
Subsequently to the adhesion of proteins cells will reach the surface of the material. 
The osteoblasts are the cells responsible matrix deposition. Therefore, several experiments 
were carried out to assess the effect of Si-HA on the proliferation and differentiation of 
osteoblasts.  
Human osteoblasts (HOBS) were seeded on the surface of the HA and Si-HA material. 
A higher number of cells was observed on the surface of 0.8 wt% Si-HA when compared to 
HA and 1.5 wt% Si-HA. It is known that the adhesion of cells onto a substrate involves 
extracellular matrix proteins, cell membrane proteins and cytoskeleton proteins, which 
interact together to induce signal transduction, promoting the action of transcription factors 
and consequently regulating gene expression [9]. Although, the difference on the number of 
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adherent cells did not reached statistical significance, the trend observed is similar to that 
observed regarding the adsorption of human serum proteins, where 0.8 wt% Si-HA showed to 
have higher binding capacity, when compared to the other materials. So, the higher adhesion 
of total proteins may account for the increase number of HOBS adhering to the 0.8 wt% Si-
HA.  
The HOBS seeded on Si-HA for a period of 27 days expressed the osteoblast 
phenotype markers, collagen type I (COL I), alkaline phosphatase (ALP) and osteocalcin 
(OC). The cells were well spread and confluent in all materials. The HOBS seeded on 0.8 
wt% Si-HA expressed higher levels of proteins when compared to HA and 1.5 wt% Si-HA. 
The ALP/COL I ratio at day 7 expressed by the cells seeded on 1.5 wt% Si-HA indicated that 
the HOBS seeded on this material were at a higher stage of differentiation. Throughout, the 
culture period the osteoblastic markers expressed by the cells seeded on the samples with the 
higher concentration of silicon (1.5 wt%) was constant, while the cells seeded on 0.8 wt% Si-
HA expressed higher concentration of proteins at different time periods of the culture. 
Although, there is release of silicon from both materials the higher release of silicon at earlier 
time points may stimulate differentiation of HOBS, as it has been demonstrated by Reffitt et 
al [10] that silicon increases the expression of osteoblast markers like COL I, ALP and OC. 
Reffit et al [10] also reported that if the concentration of silicon is too high the positive effect 
of silicon maybe diminished. It has also been reported that a stable collagenous matrix is 
important for the progression of osteoblastic differentiation and is a prerequisite for an 
increase in the ALP expression [11-15] and we previously demonstrated that 1.5 wt% Si-HA 
has a higher binding capacity to collagen. After 21 days it was possible to observe mineral 
deposits on the surface of the materials, these deposits coincide with areas of high cell density 
indicating a cell mediated process.  
The ideal bone graft would be a material that can be resorbed and induce bone 
formation, hence being completely replaced by new bone. Bone is a dynamic organ due to its 
constant remodelling, being the osteoblasts responsible for producing the matrix and 
osteoclasts for resorbing it. It was shown that the Si-HA stimulates osteoblast proliferation 
and differentiation; therefore it was now important to assess the effect of this material onto 
osteoclast differentiation and activity. Peripheral blood mononuclear cells (PBMC) and CD 
14 positive monocytes (CD 14+) were seeded onto the surface of HA and Si-HA. The 
adhesion of PBMC showed a similar trend to the adhesion of human osteoblasts and total 
protein, namely more cells adhered to 0.8 wt% Si-HA. Both materials were capable of 
supporting the differentiation of PBMC and CD 14+ into mature osteoclasts. Most of the cells 
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on the surface of the materials expressed osteoclastic markers, such as: actin rings, several 
nuclei, expressed TRAP and presented vitronectin receptors [16, 17]. The osteoclasts present 
on the surface of the materials had podosomes. It is through this structure that osteoclasts 
adhere to the surface, which originates in an intramembranous integrin (αvβ3) [18, 19]. Some 
of the actin rings presented discontinuities, which could be due to a change in osteoclast 
behaviour, resorption to migration or a decrease in the cellular activity [20]. The analyses of 
the culture medium from the osteoclasts seeded on 1.5 wt% Si-HA, on which osteoclast 
development had been stimulated, showed a higher concentration of calcium and phosphate, 
when compared between the three materials and the controls, which indicates that the 
osteoclasts were active and resorbing.  
An increased resorption activity on Si-HA was observed when compared to HA. 
Therefore, it seems that silicon has a positive effect on osteoclast activity, but the cellular 
mechanism as several uncertainties.  
The results presented here show the role of Si-HA on several physical, chemical and 
biological processes. These studies indicate that the enhanced bioactivity of the Si-HA is a 
combination of acellular and cellular mechanisms. The more negative surface and higher 
dissolution rate decreases the time required for the formation of an apatite layer, which is 
considered to be an important factor for osseointegration. And also the enhanced proliferation 
and differentiation of bone cells (human osteoblast and osteoclast) induced by the presence of 
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